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Abstract 
AcrA is the periplasmic adaptor protein component of the major efflux system AcrB-TolC of 
Salmonella Typhimurium. AcrA of S. Typhimurium SL1344 was inactivated and the mutant 
phenotype characterised. RT-PCR and western blotting were used to confirm expression of 
acrB/AcrB was retained in the acrA mutant. The AcrA mutant was hyper-susceptible to a range of 
antimicrobials and was more susceptible to some agents than strains lacking AcrB and TolC. This is 
partially explained by the increase in accumulation of Hoechst H33342, a fluorescent substrate of 
AcrAB-TolC, indicating that the inactivation of acrA resulted in reduced efflux activity. Lack of AcrA 
also attenuated the ability of S. Typhimurium to infect INT-407 and RAW 264.7 cells in vitro as 
previously published for AcrB and TolC mutants. The virulence defect of the mutants could not be 
rescued by addition of supernatant from an infection of INT-407 cells with SL1344 or addition of 
media conditioned by uninfected INT-407 cells. However, addition of media conditioned by 
overnight growth of SL1344 was able to ameliorate the virulence defect of the mutants. This 
suggests that AcrAB-TolC of SL1344 exports a factor/s required for virulence which the mutants are 
unable to export and that exogenous addition of this factor can restore the virulent phenotype. 
Inactivation of acrA conferred a phenotype distinct to that of inactivation of acrB or tolC indicating a 
role for AcrA distinct to that of other protein partners in both efflux of substrates and virulence. 
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Chapter One 
Introduction  
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1. Introduction 
1.1 Salmonella  
The genus Salmonella is a member of the Enterobacteriaceae family of Gram-negative 
bacteria. The genus is comprised of two species: S. enterica and S. bongori. While S. bongori 
mainly infects cold-blooded animals, S. enterica is a common cause of infection in warm-
blooded animals. S. enterica is comprised of six subspecies: S. enterica subspecies enterica 
(I), S. enterica subspecies salamae (II), S. enterica subspecies arizonae (IIIa), S. enterica 
subspecies diarizonae (IIIb), S. enterica subspecies houtenae (IV), and S. enterica subspecies 
indica (VI) and has been classified into more than 2500 serovars according to the Kaufmann-
White classification system, based on agglutination reactions with antisera against specific 
Salmonella antigens (Kim et al., 2006). The majority of human and domestic animal 
infections are caused by only a few serovars including Typhimurium, Enteritidis and Typhi 
which cause very different illnesses. 
1.2 Salmonella Infection 
Every year Salmonella causes three billion human infections globally (Cooke et al., 2007). Of 
which, 22 million are caused by the obligate human pathogens Salmonella Typhi or Paratyphi 
which cause invasive systemic infections (Cooke et al., 2007). These result in 200,000 deaths 
every year, mainly in the developing world (Crump et al., 2004; WHO, 2008). Symptoms 
include acute fever, diarrhoea or constipation, severe abdominal pain and a maculopapular 
rash (Ohl and Miller, 2001) and is fatal in 10-15% of cases (Graham, 2002; CDC, 2007). It is 
significantly less common in the developed world with only 299 reported cases of S. Typhi 
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and 248 cases of S. Paratyphi A in England and Wales in 2008, the vast majority of which 
were contracted by travellers to endemic regions (Figure 1.1 a) (HPA, 2009). The remainder 
of the cases are caused by non-typhoidal Salmonella (NTS) serovars such as S. Enteritidis and 
S. Typhimurium, which commonly cause gastroenteritis (Hohmann, 2001; HPA, 2009). 
Symptoms begin 12-72 hours post infection and include diarrhoea, which can be bloody, 
abdominal cramps and acute onset fever. Symptoms can last between four to seven days 
(CDC, 2007) although faecal shedding can continue for up to seven weeks post infection 
(Hohmann, 2001). Most people recover without treatment as the infection is usually 
self-limiting but hospitalisation is required in around 20% of cases (Mead et al., 1999). 
Approximately 5% of patients with gastroenteritis caused by NTS develop bacteraemia, 
which is a potentially fatal complication that is more common in developing countries 
(Hohmann, 2001). In tropical Africa S. Typhimurium and S. Enteritidis are the commonest 
causes of childhood bacteraemia with a fatality rate of around 30%. Other reported 
complications of NTS infection include pneumonia, septic arthritis and meningitis (Graham, 
2002).  
In humans the infectious dose of S. Typhimurium has been reported to be between 105-1010 
cells (Blaser and Newman, 1982) and there is a negative correlation between the ingested 
bacterial dose and the median incubation period (Abe et al., 2004). In the developed world 
95% of all NTS infections are food borne (Mead et al., 1999) and are often associated with 
consumption of contaminated poultry or eggs (Cogan and Humphrey, 2003). Other 
transmission routes include contaminated water, contact with pets (particularly birds and 
reptiles) and nosocomial transmission (Hohmann, 2001). The susceptibility of individuals to  
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Figure 1.1 The number of reported Salmonella infections in England and Wales (1990-
2008) 
a. Number of reported Salmonella Typhi, Paratyphi A, Paratyphi B and Paratyphi C 
infections in England Wales between 1990 - 2008 
 
 
 
 
 
 
 
 
b. Number of reported Salmonella Enteritidis and Typhimurium infections in England 
Wales between 1990 – 2008 
 
 
 
 
 
 
 
 
Data from www.HPA.org.uk 
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gastrointestinal Salmonella infections is dependent on risk factors including the extremes of 
ages, disruption of commensal gut flora (for example as a result of recent antimicrobial 
therapy), high gastric pH, malignancy, diabetes, HIV and therapeutic immunosuppression. 
Complicated infections are far more common in immunocompromised individuals, such as 
those with HIV or undergoing therapeutic immunosuppression because they lack the 
effective T-helper-1 (Th1) response necessary to protect against disease caused by 
intracellular pathogens (Hohmann, 2001; Graham, 2002). Persistent Salmonella infections 
can also occur and individuals are predisposed to this where there is anatomical 
perturbation (e.g. by kidney stones), abnormalities of the urinary tract or prosthetic devices 
as these sites can act as foci around which the bacteria can persist (Hohmann, 2001). 
In England and Wales there are approximately  20,000 reported cases of NTS every year 
(HPA, 2007; Rhen et al., 2007) (Figure 1.1 b) and around 200,000 in the USA (Mead et al., 
1999) although the actual number of cases is likely to be much higher as the disease is 
normally self limiting and therefore goes unreported (Rhen et al., 2007). According to the 
Health Protection Agency (HPA), reported Salmonella cases in the UK peaked at 31,482 cases 
in 1997 but then declined markedly to 9867 reported cases in 2008 (HPA, 2009). This decline 
was largely due to successful control measures, including wide scale vaccination of chickens, 
which are a major reservoir of infection (Cogan and Humphrey, 2003). However, since 2005 
there has been a rise in the number infections caused by serovars of Salmonella against 
which the vaccine provides no protection (Figure 1.1 b) (HPA, 2009). 
In England and Wales the most common Salmonella serovars are S. Enteritidis and 
S. Typhimurium although the levels of these are dynamic. During the late 1970s S. 
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Typhimurium was the predominant strain. However by the early 1980s S. Enteritidis had 
become more common with 15,153 cases in 1988 and by 1997 S. Enteritidis accounted for 
over 70% of all NTS infections in England and Wales. Provisional data for 2008 suggests that 
S. Enteritidis is still the predominant strain, accounting for 42% of the reported Salmonella 
infections in England and Wales while S. Typhimurium accounts for around 18%  (Figure 1.1 
b) (HPA, 2009). This changing epidemiology is closely linked to infection levels in chickens. 
1.3. The Salmonella Cell Wall 
The evolutionary success of the Gram-negative cell wall is reflected in the abundance of 
Gram-negative organisms and the wide variety of ecological niches in which they are found. 
It is responsible for protecting the cell, maintaining cell shape and preventing osmotic lysis. 
The cell wall of Gram-negative bacteria such as Salmonella consists of an outer membrane, 
above a thin of layer of peptidoglycan, and an inner membrane, separated by the periplasm 
(Beveridge, 1999).  
1.3.1 The Inner Membrane 
The inner membrane of Gram-negative bacteria is a phospholipid bilayer similar in structure 
and composition to the eukaryotic plasma membrane (Mühlradt, 1976). Proteins associated 
with the inner membrane are either integral inner membrane proteins with α-helical 
membrane spanning domains or lipoproteins bound to the outer leaflet via their N-terminal 
cysteine residue. The functions of these inner membrane proteins include small molecule 
transport, protein translocation and lipid biosynthesis (Ruiz et al., 2006). 
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1.3.2 The Periplasm 
The periplasm in Salmonella is typically 10-20 nm wide and accounts for approximately 
20-40% of the total cell volume (Stock et al., 1977). The periplasm consists of a wide variety 
of macromolecules including enzymes and chaperone proteins to facilitate protein folding. 
The periplasmic space also contains a thin layer of peptidoglycan that provides strength and 
shape to the cell aiding the prevention of osmotic lysis (Ruiz et al., 2006). Peptidoglycan is a 
polymer of glycan chains crosslinked by oligopeptide molecules producing an elastic matrix 
(Dmitriev et al., 2005) that is covalently bound to the outer membrane via Braun’s 
lipoprotein (Lpp) (Ruiz et al., 2006). 
1.3.3 The Outer Membrane 
The outer membrane of Gram-negative organisms is a selectively permeable barrier 
between the periplasm and the external environment that prevents various toxic 
compounds entering the cell (Nikaido, 2003; Ruiz et al., 2006). It is an asymmetric lipid 
bilayer. The inner layer is composed of phospholipids and the outer layer of phospholipids 
and lipopolysaccharide (LPS) (Doerrler, 2006). LPS is a glycolipid found exclusively in 
Gram-negative bacteria. S. Typhimurium mutants with reduced LPS levels have increased 
outer membrane permeability and consequently are hyper-susceptible to a range of 
antibiotics, dyes and detergents as well as suffering leakage of periplasmic enzymes (Vaara, 
1993; Ruiz et al., 2006). LPS consists of three parts: the core oligosaccharide, which is 
attached to the distal oligosaccharide or O-antigen, and the Lipid A domain (Raetz and 
Whitfield, 2002). The functions of the core oligosaccharide include providing a binding site 
for the distal polysaccharide side chains and stabilising the outer membrane (Heinrichs et al., 
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1998). Loss of this core region leads to an increase in the susceptibility of Salmonella to 
many antibiotics (Vaara, 1993). Unlike the core oligosaccharide, which shows very limited 
structural variation, probably due to its crucial role in membrane stability, the distal 
O-antigens vary greatly in their length, composition and structure. This antigenic variation is 
utilised by the Kaufmann-White system to classify Salmonella into serovars (Heinrichs et al., 
1998; Mimms, 2003). Mutants lacking the O-antigen show greatly reduced virulence in the 
chick model (Carroll et al., 2004). Lipid A is a highly conserved hydrophobic moiety 
responsible for anchoring LPS to the outer membrane (Mimms, 2003). It is composed of long 
fatty acid chains that are linked to a di-glucosamine backbone. Mutations in the Lipid A 
biosynthetic pathway are often lethal or lead to mutants which are super-susceptible to 
hydrophobic antibiotics and very large hydrophilic antibiotics which are normally excluded 
from the cell by the outer membrane (Vaara, 1993). Lipid A is also known as an endotoxin 
because it is partly responsible for the toxicity of many Gram-negative bacteria, including 
Salmonella, as it activates the mammalian innate immune system via the Toll-like receptor 
system. 
Changes in LPS have been shown to have profound effects on S. Typhimurium, including 
altering the level of protein secretion via type three secretion systems (T3SS). For example, 
the length of the O-Antigen has recently been linked to the level of secretion of proteins by 
the type three secretion systems (T3SS) of S. Typhimurium. Strains lacking long (containing 
approximately 35 repeats) and very long (containing approximately 100 repeats) O-Antigens 
had increased secretion of the T3SS-1 effector protein, SipA, although secretion by T3SS-2 
was unaffected (Holzer et al., 2009). In addition, mutation of waaN, a gene involved in lipid A 
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biosynthesis, resulted in reduced secretion of proteins, such as the Sips and Sops, by T3SS-1 
of S. Typhimurium. There was also a subsequent  reduction in pathogenesis in the calf ileal 
loop model of infection and a loss of ability to invade cultured human epithelial cells 
(Watson et al., 2000). 
Mutations in LPS have also been shown to affect the insertion, folding and stability of 
membrane proteins. LPS was shown to be required, along with the Skp protein, for folding 
and insertion of OmpA into phospholipid bilayers. Initially, Skp binds to OmpA, preventing 
OmpA from folding. This complex then binds to LPS which facilitates insertion and folding 
into phopholipid bilayers (Bulieris et al., 2003). LPS is also required for the proper folding of 
PhoE in E. Coli. PhoE is an outer membrane porin that is assembled into the outer 
membrane. Purified LPS with Triton X-100 and divalent cations was able to induce folding of 
the PhoE protein and the efficiency of folding increased linearly with the amount of LPS (de 
Cock and Tommassen, 1996). A subsequent study showed that it is the core and lipid A 
regions of LPS that are required for efficient folding of PhoE (de Cock et al., 1999). A role has 
also been shown for LPS in the stability of the S. Typhi protein OmpC as removal of LPS 
resulted in a reduction in the thermal stability of the protein (Arockiasamy et al., 2004). 
The S. Typhimurium outer membrane also contains approximately 60% of the protein found 
in the entire cell envelope and approximately 90% of the total lipoprotein (Ohl and Miller, 
2001). Outer membrane lipoproteins are anchored to the membrane in the same manner as 
those found on the inner membrane but are found on the inner rather than outer leaflet of 
the membrane. The integral membrane proteins of the outer membrane are very different 
from their inner membrane counterparts as they fold to form β-barrel conformations that 
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span the membrane. These function as channels permitting the influx of nutrients and the 
export of waste products that would otherwise be unable traverse the membrane due to its 
amphipathic nature (Nikaido, 2003; Doerrler, 2006; Ruiz et al., 2006).  
1.3.4 Protein Secretion Systems  
Multiple membrane associated protein secretion mechanisms have evolved to allow bacteria 
to secrete proteins across the inner and outer membranes. Many of these systems are 
required for pathogenicity. Protein secretion mechanisms are categorised into six main 
groups which are summarised in Table1.1. 1.4 Pathogenesis and Virulence of Salmonella 
Typhimurium 
1.4.1 Colonisation and adhesion 
The first stage of S. Typhimurium infection is attachment and colonisation of host intestinal 
tissues. The surface of the host intestine is made up of microvilli separated by crypts and 
covered with a layer of mucus (Mimms, 2003). The surface is non-uniform as it contains 
irregularities such as Peyer’s patches, which are one to two cm long thickenings of lymphoid 
tissue in the host ileum (Jepson and Clark, 2001). 
 After ingestion, infection by Salmonella begins by crossing the mucus layer and adhering to 
the intestinal mucosa. Bacterial attachment is important because it prevents mechanical 
removal of the bacteria from the intestine. This process is mediated by the plethora of  
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Table 1.1 Bacterial protein secretion systems 
Type Structure  Mechanism Function/Features Examples 
I Three component structure: 
Inner membrane transporter 
Periplasmic Adaptor Protein 
linked to the inner membrane 
and to the third component, the 
Outer Membrane channel   
Inner membrane transporter uses 
ATP hydrolysis to power 
transport of substrates through 
the outer membrane channel to 
the extra cellular space. 
Transport of a wide variety of 
proteinaceous and non-
proteinaceous substrates to the 
extracellular space. 
Haemolysin A transport system of 
E. coli, HlyABC (Härtlein et al., 
1983) 
 
II Consist of approximately 12 
components including an outer 
membrane secretin and a 
cytoplasmic ATPase (Peabody et 
al., 2003; Filloux, 2004; 
Cianciotto, 2005; Johnson et al., 
2006) 
Proteins are transported across 
the inner membrane by the Sec 
or Tat pathways before transport 
across the outer membrane by 
the type II secretion system. 
 
Transport of a variety of 
substrates, including some 
required for virulence, from the 
periplasm to the extracellular 
space (Gerlach and Hensel, 2007) 
Related to the type IV pilus 
machinery (Peabody et al., 2003) 
Secretion of pullulanase (PulA) by 
Klebsiella oxytoca (d'Enfert et al., 
1987) 
III Syringe-like mechanism 
composed of approximately 20 
proteins. Spans the inner 
membrane, periplasm, outer 
membrane and the membrane of 
the host cell. 
A syringe like mechanisms injects 
effector proteins directly into the 
host cell cytoplasm. 
Found predominantly in 
pathogenic bacteria where they 
are used to deliver effector 
proteins into the host cell to 
modulate the host cell behaviour 
(Ghosh, 2004; Gerlach and 
Hensel, 2007) 
Secretion of Sip and Sop proteins 
of S. enterica through the 
Salmonella Pathogenicity Island 1 
encoded T3SS (Collazo and Galán, 
1997). 
IV The archetypal VirB/D system of 
Agrobacterium tumefaciens 
spans the inner and outer 
membrane and consists of 12 
proteins, including  an 
extracellular pilus and three 
ATPases (Christie et al., 2005) 
Proteins are transferred between 
cells via a conjugation like 
mechanism.  
Can transport proteins, protein 
complexes or single stranded 
DNA either to the extracellular 
mileu or directly into the host cell 
cytoplasm. 
Related to conjugation machinery  
Toxin secretion by Bordetella 
pertussis (Farizo et al., 2000) 
VirB/D4 transfer system of A. 
tumefaciens (Christie, 1997) 
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V Autotransporters: A single 
protein with a signal peptide, 
passenger domain and 
translocation unit. 
Two partner protein system 
(TPS): Two separate proteins – 
the transported protein and its 
transporter 
The N-terminal signal peptide 
directs the protein to the sec 
pathway through the inner 
membrane, the passenger 
domain encodes the effector 
protein and the C-terminal 
translocation unit inserts into the 
membrane forming a β-barrel 
pore through which the 
passenger domain is secreted. In 
autotransporters this is all a 
single protein in the two partner 
system the transporter and 
passenger are two separate 
proteins (Jacob-Dubuisson et al., 
2004; Gerlach and Hensel, 2007) 
Autotransporter proteins 
mediate their own transport 
across the outer membrane while 
TPS proteins require a second 
protein which acts as a 
transporter. 
Secretion of large, virulence 
related proteins (Jacob-
Dubuisson et al., 2001) 
Autotransporter: Pet toxin of E. 
coli (Eslava et al., 1998) 
TPS: Filamentous haemagglutinin 
secretion through FhaC in B. 
pertussis (Jacob-Dubuisson et al., 
1999) 
VI Commonly between 15 and 25 
proteins but the structure of the 
system is currently not well 
defined (Schell et al., 2007). 
Include proteins from the 
cytoplasm, membrane and 
extracellular space (Bingle et al., 
2008). 
Transport is probably driven by 
ATP hydrolysis. For example by 
ClpV from S. Typhimurium has 
ATPase activity (Schlieker et al., 
2005). In the Edwardsiella tarda 
virulent protein (EVP) T6SS there 
are 16 proteins. At least 3 are 
secreted (EvpC, EvpI and EvpP) 
and 11 are not secreted, of 
which, one (EvpO) has ATPase 
activity (Zheng and Leung, 2007). 
Export of virulence factors (Schell 
et al., 2007) 
Many components well 
conserved (Bingle et al., 2008) 
The Edwardsiella tarda virulent 
protein (EVP) gene cluster has 
been identified as a T6SS (Zheng 
and Leung, 2007).  
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adhesins encoded in the Salmonella genome of which an important class are the fimbriae. 
Fimbriae are filamentous surface structures composed of multiple copies of the fimbrillin 
subunit and with a small number of copies of an adhesive subunit at the end (Rhen et al., 
2007). Type I fimbriae have been linked to adhesion by S. Typhimurium. For example, a 
mutant lacking the fim operon could not attach to or invade HeLa cells (Baumler et al., 
1996b). This also suggests that adhesion is a pre-requisite for invasion. Different fimbrial 
adhesins show specificity to different tissue types, for example, the long polar or lpf fimbrial 
operon and the plasmid encoded Pef fimbria mediate adhesion of S. Typhimurium 
specifically to Peyer’s patches during murine infection (Baumler et al., 1996a; Baumler et al., 
1996b; Baumler et al., 1996c; Ohl and Miller, 2001). Non-fimbrial adhesins include the 
autotransporter protein MisL. Over-expression of MisL allowed S. Typhimurium to bind to 
fibronectin on coated glass slides and furthermore, increased invasion levels into T84 cells in 
vitro (Dorsey et al., 2005).  
1.4.2 Invasion  
Salmonella is an intracellular pathogen and it uses multiple mechanisms to cross the 
intestinal barrier. Firstly, Salmonella can be internalised by professional phagocytes. 
Alternatively, Salmonella can invade the intestinal epithelia by inducing its own uptake into 
non-phagocytic enterocytes, a process called bacterially-mediated endocytosis. This requires 
a T3SS encoded by a 40 Kb genomic region called Salmonella Pathogenicity Island (SPI) 1. 
Pathogenicity islands are horizontally acquired discrete regions of the genome encoding 
genes required for pathogenicity. SPI-1 encodes a T3SS which injects bacterial effector 
proteins into the host cell cytoplasm allowing manipulation of the host cell physiology. These 
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effector proteins include the Rho-GTPase exchange factors SopE and SopE2, and SopB, an 
inositol phosphotase, which together activate host rho-GTPases which initiate 
rearrangement of the host actin cytoskeleton and destabilisation of host cell tight junctions. 
S. Typhimurium mutants lacking any one of these three effectors was still able to invade 
HeLa cells. However, when sopE, sopE2 and sopB were all inactivated the strain was unable 
to induce actin reorganisation in the host cell, preventing internalisation (Zhou et al., 2001; 
Haraga et al., 2008). Two further effector proteins SipA and SipC then bind to actin and 
further modulate its rearrangement to facilitate outward extension of the membrane ruffles 
and therefore the efficiency of bacterial uptake. SipA promotes polymerisation of actin by 
reducing the critical concentration required for actin polymerisation and stabilises the actin 
filaments by inhibiting their depolymerisation (Zhou et al., 2001; Hayward and Koronakis, 
2002; McGhie et al., 2009). SipA also works synergistically with SipC which nucleates the 
actin rearrangement (Hayward and Koronakis, 1999; Hayward and Koronakis, 2002). The 
host cytoskeleton rearrangement results in prominent membrane protrusions called ruffles 
which engulf the bacteria leading to their uptake by macropinocytosis (Haraga et al., 2008).  
The actin cytoskeleton rearrangements which cause ruffles are only transient and after 
bacterial uptake normal host cell architecture is restored; a process which is also bacterially 
mediated (Fu and Galan, 1999; Groisman and Mouslim, 2000). The SptP protein is injected 
by the SPI-1 encoded T3SS after secretion of the ruffle promoting proteins such as SopE. It is 
a GTPase activating protein that is directly responsible for the reversal of the cytoskeletal 
rearrangements, possibly to subvert host immune responses and to maintain viability of the 
host cell (Fu and Galan, 1999). 
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Another way Salmonella become internalised is via membranous epithelial (M) cells. M cells 
are specialised epithelial cells which form the follicle-associated epithelium (FAE) overlying 
the Peyer’s patches. These cells capture sample antigens from the intestine by pinocytosis, a 
non-specific process. The antigens are then transported to the lymphoid tissue in the Peyer’s 
patches below, where a protective immune response is initiated (Jepson and Clark, 2001; 
Haraga et al., 2008). However, the ability of M-cells to non-specifically transport a wide 
variety of substrates leaves them vulnerable to exploitation by Salmonella (Jepson and Clark, 
2001). S. Typhimurium has been shown to preferentially adhere to M-cells in orally infected 
mice with 34 fold more bacteria found per unit area of M-cells than per unit area of other 
enterocyte cells demonstrating the importance, and the preference of Salmonella, for this 
route of invasion (Clark et al., 1994; Ohl and Miller, 2001). Invasion of M-cells by Salmonella 
causes damage resulting in sloughing of the FAE in both the mouse and calf ileal loop models 
(Jones BD, 1994; Penheiter et al., 1997), allowing the bacteria to disseminate into adjacent 
sub-epithelial tissues (Jepson and Clark, 2001).  
Finally, it was observed that while Salmonella lacking functional SPI-1 could cause a lethal 
infection in mice after oral administration, and reach the spleen (Galan and Curtiss, 1989), it 
was not doing so via M cells or Peyer’s patches (Penheiter et al., 1997). Vazquez-Torres and 
colleagues reported Salmonella could also be taken up from the gastrointestinal system, by 
tissue macrophages expressing the CD18 antigen, and transferred directly into the 
bloodstream. Furthermore, Salmonella were unable to disseminate to the liver and spleen in 
CD18 deficient mice during oral challenge but not during peritoneal challenge (Vazquez-
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Torres et al., 1999). It has been suggested that this could be significant to the development 
of systemic immunity (Vazquez-Torres et al., 1999). 
1.4.3 Intra-cellular phase of infection 
Once Salmonella have gained access to the sub-epithelial tissue they encounter many other 
cell types including macrophages which engulf the bacterial cells. The ability of Salmonella to 
survive within the macrophage is an important virulence determinant as mutants defective 
for macrophage survival in an in vitro  assay were shown to be avirulent in the mouse after 
intraperitoneal infection (Fields et al., 1986).  
Once inside the macrophages the Salmonella must evade the antimicrobial function of the 
phagocytes and replicate in the hostile intracellular environment.  Immediately after uptake 
the Salmonella reside in a spacious phagosome (SP) formed by closure of the membrane 
ruffle (Alpuche-Aranda et al., 1994). This SP then shrinks to form a Salmonella containing 
vacuole (SCV). The SCV transiently displays markers of the early endocytic pathway but does 
not follow the normal phagolysosomal cycle as Salmonella interferes with this process by 
delaying or preventing lysosomal fusion and therefore acidification of the phagosome 
(Alpuche Aranda et al., 1992; Garvis et al., 2001; Steele-Mortimer, 2008). However, after a 
lag phase the SCV does become slightly acidic (pH 5-6). This pH change is not bacteriocidal to 
the Salmonella but acts as an important signal for the activation of genes in SPI-2 which are 
required for intramacropahge survival and therefore suggests that the change in pH is critical 
to the virulence of Salmonella (Alpuche Aranda et al., 1992; Rathman et al., 1996; Cirillo et 
al., 1998).  
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The pH change is detected by the two component system PhoP/PhoQ (Bearson et al., 1998).  
This system detects environmental signals and in response controls expression of over 200 
virulence related genes including those encoded by SPI- 2 (Miller and Mekalanos, 1990; 
Lucas and Lee, 2000). It consists of an inner membrane sensor kinase, PhoQ, and a 
transcriptional activator, PhoP. The sensor component, PhoQ, detects levels of extracellular 
cations via two non-interacting binding sites near its C-terminus (Vescovi et al., 1997). Low 
pH levels cause PhoQ to promote the phosphorylation of PhoP. This causes conformational 
changes in the DNA binding domain of PhoP, allowing it to bind to target promoter 
sequences and promote transcription of PhoP regulated genes (Yamamoto et al., 2002; Shin 
and Groisman, 2005). The absence of  PhoPQ caused attenuation  of virulence in the mouse 
model of infection after intraperitoneal infection (Miller et al., 1989). This system is also 
critical in directing adaptation to Mg2+ limiting conditions and providing resistance to many 
antimicrobial peptides including mammalian defensins (Miller et al., 1989; Bearson et al., 
1998; Groisman, 2001). 
To survive within the phagosome Salmonella must endure the bactericidal environment 
containing lysosomal hydrolases and many antimicrobial peptides, reactive oxygen 
intermediates (ROIs) and reactive nitrogen intermediates (RNIs) (Knodler and Steele-
Mortimer, 2003; Haraga et al., 2008). The ability to survive within this environment is an 
important virulence determinant. Microarray studies have shown differential regulation of 
over 900 Salmonella genes upon phagocytosis by murine J774-A cells in vitro showing the 
scale of response required to the change in environment (Eriksson et al., 2003). Pathogen 
associated molecular patterns (PAMPs) recognised by the host as an indicator of infection 
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are down-regulated or altered to avoid detection. For example SPI-I encoded flagellin, which 
is recognised by Toll-like receptor (TLR) 5, is dramatically down-regulated in response to 
PhoP/Q signalling (Miao et al., 2006). Significant LPS remodelling also occurs in response to 
PhoP/Q signalling to prevent detection by TLR-4 (Guo et al., 1997).  
SPI-2 encodes a T3SS that is required for intracellular survival and is expressed by 
intracellular Salmonella (Ochman et al., 1996; Cirillo et al., 1998; Hensel et al., 1998; Eriksson 
et al., 2003; Hautefort et al., 2008). Conversely, expression of SPI-1 which is required for 
invasion, is constantly suppressed  when inside macrophages and is only expressed during 
the late stages of infection of epithelial cells in vitro (Eriksson et al., 2003; Hautefort et al., 
2008). Salmonella lacking spiA, a component of SPI-2, had a reduced capacity to survive 
within macrophages and could not kill BALB/c mice after intraperitoneal infection (Ochman 
et al., 1996). The T3SS machinery translocates effector proteins across the vacuolar 
membrane into the host cell cytosol allowing the bacteria to modulate its external 
environment. The effectors participate in various SPI-2 functions including inhibition of 
lysosomal fusion to the phagosome (Uchiya et al., 1999), Salmonella induced filament (Sif) 
formation, maintenance of the vacuolar membrane integrity (Beuzón et al., 2000) and 
avoiding the damaging effects of ROIs and RNIs by inhibiting production of NADPH and iNOS 
as well as preventing the free radicals reaching the SCV (Vazquez-Torres et al., 2000; Gallois 
et al., 2001; Chakravortty et al., 2002; Knodler and Steele-Mortimer, 2003; Waterman and 
Holden, 2003). 
Approximately 4-6 hours after infection Salmonella begin to replicate within the SCV and this 
is accompanied by the production of Salmonella-induced filaments (Sifs). These are 
19 
 
membranous filaments that project outwards from the SCV into the cell along the 
microtubule network. They are formed following fusion of the SCV with late endocytic 
compartments and have a membrane composition similar to that of the SCV (Brumell et al., 
2001; Birmingham et al., 2005). The function of Sifs is not entirely understood however they 
cause elongation of the vacuole which could improve nutrient availability, allowing for the 
rapid bacterial replication which occurs simultaneously (Birmingham et al., 2005; Haraga et 
al., 2008).  
Salmonella can utilise the mobility of the macrophage to aid dissemination of infection via 
the host lymphatic system while evading the host immune response. Worley and colleagues 
have shown that Salmonella can enhance the motility of the infected macrophages via the 
protein SrfH which is secreted by the SPI-2 T3SS. While inside macrophages the expression of 
this gene increases by almost 100-fold. The SrfH protein is secreted across the membrane of 
the Salmonella containing vacuole (SCV) and interacts with a host regulator of motility, 
TRIP6, promoting the motility of the macrophage. In orally infected mice, this speeds up the 
systemic spread of infected cells away from the intestine and into the blood stream as well 
as other host tissues (Worley et al., 2006). 
1.4.4 Dissemination of infection  
In the early stages of infection Salmonella growth is exponential  and in the murine model of 
salmonellosis this stage sees the spread of bacteria from the blood to the spleen and liver 
(Grant et al., 2008). Further dissemination of infection depends on the bacteria escaping the 
original cell and moving on to infect other cells. This occurs when the host cell bursts, 
releasing the intracellular bacteria. Host cell lysis is a stochastic process which is 
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independent of the number of bacteria infecting the cell (Brown et al., 2006; Mastroeni et 
al., 2009). Bacteria are only extracellular for a very short time as opsonisation by 
complement factors occurs rapidly leading to phagocytosis of the Salmonella. Due to the 
massive excess of uninfected host cells compared to the number of bacteria, continuous 
spread of the bacteria to new host cells occurs (Brown et al., 2006).  
The number of bacteria in each infected host cell is described by a skewed distribution 
where most infected cells contain a small number of bacteria while only a few contain higher 
bacterial numbers (Sheppard et al., 2003; Brown et al., 2006; Mastroeni et al., 2009). 
Through the course of murine infection there is a simultaneous increase in the total bacterial 
number in the tissue and the number of infected cells while the distribution of bacteria per 
infected host cell remains fairly constant (Sheppard et al., 2003).  At the same time there is 
an increase in the number of discrete infection foci within the tissue. These are spatially 
separated sites of infection founded by a singular bacterium that expands clonally and can 
form multi-cellular pathological lesions surrounded by healthy tissue. The foci are 
functionally independent and spread of bacteria between foci is not seen (Sheppard et al., 
2003; Mastroeni et al., 2009). In summary, progression of Salmonella infection in vivo is 
predominantly due to an increase in the number of infected cells and the foundation of new 
infection foci and not by replication of large numbers of Salmonella within the same 
phagocyte. 
1.4.5 Model systems to study Salmonella infection 
Animal models of Salmonella infection are commonly used to study mechanisms of 
pathogenesis and virulence relevant to both human and animal infections. However, careful 
21 
 
thought should be given to the appropriate model as different Salmonella serovars, infection 
models and inoculation route can produce very different symptoms and pathology and 
therefore could affect conclusions drawn from experiments.  
One of the most common animal models for Salmonella infection is the mouse and this 
model has been instrumental in the identification of multiple virulence mechanisms of S. 
Typhimurium (Galan and Curtiss, 1989; Hensel et al., 1995). However, a major limitation of 
this model for studying NTS is that oral infection with S. Typhimurium causes a systemic 
infection, similar to typhoid fever, which is very different from the gastrointestinal 
symptoms that characterise human infection. Four to eight days after oral infection with S. 
Typhimurium mice develop an elevated temperature but do not develop diarrhoeal 
symptoms and exhibit a very different intestinal pathology (Kraus et al., 1999; Santos et al., 
2001). Murine S. Typhimurium infections culminate in a systemic disease with rapid 
multiplication of bacteria in the spleen and liver (Santos et al., 2001). However, treatment of 
mice with streptomycin before oral infection with S. Typhimurium results in diarrhoea and 
colitis with very similar pathology to that seen in humans making this model more useful for 
the study of S. Typhimurium pathogenesis in humans (Barthel et al., 2003). The mouse 
model of infection has also been inoculated via intra-peritoneal injection. This is useful for 
studying some aspects of virulence and pathogenicity relevant to systemic infection but is 
not informative about earlier stages and challenges of infection, such as colonisation and 
bile resistance, which Salmonella have to overcome to cause infection via the oral 
inoculation route. 
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An alternative model for the study of S. Typhimurium infection is Calves. In contrast to 
murine infections, bovine oral infections with S. Typhimurium result in an enteric disease 
characterised by diarrhoea and similar pathology to human infections making it a more 
useful model for the study of pathogenesis in humans. However, other serotypes of 
Salmonella cause different disease syndromes. For example, cattle infected with Salmonella 
Dublin, a serovar known to be associated with infection of cows, can result in abortion and a 
prolonged carriage state which is not characteristic of S. Typhimurium infections (Wray and 
Sojka, 1981; Santos et al., 2001).   
Calf ligated ileal loops can be used to model the early stages of infection and have been used 
to characterise some virulence factors such as member of SPI1 (Clarke and Gyles, 1987; Frost 
et al., 1997; Zhang et al., 2002). In this model the intestine of anesthetised calves is ligated 
to form multiple small loops, which are each separately infected with S. Typhimurium and 
the course of infection and resulting pathology can be sampled at different time points post 
infection. A major limitation of this model is that infection can only be studied for 
approximately 12 hours but a further refinement of the technique by Coombes and 
colleagues (2005) which involves unblocking the small intestine after infection allows the 
animals to survive for up to five days post operation (Santos et al., 2001; Coombes et al., 
2005). Major benefits of this improved system include the extended length of infection that 
can be studied and the ability to study an infection of intestinal tissue linked to the blood 
supply and lymphatic system. 
In addition to the vertebrate models of Salmonella infection that have been discussed, 
invertebrate models, such as the nematode Caenorhabditis elegans, have also been used. S. 
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Typhimurium SL1344 is able to establish a persistent infection and proliferate within the C. 
Elegans intestine and the infection is lethal within approximately 5 days (Aballay et al., 
2000). Mutants that had attenuated virulence in other animal models also showed a reduced 
ability to kill the worm showing that many of the molecular mechanisms required for 
infection of humans and animals are also required for infection of the worm (Aballay et al., 
2000; Labrousse et al., 2000; Tenor et al., 2004). 
While animal experiments are invaluable in the study of infection and host pathogen 
interactions, the experiments can be time consuming as well as expensive. A very common 
alternative is infection of cultured mammalian cells in vitro. This approach has been 
invaluable in the elucidation of the molecular mechanisms of host cell invasion by 
Salmonella such as the T3SS encoded by SPI-1 (Galan and Curtiss, 1989; Darwin and Miller, 
1999). A major advantage of this system is that it allows the interaction between a pathogen 
a single type of host cell to be studied. This reductionist approach removes much of the 
complexity of studying infection in a whole animal. In addition, the interaction between 
Salmonella and human cells can be studied. Common cell lines used to study S. Typhimurium 
infection include HeLa, CaCo2, Hep2 and INT-407 (Dibb-Fuller et al., 1999; Hurley and 
McCormick, 2003). There are obvious draw backs to studying a complex host pathogen 
interaction with only a single cell type. However, tissue culture experiments aid the 
formation of hypotheses about animal and human infections which can then be tested in the 
appropriate animal model in a hypothesis driven manner to substantiate any findings. 
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1.5 Treatment of Salmonella Infections 
There is no single, routine antimicrobial therapy recommended to treat otherwise healthy 
individuals displaying mild to moderate symptoms of gastrointestinal infection (Hohmann, 
2001). Treatment of these individuals with antimicrobial therapy remains controversial 
because it is often not possible to reliably identify the causative agent of a gastrointestinal 
infection upon clinical presentation and inappropriate prescribing can result. Furthermore, 
the antibiotic treatment of patients with NTS can actually prolong, rather than reduce, the 
period of faecal shedding and so clinical relapse may be more common in the treated group 
(Nelson et al., 1980; Hohmann, 2001). This relapse is probably a result of perturbation of 
commensal gut flora by the antimicrobial therapy, leading to a reduction in its protective 
effects. However, treatment is always recommended for patients who are severely ill, at the 
extremes of age or who are for other reasons deemed to be at risk of more complicated or 
disseminated infection, but only after the causative agent has been confirmed by isolation 
from blood and/or faecal samples. When a course of antimicrobial therapy is required the 
drugs of choice include fluoroquinolones (DNA gyrase inhibitors), such as ciprofloxacin, or 
trimethoprim (a dihydrofolate reductase inhibitor). Trimethoprim can also be administered 
in combination with a member of the sulphonamides, usually sulphamethoxazole (a 
competitive inhibitor of enzymes required for nucleic acid synthesis). This combination is 
known as co-trimoxazole and is used because of the synergistic action of the component 
parts but is only used as a last resort during invasive infection due to its association with rare 
but severe side effects (BNF, 2007). 
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1.6 Antibiotic Resistance 
Since the introduction of penicillin in 1944, the use of therapeutic antibiotics has become 
commonplace and it is estimated that about 100,000 tons of antibiotics are produced 
annually worldwide (Nikaido, 2009). As predicted by Fleming in his nobel prize speech in 
1945 (Fleming, 1945), the emergence of antibiotic resistance has been an inevitable 
consequence. Multiple studies have shown that the overuse and misuse of antibiotics to 
treat human infections has contributed to the growing problem of antibiotic resistance 
(Cohen, 2000). For example, a study by the European Antimicrobial Resistance Surveillance 
System (EARSS) showed that an increase in penicillin resistance in Streptococcus pneumoniae 
isolates in Europe between 1998 and 1999 correlated with an increase in use of beta-lactam 
and macrolide antibiotics (Bronzwaer et al., 2002). Another example is a study which linked 
an increase in the prescription of fluoroquinolone antibiotics for urinary tract infections in 
the Netherlands to an increase in isolation of resistant E. Coli (Goettsch et al., 2000). 
Another factor in the emergence of antibiotic resistance is the use of antibiotics in veterinary 
medicine and the use of prophylactic antibiotics in animal feed to prevent infection and 
promote growth in livestock. This has contributed to the emergence of resistance in bacteria 
which are also pathogenic to man. This presents a potential public health risk from zoonotic 
infections caused by resistant bacteria including Salmonella and Campylobacter which are 
often food borne.  A major reason for this emerging resistance is that many drugs used to 
treat animals are also used in human treatment or are structurally very similar to drugs used 
to treat humans. For example, the fluoroquinolone enrofloxacin, which has been widely 
used to treat infections in animals, will select mutants in vitro resistant to both nalidixic acid 
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and ciprofloxacin, which are both fluoroquinolones used in human treatment (Giraud et al., 
1999). The implication of this is that the consumption of enrofloxacin resistant zoonotic 
pathogens such as Salmonella, could cause infection in humans that is resistant to 
ciprofloxacin, a clinically useful antibiotic (McEwen and Fedorka Cray, 2002; Piddock, 2002; 
Tornroth-Horsefield et al., 2007; BNF, 2009).  
Antibiotic resistance is either chromosomally encoded or acquired through transferable 
elements. Chromosomally mediated resistance occurs when mutations conferring resistance 
are fixed in the population when selection pressure is applied due to exposure to a particular 
antibiotic or class of antibiotics. The number of resistant bacteria then increases as the 
resistant strain spreads from animal to animal or infects humans (Piddock, 2002). 
Alternatively antibiotic resistance can be transferable. This type of resistance was first 
recognised when plasmid encoded resistance genes from Shigella transferred to E. coli. 
Another well studied example is the transfer of the mecA gene, which confers methicillin 
resistance, to Staphylococcus aureus. The gene encodes a novel penicillin binding protein, 
PBP2A, which can now be isolated from up to 90% of all antibiotic resistant clinical isolates 
(Walsh, 2003). Transferable resistance is easily spread between strains and between species. 
Resistance of Salmonella to older antibiotics such as chloramphenicol and ampicillin have 
been present for many years and treatment failures have been reported from strains which 
are resistant to ciprofloxacin (Piddock et al., 1990; Wain et al., 1997; Parry, 2003; Parry and 
Threlfall, 2008). Salmonella isolates are commonly resistant to more than one antibiotic. 
Multiple drug resistance (MDR) are defined as resistance to antibiotics from three or more 
classes. MDR Salmonella is commonly resistant to ampicillin, chloramphenicol, streptomycin, 
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sulphonamides and tetracycline. This phenotype is associated with S. Typhimurium DT104 
and  emerged in cattle in the early 1990s and is often abbreviated to ACSSuT (Randall et al., 
2004).  
1.6.1 Mechanisms of Antibiotic Resistance  
There are four major mechanisms which mediate antibiotic resistance (i) inactivation of the 
antibiotic, (ii) modification of the target molecule, (iii) metabolic bypass and (iv) efflux of the 
antibiotic. Many bacteria commonly inactivate antibiotics by producing enzymes which 
modify the chemically reactive site of the antibiotic molecule causing it to lose its 
antimicrobial activity. A very widespread example of this type of resistance is the destruction 
of β-lactam antibiotics by β-lactamase producing bacteria. β-lactamases hydrolyse the 
reactive β-lactam ring in many clinically important antibiotics, such as penicillins and 
cephalosporins, negating their antimicrobial activity (Hawkey, 1998). For example the AmpC 
β-lactamase enzymes provide resistance to the cephalosporins in multiple bacterial species 
including Salmonella enterica, E. coli, Proteus mirabilis, Klebsiella pneumoniae and 
Enterobacter spp. (Winokur et al., 2000; Jacoby, 2009). 
Antibiotic resistance in pathogenic bacteria is also achieved by modifying the target 
molecule of the antibiotic, rendering it insensitive to the drug, while still retaining its 
function within the organism. An example of this is quinolone resistance in Salmonella and E. 
coli caused by mutations in the gyrA gene that encodes the A subunit of the DNA gyrase 
enzyme. DNA gyrase is an essential enzyme involved in DNA supercoiling. In resistant clinical 
isolates mutations are most commonly detected close to the DNA binding region of the 
enzyme, in the Quinolone Resistance Determining Region (QRDR) and more specifically 
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mutations are most common at serine 83 and aspartate 87 (Griggs et al., 1996; Piddock, 
2002). Mutations in this region reduce binding affinity of quinolones to the gyrase enzyme 
and therefore decrease susceptibility (Willmott and Maxwell, 1993; Hopkins et al., 2005). 
Another example of alteration of the target molecule is in resistance to rifampicin (Spratt, 
1994). Rifampicin exerts its antimicrobial effect by binding to the β subunit of RNA 
polymerase at a site separate from the active site. In E. coli and Mycobacterium tuberculosis 
resistance to rifampicin occurs due to mutations in the rpoB gene which encodes the β-
subunit of the RNA polymerase (Jin and Gross, 1988; Telenti et al., 1993). This leads to 
resistance because rifampicin cannot bind to the mutated RNA polymerase. A further 
example is low level mupirocin resistance in S. aureus. Mupirocin works by irreversibly 
binding to the isoleucyl tRNA synthetase and therefore preventing protein synthesis. In 
isolates of S. aureus with low level mupirocin resistance (MIC of 8 to 256 µg/ml) valine to 
phenylalanine mutations were found in the isoleucyl tRNA synthetase protein, IleS, at 
residue positions 588 and 631 (Antonio et al., 2002). 
An additional mechanism by which bacteria become resistant to antibiotics is by metabolic 
bypass. This means that the inhibited reaction is circumvented for example by recruiting 
novel enzymes to bypass the metabolic pathways that are inhibited by antibiotic treatment. 
Probably the best characterised example of resistance by metabolic bypass is the acquisition 
of, PBP2a, an alternative Penicillin Binding Protein (PBP) in methicillin resistant S. aureus 
(MRSA) (Hawkey, 1998). This novel enzyme is encoded by the mecA gene. The PBP2a 
enzyme is produced in addition to the other PBPs of S. aureus but PBP2a is not inhibited by 
antibiotics such as methicillin or other β-lactams. It is therefore still able to fulfil its role as a 
29 
 
transpeptidase in crosslinking peptidoglycan precursors so that a normal cell wall is 
produced even in the presence of otherwise lethal β-lactam concentrations (Inglis et al., 
1988; Tesch et al., 1988). Another example of metabolic bypass is high level mupirocin 
resistance in S. aureus. The majority of isolates with high level resistance to mupirocin (MIC 
of ≥1000 µg/ml) have acquired a novel isoleucyl RNA synthetase, encoded by the mupA 
gene, which fulfils the function of the chromosomally encoded IleS but is not  inhibited by 
mupirocin (Hodgson et al., 1994; Udo et al., 2001; Patel et al., 2009). Furthermore, 
sulphonamide antibiotics work by competitively inhibiting the enzyme dihydropteroate 
synthetase. Resistance occurs by acquisition of a plasmid encoded enzyme which performs 
the same function but is resistant to far higher levels of sulphonamide (Wise and Abou-
Donia, 1975). 
 1.6.2 Efflux as a Mechanism of Resistance  
The fourth major mechanism of resistance is active efflux of antibiotics. Antimicrobial 
compounds are actively pumped out of the cell through membrane spanning efflux pumps, 
keeping the internal concentration below levels that are toxic to the bacteria. This 
mechanism is responsible for the intrinsic resistance that many Gram-negative bacteria have 
to certain classes of antibiotic  and confers resistance to multiple classes of antibiotics, dyes 
and detergents which are structurally distinct (Li and Nikaido, 2004; Piddock, 2006a). 
Increased resistance via efflux can be due to either increased expression of the efflux pump, 
often due to perturbations of the regulatory network, or mutation making efflux more 
efficient (Piddock, 2006a). 
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Antibiotic resistance due to over-expression of efflux pumps is a growing clinical problem in 
multiple bacterial species. For example, over-expression of the OprM efflux pump protein 
was detected in 11 patients with MDR P. aeruginosa infections (Ziha-Zarifi et al., 1999) while 
the mexB, mexD, mexF or mexY genes were over-expressed in fluoroquinolone resistant 
isolates (Oh et al., 2003). Multidrug resistant isolates of Campylobacter jejuni from both 
humans and poultry were shown to over-express cmeB or cmeF (Pumbwe et al., 2004) and 
over-expression of acrAB/AcrAB in Salmonella and E. coli has been implicated many times as 
a resistance mechanism in both human clinical and veterinary isolates (Piddock et al., 2000; 
Webber and Piddock, 2003; Baucheron et al., 2004b; Chen et al., 2007). MDR bacteria can 
also over-produce more than one efflux system simultaneously. For instance, of 450 clinical 
isolates of ticarcillin resistant P.  aeruginosa  46% over-expressed mexAB-oprM and 58% 
over-expressed mexXY; while 28% of isolates simultaneously over-expressed both systems 
(Hocquet et al., 2007). Enhanced efflux is also implicated in rapidly emerging clinical 
resistance to new antimicrobials such as tigecycline, for which over-expression of acrAB was 
detected in E. coli and Enterobacter cloacae (Keeney et al., 2007; Keeney et al., 2008). 
The plethora of efflux pumps which have been associated with MDR have been classified 
into the following five families: the ATP binding cassette (ABC) superfamily; the major 
facilitator superfamily (MFS); the multidrug and toxic compound extrusion (MATE) family; 
the small multidrug resistance (SMR) family; and the resistance nodulation division (RND) 
superfamily. This classification is based on the number of components from which the 
pumps are composed, the energy source on which they run, the class of substrate they 
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transport and the number of membrane spanning regions (Putman et al., 2000; Piddock, 
2006a). 
1.7 The RND Superfamily of Efflux Pumps 
Members of the RND protein family are permeases with 12 α-helical transmembrane 
domains and two large extra-cytoplasmic hydrophilic loops (Saier et al., 1994; Saier et al., 
1998; Tseng et al., 1999). This unusual protein structure is a result of an internal gene 
duplication event before divergence of the family members (Dinh et al., 1994; Saier et al., 
1994). Members of the RND superfamily of efflux pumps are found ubiquitously throughout 
the Bacteria, Archaea and Eukaryotes and are divided phylogenetically into seven families 
(Tseng et al., 1999; Saier and Paulsen, 2001). Families one to three are found in the Gram-
negative bacteria, family four is found in both Gram-positive and Gram-negative bacteria, 
family five are restricted to the Gram-positive bacteria, family six is found in the eukaryotes 
and family seven is found in the archaea and spirochetes (Tseng et al., 1999; Saier and 
Paulsen, 2001).  
The three families found in the Gram-negative bacteria function in complex with two other 
proteins, an outer membrane channel and a periplasmic adaptor protein (previously known 
as membrane fusion protein), to form a tri-partite efflux pump that spans both the inner and 
outer membrane. The RND pump is situated in the inner membrane and utilises the proton 
motive force to efflux a wide variety of substrates across the entire cell envelope to the 
extracellular space without the creation of any periplasmic intermediates (Tikhonova and 
Zgurskaya, 2004). These multi-protein complexes can transport a wide variety of substrates 
and their phylogeny correlates with substrate specificity of the pump (Saier et al., 1998; 
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Saier and Paulsen, 2001). Family one exports heavy metals, family two transport many 
structurally diverse drugs and family three export lipo-oligosaccharides involved in nitrogen 
fixation during nodulation (Saier et al., 1998; Saier and Paulsen, 2001). The phylogenetic 
relationship of the RND pump correlates well with that of the periplasmic adaptor protein 
(PAP) component suggesting that the two components co-evolved, however this is not true 
of the outer membrane channels which appear to have evolved independently (Paulsen et 
al., 1997; Saier and Paulsen, 2001).  
The periplasmic adaptor proteins were previously known as membrane fusion proteins. They 
were so called due to significant sequence homology to the membrane fusion protein of 
simian paramyxovirus 5 (Dinh et al., 1994). However, the term membrane fusion protein is 
misleading and does not reflect the function of this family of proteins. The term periplasmic 
adaptor protein (PAP) is becoming more common and has been adopted throughout this 
thesis. 
Five RND type efflux pumps (along with corresponding PAP) have been detected in 
S. Typhimurium: AcrAB, AcrEF, MdtABC, MdsABC and AcrD which is not encoded alongside 
its own periplasmic adaptor protein. 
1.8 The AcrAB-TolC Efflux Pump  
The three components of AcrAB-TolC efflux pump are AcrB, the inner membrane RND 
transporter protein, AcrA, the periplasmic adaptor protein (PAP) and TolC, the outer 
membrane protein channel (Figure 1.2 and 1.3). Its substrates are structurally diverse with 
different charges and a range of molecular weights. They include antibiotics from multiple 
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Figure 1.2 The assembled structure of the AcrAB-TolC tri-partite efflux system 
 
 
 
 
  
TolC 
AcrA 
AcrB 
Inner membrane 
From Blair and Piddock, 2009 
Image originally provided by Martyn Symmons, University of Cambridge. 
Outer membrane 
34 
 
Figure 1.3 The crystal structures of the components of the AcrAB-TolC efflux pump of E. coli 
 
 
 
 
 
 
  
A. TolC             B. AcrA       C. AcrB 
From Koronakis et al., 2004 From Murakami et al., 2002 
Personal communication Martyn 
Symmons (University of Cambridge)  
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 classes, including the fluoroquinolones (e.g. ciprofloxacin), β-lactams (e.g. oxacillin) and the 
tetracyclines (e.g. tetracycline), detergents including SDS, Triton X-100 and bile salts, as well 
as various dyes and disinfectants (Yu et al., 2003; Eaves et al., 2004b; Poole, 2005; Piddock, 
2006a; Seeger et al., 2008a; Tatsumi and Wachi, 2008).  
AcrAB-TolC and other members of the RND family, have been associated with intrinsic 
resistance to a range of antibiotics, dyes, disinfectants and detergents in various members of 
the Gram-negative bacteria (Okusu et al., 1996; Piddock et al., 2000; Nikaido and Zgurskaya, 
2001; Baucheron et al., 2002; Eaves et al., 2004b; Baucheron et al., 2005; Buckley et al., 
2006; Nishino et al., 2006). The AcrAB-TolC system is also implicated in the development of 
clinically relevant levels of resistance to various antimicrobial agents including the 
fluoroquinolones in both S. enterica and E. coli (Oethinger et al., 2000; Piddock et al., 2000; 
de Cristobal et al., 2006; Webber et al., 2008). Over-expression of components of AcrAB-TolC 
has been associated with antibiotic resistance in both clinical and veterinary isolates of 
S. enterica as well as in laboratory mutants  (Giraud et al., 2000; Piddock et al., 2000; Wang 
et al., 2001; Baucheron et al., 2002; Webber and Piddock, 2003; Baucheron et al., 2004b; 
Chen et al., 2007). Moreover, strains lacking components of the system showed increased 
susceptibility to various antimicrobial agents, with inactivation of tolC conferring 
hyper-susceptibility to  a wider range of agents than inactivation of acrB (Sulavik et al., 2001; 
Baucheron et al., 2002; Baucheron et al., 2004a; Eaves et al., 2004b; Buckley et al., 2006; 
Nishino et al., 2006). However, when components of other S. enterica RND systems were 
inactivated (acrD and acrF) the effect on susceptibility was much less marked although this 
did result in over-expression of acrB (Eaves et al., 2004b).  
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The AcrAB-TolC system of Salmonella is very similar to that in E. coli (94%, 97% and 94% 
similarity for acrA, acrB and tolC, respectively) but its structure and function have been more 
widely studied in E. coli (Table 1.2). Therefore, the following text focuses on work with 
E. coli. However, due to the significant DNA sequence, protein homology and similarities in 
effects upon antibiotic resistance in mutants it is reasonable to assume that the protein 
structure and pump mechanism is highly relevant to Salmonella (Piddock, 2006b).  
1.8.1 TolC 
TolC is a protein channel located in the outer membrane responsible for the expulsion of 
many compounds into the extracellular space. TolC, and members of the protein family to 
which it belongs, are ubiquitous throughout Gram-negative bacteria (Eswaran et al., 2004; 
Koronakis et al., 2004). Some of these outer membrane factors (OMFs), such as VceC of 
Vibrio cholerae, can only function with a specific PAP-RND pump (Federici et al., 2005) while 
others, such as TolC, act as the outer membrane channel to multiple RND pumps, including 
AcrD (Hirakawa et al., 2003; Nishino et al., 2003), AcrEF (Nishino et al., 2003), MdsAB 
(Nishino et al., 2006) and MdtABC (Nagakubo et al., 2002), as well as for the MFS systems 
EmrAB and EmrKY (Nishino and Yamaguchi, 2002) and also the ABC drug transporter MacAB 
(Kobayashi et al., 2001b). Furthermore TolC can functionally replace VceC of Vibrio cholerae 
to function with the VceAB pump but VceC cannot functionally interact with AcrAB of E. coli 
(Vediyappan et al., 2006).  
 Crystal structures have revealed that TolC is a composed of three identical protomers each 
consisting of 428 residues (Figure 1.3 a). Each protomer has a 40Å long β-barrel domain 
anchored to the outer membrane and a 100Å long α-helical domain consisting of 12 coiled  
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Table 1.2 Percentage identity and percentage similarity to homologues of AcrAB-TolC 
 
  % Identity % Similarity 
S. Typhimurium E. coli K12   
AcrA AcrA 91 94 
AcrB AcrB 94 97 
TolC TolC 89 94 
E. coli K12 P. aeruginosa   
AcrA MexA 56 71 
AcrB MexB 69 83 
TolC OprM 18 35 
E. coli K12 Campylobacter jejuni   
AcrA CmeA 31 51 
AcrB CmeB 41 63 
TolC CmeC 24 41 
 
Data from Piddock, 2006a 
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coils which project into the periplasm. Together the monomers form an outer membrane 
pore and a periplasmic tunnel which projects into the periplasm and narrows to a closed end 
approximately 2 Å  in diameter (Koronakis et al., 2000; Koronakis et al., 2004). The channel is 
permanently open on the extracellular surface but is restricted on the periplasmic side by 
di-sulphide bridges between cysteine residues on the coiled coils (Eswaran et al., 2004). The 
channel is opened when the coiled coil helices move to the periphery of the channel by 
untwisting in an iris like movement (Koronakis et al., 2000; Andersen et al., 2002).  
1.8.2 AcrB 
AcrB is the RND efflux pump component of AcrAB-TolC and is responsible for the substrate 
specificity and energy transduction of the system (Elkins and Nikaido, 2002). The crystal 
structure of AcrB has been solved and shows that AcrB is a complex of three identical 
protomers forming an integral membrane protein complex within the cytoplasmic 
membrane that is “jellyfish shaped” (Murakami et al., 2002) (Figure 1.3 c). Each protomer is 
composed of 1049 amino acids and has three domains: a transmembrane domain, a porter 
domain and a periplasmic TolC docking domain (Murakami et al., 2006; Seeger et al., 2006) 
(Figure 1.3 c).  
The trans-membrane domain is formed by 12 membrane spanning α-helices. The fourth and 
tenth trans-membrane domains contain a triplet of charged amino acid residues, Asp 407, 
Asp 408 and Lys 940. These are vital for the utilisation of the proton motive force and are in 
a spatially separate location from the substrate binding pocket (Murakami et al., 2006; 
Takatsuka and Nikaido, 2006; Seeger et al., 2009). The trans-membrane domains of AcrB and 
MexB are particularly well conserved with almost all residues being identical, including the 
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three amino acids involved in this putative proton translocation site suggesting this may be a 
mechanism common to all RND systems (Sennhauser et al., 2009).  
There are two large periplasmic loops protruding from the transmembrane domain formed 
between the first and second, and seventh and eighth transmembrane domains each 
consisting of around 300 amino acids. The importance of the periplasmic loops was shown 
using chimeric studies in which, the loops from AcrB were replaced with the highly similar 
loops from AcrD in E. coli. The substrate specificity of the chimeric protein resembled that of 
AcrD, not AcrB, suggesting that the periplasmic loops are involved in substrate specificity 
(Elkins and Nikaido, 2002; Tikhonova et al., 2002). Furthermore, work with another RND 
efflux pump of E. coli, YhiV, which has significant homology to AcrB, has shown that a 
mutation in the periplasmic loop region affected susceptibility to different antimicrobials in 
different ways. For example, a mutation which changed the valine residue at position 610 to 
a phenylalanine, increased resistance to linezolid and tetracycline but increased 
susceptibility to PAβN and azithromycin indicating further complexity in the substrate 
specificity imposed by the periplasmic loops (Bohnert et al., 2007).  
The porter domain of each protomer is made up of four subdomains, PN1, PN2, PC1 and 
PC2, arranged such that their β-sheets create the substrate binding pocket rich in aromatic 
residues, particularly phenylalanines, that interact with the structurally varied substrates 
(Murakami et al., 2006; Seeger et al., 2006). Crystallisation of AcrB in complex with bile acid 
showed that the binding site for this natural substrate is in a similar position to that for other 
published complexes including ethidium bromide, ciprofloxacin and PAβN (Yu et al., 2005; 
Drew et al., 2008). Site directed mutagenesis was used to show that mutation of different 
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phenylalanine residues within the binding pocket had variable effects on susceptibility to 
substrates and highlighted the F610 residue as having a particularly significant and broad 
impact on susceptibility (Bohnert et al., 2008). Conversely, a substitution at the AcrB 616 
residue was found to be particularly relevant for macrolide resistance (Wehmeier et al., 
2009) and a serine 715 substitution had a specific effect on bile resistance (Drew et al., 
2008). Redundancy of phenylalanines in the pocket may partially account for the varied 
consequences of substituting different residues. Some substrates are still accommodated in 
a mutated binding pocket while other larger substrates, such as the macrolides, are unable 
to adapt to changes caused by a single substitution (Bohnert et al., 2008).  
Loops which protrude from the periplasmic TolC docking domain into adjacent monomers 
are responsible for holding the three monomers together (Seeger et al., 2008a; Sennhauser 
et al., 2009).  
Although the composition of each monomer is identical, three different teams have 
independently shown that the structure of AcrB is asymmetric. Each of the monomers are 
found in one of three different conformations and conformational cycling  is responsible for 
the pumping mechanism of AcrB (Murakami et al., 2006; Seeger et al., 2006; Sennhauser et 
al., 2007; Seeger et al., 2008b; Takatsuka and Nikaido, 2009) (discussed further in section 
1.10).  
1.8.3 AcrA  
AcrA is the periplasmic adaptor protein component of AcrAB-TolC and has been shown to 
physically interact with both AcrB and TolC (Zgurskaya and Nikaido, 2000; Augustus et al., 
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2004; Husain et al., 2004; Tikhonova and Zgurskaya, 2004; Touze et al., 2004; Stenberg et al., 
2005). The cross-linking efficiency between AcrA and AcrB was not dependant on the 
presence of TolC (Zgurskaya and Nikaido, 2000; Tikhonova and Zgurskaya, 2004; Touze et al., 
2004). Similarly, the efficiency of cross linking of AcrA and TolC was not dependent on AcrB 
(Augustus et al., 2004; Touze et al., 2004). Furthermore, linking of AcrB and TolC could be 
detected in the absence of AcrA although the interaction was weak (Touze et al., 2004; 
Tamura et al., 2005).  
Sequence analyses have shown that AcrA is a lipoprotein and hydropathy plots have 
suggested there are no transmembrane domains. It is bound to the inner membrane via an 
N-terminal lipid moiety (Ma et al., 1993). A partial crystal structure of AcrA from E. coli was 
published by Mikolosko and colleagues in 2006. It was found to be 105 Å  long and sickle 
shaped, in a similar manner to MexA, its homologue in Pseudomonas aeruginosa (Akama et 
al., 2004; Higgins et al., 2004; Mikolosko et al., 2006). Despite sharing 62% sequence identity 
and 73% similarity, AcrA and MexA were unable to complement each other’s function 
(Tikhonova et al., 2002). Partial crystal structures of AcrA and MexA revealed three distinct 
domains: a β-barrel, a central lipoyl domain and an α-helical coiled coil hairpin (Ip et al., 
2003; Akama et al., 2004; Higgins et al., 2004; Mikolosko et al., 2006) (Figure 1.3 b). The β-
barrel domain has six anti-parallel β strands with a short α-helix (Zgurskaya and Nikaido, 
2000; Mikolosko et al., 2006). The lipoyl domain connects the α-helical hairpin and the 
β-barrel domain and is highly conserved among the family (Zgurskaya et al., 2008). The 
α-helical hairpin domain is the most varied region within the PAP family with some of the 
Gram negative members lacking this domain completely (Bunikis et al., 2008; Zgurskaya et 
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al., 2008).  The AcrA hairpin domain is 58 Å long and has been shown to be of great 
functional significance as deletion of the 74 residues which form the hairpin resulted in a 100 
fold decrease in the amount of AcrA protein and susceptibility to a range of antimicrobial 
substrates (Stegmeier et al., 2006). It was suggested that removal of the hairpin domain 
destabilised the protein, preventing a functional efflux complex from forming. It is the C-
terminal of the α-helical hairpin of AcrA which interacts with an intramolecular groove 
between the inner and outer periplasmic coiled coils of the outer membrane channel, TolC 
(Bokma et al., 2006; Stegmeier et al., 2006; Lobedanz et al., 2007). The complete structure of 
MexA and AcrA, published in 2009, is congruent with the earlier versions although it also 
includes the contribution of N and the C termini to the structure which was previously 
omitted due the apparent disordered nature of this domain (Symmons et al., 2009). The N 
terminus (residues 13-27) and C terminus (residues 262-339) together form the membrane 
proximal (MP) domain which is a compact β roll linked to the β barrel domain by a β-ribbon 
(Symmons et al., 2009) (Figure 1.3 b). 
The packing state and stoichiometry of AcrA in vivo has, until very recently, been unclear 
(Zgurskaya et al., 2008). In vitro, the soluble form of the protein appeared to be monomeric 
but subsequent cross-linking studies by the same authors appeared to show that only 
oligomers of three AcrA monomers could form complexes with each AcrB monomer 
(Zgurskaya and Nikaido, 1999a, 2000). X-ray structure analysis suggested  that four AcrA 
molecules were arranged as a dimer of dimers (Mikolosko et al., 2006) and another 
modelling approach suggested that a total of six AcrA molecules were present in the 
complex with two binding to each TolC monomer (Stegmeier et al., 2006). However, 
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evidence has been accumulating that three AcrA molecules are present in each functional 
AcrAB-TolC complex. It was previously suggested that AcrA exists as a trimer as seen in AcrB 
and TolC (Stenberg et al., 2005; Lobedanz et al., 2007). Recently, following the completion of 
the AcrA crystal structure, more evidence from modelling with the complete structures of 
the three components and validated by extensive cross-linking has supported a 
stoichiometry of 3 AcrB: 3 AcrA: 3 TolC (Symmons et al., 2009) (Figure 1.2). Interestingly, this 
is congruent with an earlier study which predicted that AcrA would be trimeric based upon 
known structures and predicting the most energetically favourable stoichiometric 
composition (Fernandez-Recio et al., 2004). However, this is in contrast with recent data 
suggesting that the stoichiometry of the interaction between MexA and OprM varies from 2 
to 6 MexA molecules per OprM trimer (Reffay et al., 2009). Two further putative RND 
systems have been described which include two different PAPs. The Tri-OpmH efflux system 
of P. aeruginosa required both TriA and TriB for full efflux function (Mima et al., 2007). 
Furthermore, the ZrpADBC of Serratia sp. was found to encode another efflux pump with 
two PAPs, ZrpA and ZrpD, however, only ZrpD was required for efflux function (Gristwood et 
al., 2008).  
Importantly, conformational flexibility has been revealed in the structure of both AcrA (Ip et 
al., 2003; Mikolosko et al., 2006) and MexA (Vaccaro et al., 2006). Conformational changes 
in AcrA were detected in vitro in response to acidic pH which is physiologically relevant 
because drug efflux is linked to pH fluctuations in the periplasm which could trigger changes 
in AcrA structure (Ip et al., 2003). Subsequently crystallisation revealed four different AcrA 
conformations (Mikolosko et al., 2006). The flexibility is thought to come predominantly 
44 
 
from the hinge between the lipoyl domain and the α-helical hairpin and β-barrel domains 
and is reversible. Further flexibility was revealed when the crystal structure of AcrA was 
completed as the newly modelled MP domain was shown to rotate (Symmons et al., 2009).  
1.8.4 A fourth component: YajC 
Crystal structures of endogenous AcrB complexed with a novel single transmembrane 
protein have recently been reported (Tornroth-Horsefield et al., 2007). Endogenous AcrB 
was successfully crystallised and the structure solved by X-ray diffraction. This predicted that 
AcrB formed a complex with a previously undescribed protein termed YajC once the AcrAB-
TolC efflux complex had assembled, inducing a functionally significant rotation of the porter 
domain of AcrB relative to the transmembrane domain. Deletion of YajC resulted in only a 
modest increase in susceptibility to ampicillin and nafcillin. Tornroth-Horsefield also 
suggested that the N-terminus of YajC could interact with AcrA and that AcrA could transmit 
the rotation in AcrB to TolC, facilitating the opening of the channel (Tornroth-Horsefield et 
al., 2007). 
1.9 Interactions between components of AcrAB-TolC 
The interaction between AcrA and TolC is between the α-helical hairpin domain of AcrA and 
the intra-molecular groove between the inner and outer periplasmic coiled coils of the outer 
membrane channel, TolC, and the lipoyl and β-barrel domains of AcrA project away from the 
TolC complex (Bokma et al., 2006; Stegmeier et al., 2006; Lobedanz et al., 2007). Importantly 
this model allows sufficient room for the movement of TolC during transition to its open 
state (Lobedanz et al., 2007). Similar observations have also been made for the interactions 
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between the PAPs MexA or MexE with the outer membrane proteins OprN or OprM showing 
that this is representative of the RND family as a whole and not unique to AcrAB-TolC (Eda et 
al., 2006; Stegmeier et al., 2006). 
The inner membrane domain of AcrB extends into the periplasm and interacts with the 
coiled coils of TolC. It was shown to interact with TolC by site-directed di-sulphide cross 
linking between cysteine residues on the tips of the hairpins of AcrB and the ends of the 
coiled coils of TolC (Tamura et al., 2005) although there is some evidence that AcrA is 
required to stabilise this interaction in vivo (Touze et al., 2004; Lobedanz et al., 2007; 
Symmons et al., 2009). 
The interaction between AcrA and AcrB occurs independently of TolC or a substrate 
(Zgurskaya and Nikaido, 2000). It has been shown for both MexA and AcrA, that C-terminal is 
involved in interaction with the RND pump (Elkins and Nikaido, 2003; Nehme et al., 2004; 
Nehme and Poole, 2007). The membrane proximal (MP) domain of AcrA interacts with the 
porter subdomains PN2 and PC1 while the β-barrel domain contacts the upper sections of 
these domains and also the docking domains DN and DC. The lipoyl domain of AcrA binds 
between the two halves of the TolC docking domain while the α-helical hairpin extends 
upwards to interact with TolC (Symmons et al., 2009). The surface of the PN2, PC1, DN and 
DC subdomains of AcrB, which are closely associated with AcrA, are relatively stable and do 
not undergo large conformational changes associated with the functionally rotating 
mechanism which has been described for AcrB (Murakami et al., 2006; Seeger et al., 2008a). 
On the periplasmic surface the largest conformational change comes from the PC2 domain 
which is spatially separated from the AcrA attachment site. Symmons and colleagues (2009) 
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suggest this indicates that once docked, the conformational change required of the PAP 
would be limited although the flexibility is probably required for assembly of the pump 
(Symmons et al., 2009). 
1.10 Mechanism of transport by AcrAB-TolC 
The understanding of the mechanism of action of the AcrAB-TolC efflux pump has advanced 
enormously in the last decade. In 2006, two teams showed that the three protomers of AcrB 
each exist in one of three different conformations at any one time and that this structure is 
central to its operation (Murakami et al., 2006; Schuldiner, 2006; Seeger et al., 2006). 
Murakami and colleagues referred to the three protomer conformations as access, binding 
and extrusion and suggest that AcrB functions in a three step binding change mechanism 
beginning with the substrate entering the protomer in the access state from the periplasm 
(Murakami et al., 2006) (Figure 1.4). At this point it is thought that the substrate binds to the 
inside of the binding pocket which then expands in size allowing the substrate to move 
inside, the protomer is then in the binding conformation. At this stage the exit from the 
channel, into the TolC funnel, is blocked by an inclined helical domain. The protomer enters 
the extrusion state as the entry to the binding pocket is closed, the substrate moves through 
the channel binding to different positions in the pocket and the exit is opened as the helix 
moves away from it. The bound substrate is then finally pushed out of the binding pocket 
and into the funnel towards TolC (Murakami et al., 2006). The binding pocket contracts as 
the subdomains PN1 and PC2 close (Sennhauser et al., 2007). As previously mentioned the 
conformational changes are powered by the proton motive force across the membrane 
through the protonation and de-protonation of three charged residues, Aspartate-407,  
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Figure 1.4 The proposed functionally rotating mechanism of the AcrB efflux pump of E. coli (Adapted from Schuldiner, 2006) 
 
a. The side view of the AcrAB-TolC complex during drug transport. The substrate is depicted as a red hexagon. 
b.  The proposed functionally rotating mechanism of AcrB. The drug enters the AcrB pump while it is in the ‘access’ conformation 
(purple and denoted by A) and binds to the complex in its ‘binding’ conformation (pink and denoted by B) and then exits the 
pump once it is in the extrusion conformation (blue and denoted by E) and the substrate is pushed towards the outer membrane 
channel, TolC. These conformational changes are powered by utilisation of the proton motive force.  
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Aspartate-408 and Lysine-940 in the transmembrane domain of AcrB (Murakami et al., 2006; 
Seeger et al., 2006; Takatsuka and Nikaido, 2006)t. 
 Biochemical evidence to support the functionally rotating mechanism has recently been 
published.  Seeger and colleagues (Seeger et al., 2008b) introduced constraining di-sulphide 
bonds between sub-domains of AcrB; these inhibited movement and pump function and 
increased susceptibility to toxic compounds. This effect was reversed after exposure to the 
reducing agent dithiothreitol, removing the constraints (Seeger et al., 2008b). Takatsuka and 
Nikaido (Takatsuka and Nikaido, 2009) took the novel approach of creating a single “giant 
gene” containing three acrB sequences connected by short linker sequences enabling 
inactivation of a single protomer in the trimeric complex. Inactivation of one protomer 
abolished the activity of the whole complex confirming that the AcrB trimer is the functional 
unit and providing strong evidence for the functionally rotating hypothesis (Takatsuka and 
Nikaido, 2009). 
From AcrB, the substrate must then progress through the outer membrane channel, TolC. 
The mechanism of opening of TolC was elucidated by removal of individual connections 
between α-helices of the same monomer and between different monomers which gradually 
increased conductance across the membrane representing slight relaxation of the tightly 
packed helices obstructing the entrance to the pore. Furthermore, elimination of multiple 
connections allowed the pore to open with the helices rearranging in an iris like movement 
(Andersen et al., 2002). In vivo support for this hypothesis comes from an opposing 
experimental strategy of creating a TolC channel that is locked in the closed conformation by 
covalent bonds which constrain the periplasmic aperture (Eswaran et al., 2003). This did not 
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prevent assembly of the Type I export machinery but abolished TolC mediated export 
demonstrating that untwisting of the α-helices is vital to TolC function (Eswaran et al., 2003). 
It has been postulated that in vivo this opening mechanism is triggered by recruitment of 
TolC by the inner membrane transporter which provides energy for the process (Thanabalu 
et al., 1998; Balakrishnan et al., 2001) and the conformation is then stabilised by the adaptor 
protein (Andersen et al., 2002). More recently, it has been suggested that the iris opening 
analogy may actually be too simplistic to describe the TolC opening and that an additional 
peristaltic motion in the periplasmic tunnel may aid movement of the substrate along the 
tunnel (Vaccaro et al., 2008).  
Another proposed mechanism is that, once AcrA is bound to AcrB, it then recruits TolC to the 
complex causing it to open and then the TolC channel remains in a constitutively open state, 
allowing the high-throughput transport displayed by this system (Symmons et al., 2009).  
The “data driven modelling” approach employed suggests that the interaction between TolC 
and AcrA was most favourable when TolC was in its open state and that closure of TolC is not 
required because substrates can pass straight from AcrB to TolC without leakage into the 
periplasm as the connection between the two components is successfully stabilised by AcrA 
(Symmons et al., 2009). 
1.10.1 The role of AcrA in transport by AcrAB-TolC  
Various hypotheses have been put forward for the precise role of AcrA and its PAP 
homologues in transport but no consensus has been reached. Firstly there is evidence that 
AcrA and MexA are involved in the assembly of the AcrAB-TolC pump complex (Mokhonov et 
al., 2004; Tikhonova and Zgurskaya, 2004; Touze et al., 2004; Ge et al., 2009; Symmons et al., 
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2009). Touze and colleagues (2004) have shown that the PAP is required for assembly of an 
active pump complex and other groups have suggested that AcrA is required to bring the 
outer and inner membrane components into close proximity (Tikhonova and Zgurskaya, 
2004; Touze et al., 2004; Zgurskaya et al., 2008).   
The periplasmic adaptor protein component could also be required to stabilise the pump 
complex (Touze et al., 2004; Lobedanz et al., 2007; Symmons et al., 2009). Symmons and 
colleagues, for example, suggest that three single AcrA molecules each bind to a single 
AcrB-TolC unit, stabilising the complex. In this model the link between the α-helical hairpin 
domain of AcrA and the coiled coils of TolC was most compatible when TolC was in the open-
state and the authors suggest that AcrA could stabilise the open conformation in the 
assembled tripartite pump (Symmons et al., 2009). 
Other studies suggest that AcrA is involved in conveying conformational changes in AcrB and 
mediating the opening of the outer membrane channel  or  actively transducing energy from 
AcrB to TolC (Ip et al., 2003; Mikolosko et al., 2006; Vaccaro et al., 2006; Bavro et al., 2008; 
Krishnamoorthy et al., 2008). The proposed mechanism for this involves protein-protein 
interactions between the coiled coil hairpin of AcrA, which has been demonstrated to have 
considerable conformational flexibility, and the coiled coils of TolC. However, it is as yet 
unclear whether the observed conformational changes in AcrA play an active role in opening 
the outer membrane channel to allow efflux or whether it in fact it is passive (Mikolosko et 
al., 2006).  Interestingly, the extent of conformational change demonstrated in AcrA is of a 
similar magnitude to that seen during the opening of the TolC channel leading to speculation 
that AcrA could facilitate the opening of the channel (Koronakis et al., 2000; Andersen et al., 
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2002; Ip et al., 2003; Mikolosko et al., 2006; Bavro et al., 2008).  Bavro and colleagues 
suggest a model in which sequential interplay from all three components is required. They 
propose that conformational change in an activated AcrB causes partial opening of TolC 
which exposes an inter-protomer groove, allowing AcrA to properly bind which conveys the 
energy from AcrB, driving the complete opening of the TolC channel (Bavro et al., 2008). 
Recent evidence following the publication of the complete AcrA structure suggests that this 
may be unlikely as only limited conformational change is actually required of AcrA in their 
fully assembled model. While the authors accept that transmission of conformational 
change by the PAP is not precluded, they suggest it is unlikely as the adaptor protein is 
bound to areas of the AcrB which do not undergo significant conformational changes  and 
put forward the hypothesis that, once fully assembled, the TolC channel remains 
constitutively open (Symmons et al., 2009). 
Several other periplasmic adaptor proteins have been shown to have a role in substrate 
binding although this process is not well understood (Balakrishnan et al., 2001; Borges-
Walmsley et al., 2003; Bagai et al., 2007). For example, the PAP EmrA of E. coli has been 
shown to have a drug binding site and the authors speculated that it may have a role in 
transferring substrates to the outer membrane channel (Borges-Walmsley et al., 2003). The 
recently published structure of the assembled tri-partite AcrAB-TolC efflux pump of E. coli 
showed that the AcrA protein is not in contact with the cleft between the PC1 and PC2 
subdomains which is important for substrate access but the authors point out that a 
hydrophobic binding pocket between the PN2 and PC1 subdomains is very close to the site 
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of binding of the PAP membrane proximal domain and therefore a role for the PAP in 
substrate cannot be ruled out (Symmons et al., 2009). 
Finally, it has also been suggested that AcrA is able to modulate the activity level of the RND 
pump. The first evidence for this was presented by Zgurskaya and colleagues (1999) who 
demonstrated that transport and energy consumption by purified AcrB reconstituted into 
proteoliposomes was dramatically increased by addition of AcrA (Zgurskaya and Nikaido, 
1999b). Furthermore, experiments with purified AcrD (a homologue of AcrB) reconstituted 
into proteoliposomes showed that it could transport aminoglycoside antibiotics, in a pH 
dependent fashion, but that activation by AcrA was required for this process (Aires and 
Nikaido, 2005). The PAP MtrC from Neisseria Gonorrhoeae has been shown to have a role in 
activating the RND pump, MtrD (Zhang et al., 2009). 
1.11 Genetic organisation of AcrAB-TolC 
The acrA and acrB genes in E. coli and S. Typhimurium are found together in a single operon, 
separated by only 22 base pairs. The local repressor, acrR, is also co-located with acrAB but 
is divergently transcribed (Ma et al., 1996). The tolC gene is encoded separately on the 
genome. The acrAB locus of E. coli was first mapped in 1965 by analysis of acriflavine 
sensitive E. coli  mutants (Nakamura, 1965). 
In E. coli there are two transcription start sites, one upstream of acrA, from which 
transcription of the acrAB transcript is initiated. More recently another transcription start 
site has been described 282 base pairs upstream of acrB (and within acrA) from which 
transcription of acrB alone begins although experimental evidence for this in the literature is 
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limited (Gama-Castro et al., 2008) (Figure 1.5). However, this is congruent with earlier data 
from this laboratory where a northern blot using an acrB probe showed two distinct bands 
suggesting the presence of two acrB transcripts of differential size (Webber, 2002). Both of 
the transcriptional start sites described are conserved in Salmonella suggesting the 
mechanism is likely to be the same. 
The ribosomal binding sites upstream of acrA and acrB have not been experimentally 
defined. The lack of a defined second ribosomal start site upstream of acrB means that 
translational coupling remains a possibility. Translational coupling is the sequential 
translation of the products of multiple genes, found in the same operon, without the need 
for the ribosome to disengage. Instead the ribosome terminates translation of one gene and 
then immediately initiates translation of the next. Translational coupling allows the ratio of 
two related gene products to be maintained and removes the requirement for a second 
ribosomal binding site (Inokuchi et al., 2000; Saier, 2008).  
1.12 Control of AcrAB-TolC expression  
Expression of efflux pump genes is subject to multiple levels of regulation by a complex array 
of regulatory genes (Figure 1.6). The acrAB genes are regulated at a local level by the 
product of the acrR gene which represses transcription of acrAB (Ma et al., 1996). AcrR is a 
member of the TetR family of transcriptional regulators which have a helix-turn-helix DNA 
binding motif at the N-terminal and a ligand binding domain at the C-terminal.  The acrR 
gene is located 141 bp upstream of the acrA gene and is transcribed divergently (Figure 1.5 
and 1.6). It was shown in E. coli that the AcrR protein prevents transcription of acrAB by 
binding to a 24 bp palindromic inverted repeat sequence between the acrR and  
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Figure 1.5 The genetic organisation of acrAB in E. coli 
 
 
 
 
 
 
 
 
 
 
 
 
Diagram from www.ecocyc.org Green boxes represent transcriptional activators. Pink boxes represent transcriptional repressors. 
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Figure 1.6 The regulation of acrAB-tolC transcription 
 
 
 
 
Figure courtesy of Dr Mark Webber, University of Birmingham 
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acrA genes which overlaps with the acrAB promoter sequence (Su et al., 2007b). It is thought 
that transcription of acrAB is achieved when ligands such as ethidium bromide bind to the C-
terminal of AcrR, causing conformational changes in the regulatory protein. This results in 
dissociation of AcrR from its target DNA sequence allowing transcription of the acrAB genes. 
AcrR and AcrB respond to the same ligands with very similar affinities so, at the local 
regulatory level, presence of a pump substrate, such as ethidium bromide, acts as a ligand to 
the local repressor protein, allowing transcription of acrAB and subsequent production of 
the efflux system which pumps out the toxic substance (Su et al., 2007a; Su et al., 2007b). In 
Salmonella enterica serovar Choleraesius a mutation in the acrR gene, causing insertion of a 
stop codon, resulted in over-expression of acrAB and this contributed to ciprofloxacin 
resistance (Chiu et al., 2005). 
AcrAB is also regulated at the global level where the predominant regulators in S. enterica 
are the RamA, MarA, SoxS and Rob which are members of the XylS/AraC family of 
transcriptional regulators. RamA is a transcriptional activator of acrAB found in S. enterica, 
Enterobacter cloacae and Klebsiella pneumoniae  but not in E. coli (van der Straaten et al., 
2004; Ruzin et al., 2005; Keeney et al., 2007). RamA is responsible for causing up-regulation 
of transcription of acrAB-tolC in response to environmental signals such as indole by binding 
to sites upstream of both acrAB and tolC (Nikaido et al., 2008). When ramA was inactivated, 
expression of acrB was reduced but antibiotic susceptibility was unaffected (van der Straaten 
et al., 2004; Bailey et al., 2008). High level over-expression of ramA in S. Typhimurium led a 
15 fold increase in expression of acrB and conferred resistance to nalidixic acid, 
chloramphenicol, tetracycline and triclosan (Bailey et al., 2008). Over-expression of ramA 
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has also  been detected in MDR laboratory mutants and clinical and veterinary isolates 
where it is linked with increased expression of AcrAB, AcrEF and MdtABC (Giraud et al., 
2000; Piddock et al., 2000; Abouzeed et al., 2008; Bailey et al., 2008; Feuerriegel and Heisig, 
2008; O'Regan et al., 2009; Zheng et al., 2009). For example Zheng and colleagues (2009) 
recently reported that a nine bp deletion in the ramA promoter led to constitutive 
expression of ramA, which was directly associated with over-expression of acrAB and acrEF 
leading to an MDR phenotype (Zheng et al., 2009). 
Expression of ramA is controlled by the transcriptional repressor RamR. Inactivation of ramR 
led to over-expression of ramA, which caused four-fold over-expression of the acrAB and 
subsequent MDR (Abouzeed et al., 2008). In addition, fluoroquinolone and quinolone 
resistant isolates of S. Typhimurium were shown to have non-synonymous point mutations 
in ramR causing over-expression of AcrAB (Abouzeed et al., 2008). 
Unlike RamA, the transcriptional activators MarA, SoxS and Rob are found in both 
Salmonella and E. coli between which they share significant homology and function. SoxS is 
another member of the AraC/Xyls family of transcriptional regulators and is responsible for 
activation of at least a dozen genes involved in the response to oxidative stress including 
acrB (White et al., 1997). SoxS is regulated by SoxR which is co-located with soxS on the 
genome. The soxS and soxR genes are separated by only 85 bp and are divergently 
transcribed (Amabile-Cuevas and Demple, 1991). The SoxR protein is activated by either 
oxidation (Nunoshiba et al., 1992) or nitrosylation (Ding and Demple, 2000) causing it to 
induce expression of SoxS and subsequent expression of acrAB. In E. coli increased 
expression of soxS was shown to contribute to MDR in six post-therapy isolates (Webber and 
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Piddock, 2001). Furthermore, a similar effect was caused by a mutation in soxR causing 
constitutive expression of both soxR and consequently soxS, which contributed to the 
multiple antibiotic resistance phenotype of three clinical isolates (Koutsolioutsou et al., 
2005). Constitutive expression of soxRS can also contribute to MDR in Salmonella. A post 
therapy clinical isolate of S. Typhimurium had a point mutation in the soxR gene, causing 
constitutive expression and consequent quinolone resistance (Koutsolioutsou et al., 2001). 
The multiple antibiotic resistance or mar locus of E. coli and Salmonella consists of the genes 
marA, marB, marC and marR. MarA is a DNA binding transcriptional activator which controls 
the expression of over 60 genes in E. coli, including acrAB and tolC, by binding to a consensus 
sequence called the ‘marbox’ close to the promoter of genes in the regulon (Okusu et al., 
1996; Martin et al., 1999; Barbosa and Levy, 2000). Inactivation of marA in antibiotic 
resistant strains of E. coli abolished the resistance phenotype (Cohen et al., 1993). 
Furthermore, loss of function mutations in the local repressor, marR, led to over-expression 
of marA and to increased resistance to various antibiotics (Maneewannakul and Levy, 1996; 
Okusu et al., 1996). 
Expression of E. coli marA in S. Typhimurium conferred the multiple antibiotic resistance 
phenotype, showing the similarity of the Mar protein and regulon in the two species (Sulavik 
et al., 1997). Elevated levels of MarA were detected along with increased expression of AcrB, 
AcrD and AcrF in MDR post therapy isolates of Salmonella Typhimurium and inactivation of 
acrB or acrF caused a compensatory upregulation of marA (Eaves et al., 2004b) 
Another member of the XylS/AraC family, Rob, is a constitutively expressed and involved in 
organic solvent tolerance. In E. coli over-expression of Rob, was reported to cause an 
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increase in antimicrobial resistance and up-regulation of acrAB by 1.9 fold  (Linde et al., 
2004). Deletion rob increased susceptibility to organic solvents while over-expression led to 
resistance and moderate levels of drug resistance, due to slight over-expression of AcrAB-
TolC (White et al., 1997; Bennik et al., 2000). 
 Recently another regulatory gene, acrS, which is located upstream of acrEF, has also been 
shown to have a regulatory effect on acrAB (Hirakawa et al., 2008). 
1.13 Promiscuity of AcrAB-TolC components  
Although the components of the AcrAB-TolC pump function together as a tri-partite pump, 
this is not the only context in which the individual components can function. For example In 
E. coli, TolC has been shown to be required for the function of at least seven other efflux 
systems. These include the RND pumps AcrD (Hirakawa et al., 2003; Nishino et al., 2003), 
AcrEF (Nishino et al., 2003), MdsAB (Nishino et al., 2006) and MdtABC (Nagakubo et al., 
2002), as well the MFS systems EmrAB and EmrKY (Nishino and Yamaguchi, 2002) and the 
ABC drug transporter MacAB (Kobayashi et al., 2001b). Over-expression of acrD in a strain 
lacking functional AcrB conferred a significant rise in β-lactam resistance but this resistance 
was not seen when acrD was over-expressed in a strain which also lacked tolC suggesting 
that TolC was required for the function of this pump (Nishino et al., 2003).   
AcrA has also been shown to associate with at least three other transporters. These include 
AcrD (Elkins and Nikaido, 2002, 2003), AcrF (Kobayashi et al., 2001a; Elkins and Nikaido, 
2003) and MdtF (Elkins and Nikaido, 2003). The ability of AcrD to efflux amphiphilic 
substrates, such as novobiocin and bile salts, was shown to be dependent on the presence of 
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AcrA. Furthermore, cross-linking studies followed by immunoblotting with anti-AcrB and 
anti-AcrA antibodies showed that AcrA can form stable complexes with both AcrB and AcrD 
(Elkins and Nikaido, 2002). Both the promiscuous interactions described have been 
confirmed by Hirakawa and colleagues (Hirakawa et al., 2003) who showed that 
over-expression of AcrD in a ΔacrB background gave resistance to novobiocin but when AcrD 
was over-expressed in either a ΔacrAB or ΔtolC background this increase in resistance was 
not seen. This implicates both AcrA and TolC in interactions with AcrD (Hirakawa et al., 
2003). 
Further insights into the functional associations of pump components have been gained 
from experiments in which components of AcrAB-TolC from E. coli and the homologous 
MexAB-OprM system from P. aeruginosa were combined to make chimeric pumps 
(Stegmeier et al., 2006; Krishnamoorthy et al., 2008). E. coli AcrAB will form a non-functional 
complex with the outer membrane channel of P. aeruginosa, OprM (Stegmeier et al., 2006). 
Furthermore, a partly functional chimera consisting of AcrA with MexB and TolC can be 
formed, giving resistance to some, but not all, MexB substrates (Krishnamoorthy et al., 
2008). Mutations were identified which restored full functionality to the chimeric pump and 
as a result it was suggested that the reduced functionality was probably due to misalignment 
between the foreign components. This chimeric approach shows that the functional 
association of efflux pump components contains a degree of flexibility. However, this 
flexibility is not complete as neither MexAB-TolC, MexA-AcrB-TolC nor AcrA-MexB-OprM 
combinations  were functional (Krishnamoorthy et al., 2008). Furthermore, while AcrB can 
be forced to make promiscuous interactions with efflux pump components other than AcrA 
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and TolC, there is no evidence that it does so naturally. However, AcrB has recently been 
shown to have a role in a completely separate process, contact-dependant growth inhibition 
(CDI), possibly as a downstream target for the CDI signal, and this is independent of both 
AcrA and TolC (Aoki et al., 2008).  
1.14 The Physiological Role of AcrAB-TolC  
In addition to an established role in innate antimicrobial resistance, MDR efflux pumps, 
including AcrAB-TolC, have been shown contribute to the basic biology of various pathogens 
(Piddock, 2006b). Work in this laboratory has contributed to this theory. Various efflux 
mutants (including acrB::aph and tolC::aph) were constructed and the effect of the 
mutations on the antibiotic susceptibility and virulence was investigated (Eaves et al., 2004a; 
Buckley et al., 2006). Tissue culture experiments showed that acrB mutants retained their 
ability to adhere to human embryonic intestine cells (INT-407) but invaded poorly (Buckley 
et al., 2006). Conversely, in mouse macrophages (RAW 264.7) the mutants lost the ability to 
invade in vitro. Mutants lacking tolC adhered poorly to both INT-407 and RAW 264.7 cells 
lines in vitro and could not invade the mouse macrophages (Buckley et al., 2006). Electron 
microscopy revealed that the acrB and tolC mutants induced fewer membrane ruffles on the 
surface of infected INT-407 cells. Furthermore, in vivo experiments in the avian host (in 
collaboration with Professor Martin Woodward at the Veterinary Laboratories Agency in 
Surrey) showed that colonisation and persistence was significantly reduced in mutants 
lacking either acrB or tolC. Complementation ablated the mutant phenotypes in both cases 
(Buckley et al., 2006). This work showed that the AcrB and TolC proteins are needed for 
adhesion and invasion of S. Typhimurium in vitro and colonisation and persistence in the 
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chicken so therefore have an important role in virulence. This work fitted well with a 
growing body of evidence that RND systems are required for the virulence of several species 
as mutants lacking functional RND efflux systems or components thereof are attenuated 
(Stone and Miller, 1995; Lacroix et al., 1996; Hirakata et al., 2002; Jerse et al., 2003; Lin et 
al., 2003; Burse et al., 2004; Chan and Chua, 2005; Buckley et al., 2006; Nishino et al., 2006; 
Piddock, 2006b; Bina et al., 2008; Bunikis et al., 2008). AcrB was shown to be required for 
the intestinal colonisation of mice and also for resistance to detergents including bile 
(Lacroix et al., 1996). Nishino and colleagues reported that S. Typhimurium lacking the 
AcrAB-TolC or MacAB efflux systems had attenuated virulence in the mouse model after 
intragastric inoculation and that when nine other drug efflux genes were deleted 
simultaneously the resulting strain was rendered completely avirulent in this model (Nishino 
et al., 2006). AcrAB-TolC of the plant pathogen Erwinia amylovora is needed for virulence 
(Burse et al., 2004) while MtrCDE (homologous to AcrAB-TolC) was required for survival of 
Neisseria gonorrhoeae in the female mouse genital tract model (Jerse et al., 2003) and the 
MexAB-OprM mutants of P. aeruginosa had a reduced ability to invade Madin-Darby Canine 
Kidney (MDCK) cells (Hirakata et al., 2002). More recently, the same team has shown that 
addition of the efflux pump inhibitor PAβN significantly reduced the invasive ability of P. 
aeruginosa in a concentration dependant manner (Hirakata et al., 2009). C. jejuni lacking the 
CmeABC efflux pump (homologous to AcrAB-TolC), which mediates resistance to bile in the 
intestinal tract, could not colonize chickens. Furthermore, oral administration of the efflux 
pump inhibitor PAβN to chickens 2-4 days post inoculation with  C. jejuni  significantly 
reduced colonisation suggesting that the reduction in virulence was due, at least in part, to a 
reduction in efflux (Lin et al., 2003; Lin and Martinez, 2006). Collectively, these data provide 
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compelling evidence these efflux systems are vital for pathogenicity and virulence of a range 
of Gram-negative bacteria.  
The contribution of these efflux systems to pathogenicity can be partially explained by the 
finding that many MDR efflux pumps, or certain components thereof, are also responsible 
for exporting host derived substrates such as bile salts, steroid hormones and fatty acids 
allowing the bacteria to survive within the hostile host environment (Ma et al., 1995; 
Thanassi et al., 1997; Elkins and Mullis, 2006; Drew et al., 2008). Deletion of acrAB in E. coli 
led to increased susceptibility to bile salts and decanoate (a fatty acid) and the expression of 
these genes were elevated in the presence of decanoate (Ma et al., 1995; Rosenberg et al., 
2003; Nikaido et al., 2008). Furthermore, expression of acrAB in Salmonella Typhimurium 
and acrD, acrE, emrK, mdtA, and mdtE of E. coli are induced by the presence of indole or 
bile, both of which are present in the human intestine, allowing these toxic compounds to be 
exported permitting bacterial survival within the host (Hirakawa et al., 2005; Nikaido et al., 
2008). The affinity of AcrAB from E. coli to a range of substrates was measured following in 
vitro reconstitution of AcrAB into proteoliposomes. The results showed that AcrAB had a far 
greater affinity for bile acids than for the antibiotics tested and the authors suggest this 
shows that AcrB is better adapted for the efflux of bile acids and that this is the function for 
which it evolved (Zgurskaya and Nikaido, 1999b; White et al., 2005). Numerous genome 
wide mutagenesis studies of S. Typhimurium have been reported which aimed to identify 
genes involved in virulence in the mouse model. Interestingly, in three studies which all used 
the intraperitoneal method of infection, none identified the AcrAB-TolC system as being 
important for virulence (Lawley et al., 2006; Chaudhuri et al., 2009; Santiviago et al., 2009). 
64 
 
This suggests that, while these proteins appear to be important for oral infection, where 
Salmonella would have to survive the hostile environment of the gut and resist the 
antimicrobial effects of bile, they are not needed when inoculation is directly into the 
peritoneal cavity.  
Another class of host derived molecules which are substrates of RND efflux pumps are the 
antimicrobial peptides (AMPs) (Shafer et al., 1998; Tzeng et al., 2005; Eswarappa et al., 
2008). AMPs are produced by various host cells including the epithelia of the gastrointestinal 
tract and exert their antimicrobial effect by insertion into the negatively charged bacterial 
membrane, creating channels which cause osmotic damage. The human AMP LL-37 and the 
porcine protegrin-1 are substrates of the MtrCDE complex of Neisseria gonorrhoeae leading 
to the hypothesis that efflux may have evolved as a mechanism to circumvent the innate 
antimicrobial defences of the host (Warner et al., 2008). Furthermore, mutation of mtrR, 
which represses mtrCDE transcription, led not only to increased resistance to antimicrobials 
including host derived peptides, but also to an increase in fitness in the in vivo mouse model 
of infection suggesting that resistance to AMPs could contribute to virulence (Warner et al., 
2007; Warner et al., 2008; Folster et al., 2009).  AMPs may not be substrates of all RND 
pumps or may have a species specific role as resistance to several AMPs was not affected by 
mutation of acrAB in E. coli or mexAB of P. aeruginosa (Rieg et al., 2009). However, in 
contrast, another team have suggested that AcrAB-TolC along with regulators thereof are in 
fact involved in resistance to human AMPs including LL-37, Polymyxin B and β-defensins as 
deletion of acrB or tolC increased susceptibility to these AMPs (Warner and Levy, 2009). 
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Furthermore, over-expression of marA in the presence of AcrAB decreased susceptibility to 
these AMPs (Warner and Levy, 2009).  
However, the transport of host derived molecules does not explain the attenuation seen in 
vitro as these host factors are largely absent. Hirakata and colleagues showed that the 
reduction in invasiveness seen in P. aeruginosa mutants lacking MexAB-OprM was restored 
not only by complementation of the disrupted genes but also by addition of culture 
supernatant from MDCK cells infected with wild-type P. aeruginosa (Hirakata et al., 2002). 
This suggests that an exported factor, present in the supernatant, is able to ameliorate the 
adhesion and invasion defects in the mutant. 
Alternatively, it has been proposed that the impaired ability of efflux mutants to cause 
infection could be due to altered expression of other genes or groups of genes that are 
linked to the ability to cause infection. For Salmonellae the attenuation due to lack of TolC 
has been associated with reduced expression of SPI-1 genes and subsequently reduced 
secretion of T3SS-1 effectors (Virlogeux-Payant et al., 2008; Webber et al., 2009). Likewise, 
inactivation of acrB led to reduced expression of SPI-1 genes and its effectors and  other 
pathogenicity related genes (Webber et al., 2009). Webber et al., (2009) also showed that 
lack of functional AcrA was associated with decreased expression of genes found in SPI-2. 
Inactivation of acrA, acrB or tolC had different effects on the transcriptome. For example, 
expression of genes involved in anaerobic metabolism were increased in the absence of AcrA 
but decreased in the absence of AcrB although both strains had an impaired ability to grow 
in anaerobic conditions. Also, changes in motility gene expression was seen following 
inactivation of acrB or tolC, but not acrA though only the acrB mutant had reduced motility 
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compared to wild-type (Webber et al., 2009).  This suggests that the attenuation of virulence 
in strains lacking AcrA, AcrB or TolC could be mediated by different mechanisms. 
Another suggestion is that AcrAB-TolC and its homologues are also responsible for the 
export of metabolic products (Helling et al., 2002; Poole, 2005; Huang et al., 2008; Rosner 
and Martin, 2009). Rosner and Martin recently hypothesised that in E. coli intracellular 
accumulation of toxic bacterial metabolites during growth led to up-regulation of MarA, SoxS 
and Rob, which stimulates production of the TolC protein to remove the metabolites (Rosner 
and Martin, 2009). This is in agreement with an earlier study by Helling and colleagues 
suggesting that AcrAB-TolC is required to export products of normal metabolism to prevent 
them building up to toxic levels (Helling et al., 2002).  
A further novel physiological role for AcrB in E. coli in contact-dependent growth inhibition 
(CDI) has been proposed that is independent of both AcrA and TolC (Aoki et al., 2008). CDI is 
the regulation of growth via cell to cell contact and significant numbers of mutants with 
resistance to CDI showed mutations in acrB or bamA, the latter of which is a member of the 
Omp85 family of essential outer membrane proteins. The specific role of AcrB in this process 
has not been elucidated but it may be a downstream target for the CDI signal (Aoki et al., 
2008). 
Other possible explanations for the involvement of efflux pumps in pathogenicity will be 
investigated during this project. 
Hypotheses 
The hypotheses to be explored in this project are: 
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 Inactivation of acrA will confer hypersusceptibility to a range of antimicrobial 
compounds. 
 Inactivation of acrA will attenuate the ability of S. Typhimurium to infect INT-407 
cells and RAW 263.7 cells in vitro. 
 A virulence related factor is exported by AcrAB-TolC but is not exported, or not 
exported efficiently in the mutants lacking components of the system. Exogenous 
addition of this factor may be able to restore the virulence defect of the efflux 
mutants. 
 
Aims and objectives  
 To inactivate acrA in Salmonella Typhimurium and ensure that acrB/AcrB is still 
expressed. 
 To characterise the effect of lack of AcrA on the growth, innate antimicrobial 
resistance profile, bacterial morphology and level of Hoechst H33342 accumulation 
(efflux activity). 
 To determine the effect of lack of AcrA on the ability of SL1344 to infect INT-407 cells 
and RAW 264.7 in vitro. 
 To determine whether a virulence related factor, exported by AcrAB-TolC in SL1344, 
is able to restore the invasiveness of the efflux mutants. 
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Chapter Two 
Materials and Methods  
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2. Materials and Methods 
2.1 Bacterial strains, growth, storage and identification 
Salmonella enterica serovar Typhimurium SL1344 (laboratory code, L354; Table 2.1) was used as the 
wild-type strain (Wray and Sojka, 1978). This strain was chosen because it is a pathogenic strain 
isolated from an experimentally infected calf. This means that aspects of pathogenesis and virulence 
can be studied using this strain unlike another common type strain, LT2, which is avirulent due to a 
mutation in the rpos gene (Wilmes-Riesenberg et al., 1997). This strain has also been used for 
previous work on Salmonella in this and multiple other laboratories.  
The acrA gene of SL1344 was inactivated by insertion of the aph gene, conferring kanamycin 
resistance, to give an acrA mutant with the laboratory code L823 (acrA::aph). The disrupted acrA 
region was transduced into SL1344 giving L884 (section 2.3), the aph gene was removed from L823 
and L884 giving L976 and L978 (Section 2.4) and acrA was cloned into pWKS30 and transformed into 
L354, L823 and L884 giving L980, L975 and L979, respectively (Section 2.5) (Table 2.1). The 
phenotype of the acrA mutants was compared to other mutants previously constructed in this 
laboratory: L109 (tolC::aph; transductant of original mutant L108) and L110 (acrB::aph; transductant 
of original mutant L643) (Eaves et al., 2004; Buckley et al., 2006).  
All strains were routinely grown on Luria-Bertani (LB) agar (Sigma-Aldrich Ltd., UK), supplemented 
with appropriate antibiotics where necessary, and incubated overnight at 37°C (Table 2.2). Overnight 
cultures were grown in LB broth (Sigma-Aldrich Ltd., UK), supplemented with appropriate antibiotics 
where necessary, and incubated overnight at 37°C with aeration. Where stated, minimal media 
(Teknova) was also used. Minimal media was prepared by adding 100ml of 10 x MOPs buffer 
(Teknova, M2101) to 10ml 20% Glucose (Teknova, G0520), 10ml 0.132M Potassium phosphate 
(Teknova, M2102). L- Histidine was also added to a final concentration of 45 mM because SL1344 is a  
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Table 2.1 Strains used during this study 
Birmingham Code Genotype/plasmid 
Resistance 
Phenotype 
Reference 
L354 S. enterica serovar Typhimurium 
SL1344 
 Wray and Sojka, 1978 
I633 E. coli K12 with pKD4 AmpR, Kan R. Datsenko and Wanner, 
2000 
L642 SL1344 with pKD46 AmpR Datsenko and Wanner, 
2000 
L108 SL1344 tolC::aph  KanR Buckley et al., 2006 
L109 SL1344 tolC::aph  
Transduced from L108 to SL1344 
using P22 phage 
KanR Buckley et al., 2006 
L742 ΔtolC 
L108 treated with pCP20 
KanS Eaves, unpublished 
data 
L643 SL1344 acrB::aph KanR Eaves et al., 2004 
Buckley et al., 2006 
L110 SL1344 acrB::aph.  
Transduced from L643 to SL1344 
using P22 phage 
KanR Eaves et al., 2004 
Buckley et al., 2006 
L644 ΔacrB 
L643 treated with pCP20 
KanS Buckley et al., 2006 
L823 
 
 
SL1344 acrA::aph  KanR This study  
L884 SL1344 acrA::aph 
Transduced from L823 to SL1344 
using P22 phage 
KanR This study 
L976 ΔacrA 
 L884 treated with pCP20.  
KanS This study 
I906 E. coli K12 with pWKS30 vector AmpR Wang and Kushner, 
1991 
L917 SL1344 with pWKS30 vector  AmpR This study 
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L918 L823 with pWKS30 vector AmpR, Kan R. This study 
L996 L884 with pWKS30 vector AmpR, Kan R This study 
I750 E. coli DH5α with pWKS30acrA AmpR This study 
L980 SL1344 with pWKS30acrA AmpR This study 
L975 L823 with pWKS30acrA AmpR, Kan R. This study 
L979 L884 with pWKS30acrA AmpR, Kan R This study 
L1019 SL1344 with pUA66pacpP Kan R This study 
L1020 L644 (ΔacrB) with pUA66pacpP Kan R This study 
L1021 L742 (ΔtolC) with pUA66pacpP Kan R This study 
L1022 L976 (ΔacrA) with pUA66pacpP Kan R This study 
kan, kanamycin; amp, ampicillin 
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Table 2.2 Antibiotics, dyes and detergents used in this study 
Agent Solvent Supplier 
Ampicillin Sodium Bicarbonate and Water Fluka Biochemika, Sigma-
Aldrich, UK 
Kanamycin Water Fluka Biochemika, Sigma-
Aldrich, UK 
Ethidium Bromide Water Sigma-Aldrich, UK 
Fusidic Acid Water Sigma-Aldrich, UK 
Acriflavine Water Sigma-Aldrich, UK 
Bile Water Fluka Biochemika, Sigma-
Aldrich, UK 
SDS 
(Lauryl Sulphate) 
Water Sigma-Aldrich, UK 
Triclosan 
 
70% Methanol Sigma-Aldrich, UK 
Nalidixic acid Sodium Hydroxide and Water Sigma-Aldrich, UK 
Ciprofloxacin Acetic Acid and Water Sigma-Aldrich, UK 
Chloramphenicol 70% Methanol Sigma-Aldrich, UK 
Tetracycline Water Sigma-Aldrich, UK 
Gentamicin - Sigma-Aldrich, UK 
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histidine auxotroph. This mixture was made up to 1 L with H20 and filter sterilised. ProtectTM beads 
(Technical Service Consultants Ltd, UK) were used for long term storage. Salmonella strains were 
stored at -20°C and E. coli strains were stored at -80°C. 
For identification purposes all bacteria were grown on Salmonella-selective Xylose Lysine 
Deoxycholate (XLD) agar (Sigma-Aldrich Ltd., UK) and MacConkey agar (Sigma-Aldrich Ltd., UK). The 
appearance of colonies with black centres on XLD suggested that the bacteria present were 
Salmonella while on MacConkey agar white/colourless colonies were indicative of Salmonella. The 
bacteria were all Gram stained and subsequently observed microscopically to ensure they were rod 
shaped Gram negative bacteria. Analytical profile index (API) testing, (Biomerieux, France) was used 
according to the manufacturer’s instructions to check bacterial identity. Serotyping was performed at 
the Veterinary Laboratories Agency, Surrey. 
2.2 Disruption of acrA in S. Typhimurium 
The acrA gene was inactivated using the protocol described by Datsenko and Wanner (2000). This 
method causes disruption of chromosomal genes by homologous recombination with PCR products 
containing the aph gene whose product provides kanamycin resistance. This relies on the plasmid 
encoded λ red recombination system, which is based on the recombination systems found naturally 
in bacteriophages. In the first instance the aph gene was amplified from the pKD4 plasmid using 
primers that also have 40 bp of homology to the gene of interest. The second stage involves 
transforming the recipient strain, containing the pKD46 plasmid, with the PCR construct. 
Homologous recombination follows, mediated by the λ red recombinase system, to leave a mutant 
with the chromosomal gene of interest disrupted by the kanamycin resistance gene, aph. Mutants 
are then selected by growing on LB agar supplemented with 25μg/ml kanamycin (Datsenko and 
Wanner, 2000). 
74 
 
2.2.1 Isolation of the pKD4 plasmid 
The pKD4 plasmid (Table 2.3) was isolated from E. coli strain I633. The strain was grown overnight at 
30°C in LB broth with 50 µg/ml of ampicillin. The QIAprep® Miniprep Kit (QIAGEN, 27104) was used to 
harvest the plasmid, following the low copy number protocol to ensure maximum yield.  
Agarose gels were prepared by adding 1 g of electrophoresis grade agarose (Invitrogen Ltd, UK, 
15510-027) to 100 ml of 1% Tris-Boric acid-EDTA (TBE). The agarose was dissolved by heating in a 
650 W microwave for approximately 90 seconds. The solution was allowed to cool before ethidium 
bromide was added to a final concentration of 0.1 µg/ml. The molten agarose was poured into a gel 
tray and allowed to set before being immersed in 1% TBE in the gel tank. Five micro litres of each 
sample was then loaded onto the gel along with a DNA sizing ladder of suitable size range (Bioline). 
Electrophoresis was used to separate the samples at 100 volts for one hour.  
The quantity of plasmid collected was determined using the ‘Gene genius’ image analyser (Syngene, 
UK) and the Gene Tools software package (Syngene). The stock of isolated plasmid was stored at 
-20°C. 
2.2.2 Generation of the PCR product to inactivate acrA 
Primers 568 and 569 (Table 2.4) were designed using the PRIMER v.2.00 software (Scientific and 
Educational Software, UK). All primers were produced by Invitrogen (Invitrogen Ltd., UK) and are 
listed in Table 2.4. On arrival the primers were re-hydrated with UltraPure water (Invitrogen, UK) to a 
concentration of 100 μM and from this 25 μM working stock solutions of each primer were made. All 
primers were stored at -20°C. 
 Each primer had 40bp of homology to the target gene, acrA, 20bp of homology to the aph gene 
coding for kanamycin resistance which is found on the PKD4 plasmid and also a 3’ GC clamp. The  
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Table 2.3 Plasmids used in this study 
 
 
kan, kanamycin; amp, ampicillin 
Plasmid Description Antibiotic Resistance 
Determinants 
Reference 
pKD4 Used as PCR template to create construct for insertion into the gene of 
interest 
AmpR. KanR. Datsenko & Wanner, 2000 
pKD46 Encodes the  red recombination system to aid homologous 
recombination.  
AmpR. Datsenko & Wanner, 2000 
pCP20 Temperature sensitive plasmid which encodes the FLP gene whose 
product removes FLT-flanked antibiotic resistance determinants.  
AmpR. Datsenko & Wanner, 2000 
pWKS30 Low copy number vector used for complementation AmpR. Wang & Kushner, 1991 
pUA66pacpP Plasmid which encodes gfp  KanR Neil Burton, personal 
communication 
76 
 
primers were designed to insert the aph gene between base pairs 297 and 1326 of the acrA gene 
causing juxtaposition of the 99th and 442nd codons. As the acrB gene is directly downstream of acrA, 
it was possible that removal of this section could cause polar effects which interfered with acrB 
transcription and subsequent translation to AcrB. Section 2.6.1 describes the method used for 
Reverse Transcriptase (RT) PCR to ensure acrB transcription was not affected while Section 2.6.2 
describes the Western Blotting method used to check that the AcrB protein was translated at similar 
levels to wild-type. 
PCR reactions were set up using 45 µl of 1.1 x ReddyMix™ PCR master mix (AB-0575-LD, ABgene, UK). 
In each reaction volume this master mix contains 0.625 units of Taq DNA polymerase, 75mM Tris-
HCl, 20mM (NH4)2SO4, 1.5mM MgCl2, 0.01% Tween-20 and 0.2mM each of dATP, dCTP, dGTP and 
dTTP. 1.5 µl of a 25 µM stock of each of the inactivation primers and 2 µl of isolated pKD4 plasmid, as 
the template DNA, were added to the master mix. The initial denaturation step was carried out at 
95°C for five minutes. This was followed by 30 cycles of denaturation at 95°C for 30 seconds, 
annealing at 52°C for 30 seconds and elongation at 72°C for 2 minutes. This was followed by a final 
elongation stage at 72°C for ten minutes (Table 5, PCR 1).  
The PCR product was purified using the QIAGEN® PCR Purification Kit (QIAGEN, 28106). The product 
was eluted in 30 µl of ultrapure water (Invitrogen) to ensure maximum DNA yield and minimum salt 
concentration to increase the chances of successful electroporation. The size of the purified PCR 
product was analysed by running the sample on a 1% agarose gel with Hyperladder 1 (Bioline, BIO-
33025). This was electrophoresed at 100 volts for one hour and viewed on the ‘gene genius’ image  
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Table 2.4 Primers used in this study 
Primer 
Number 
Description Sequence 
568 acrA inactivation Forward AGC GCT AAC AGG ATG TGA CGA CAA ACA GGA CCA GCA AGG CGT GTA GGC TGG AGC TGC TTC* 
569 acrA inactivation Reverse CTG TAC TTT AAC CTG TGC GCC AGG ACG TAC TTT TTG CAG CGG GAA TTA GCC ATG GTC CAT* 
570 acrA Upstream Check ACA TCC AGG ATG TGT TGT CG 
571 acrA Downstream Check CAA TCG TCG GAT ATT GCG CT 
566 acrA Internal Check Forward GCA GTA CAT CAG TAA GCA GG 
567 acrA Internal Check Reverse CCT TGC GTT ACG GAT GAC TT 
324 16s Internal Forward CCT CAG CAC ATT GAC GTT AC 
325 16s Internal Reverse TTC CTC CAG ATC TCT ACG CA 
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334 acrB Internal Check Forward CGT GTT ATG ACG GAA GAA GG 
335 acrB Internal Check Reverse GCC ATA CCG ACG ACG ATA AT 
237 Kt - Internal aph Reverse CGG CCA CAG TCG ATG AAT CC 
239 K2 – Internal aph Forward CGG TGC CCT GAA TGA ACT GC 
648 acrA complementation 
Forward 
TCA AGC TTA CAT CCA GGA TGT GTT GTC G 
649 acrA complementation 
Reverse 
TCG GAT CCA TCG TCG GAT ATT GCG CTA C 
 
* Highlighted areas correspond to the 20bp of homology to the kanamycin resistance cassette 
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Table 2.5 Parameters and primers used for each PCR reaction. 
 
   PCR parameters ( x 30 cycles)  
PCR 
Number 
Primer 1 Primer 2 Initial 
Denaturation 
Denaturation Annealing Extension Final Extension 
1 
568 
acrA inactivation 
Forward 
569 
acrA inactivation Reverse 
95 C (5 min) 95 C (30 sec) 52 C (30 sec) 72 C (2 min) 72 C (10 min) 
2 
570  
acrA Upstream check 
571  
acrA Downstream check 
95 C (5 min) 95 C (30 sec) 52 C (30 sec) 72 C (2 min) 72 C (10 min) 
3 
566 
acrA Internal Check 
Forward 
567 
acrA Internal Check 
Reverse 
95 C (5 min) 95 C (30 sec) 51 C (30 sec) 72 C (2 min) 72 C (10 min) 
4 
334 
acrB Internal Check 
Forward 
335 
acrB Internal Check 
Reverse 
95 C (5 min) 95 C (30 sec) 51 C (30 sec) 72 C (2 min) 72 C (10 min) 
5 
324 
16s Internal Forward 
325 
16s Internal Reverse 
95 C (5 min) 95 C (30 sec) 51 C (30 sec) 72 C (2 min) 72 C (10 min) 
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6 
570  
acrA Upstream check 
237  
Internal aph Reverse 
95 C (5 min) 95 C (30 sec) 52 C (30 sec) 72 C (2 min) 72 C (10 min) 
7 
239 
Internal aph Forward 
571  
acrA Downstream check 
95 C (5 min) 95 C (30 sec) 52 C (30 sec) 72 C (2 min) 72 C (10 min) 
8 
239 
Internal aph Forward 
237  
Internal aph Reverse 
95 C (5 min) 95 C (30 sec) 51 C (30 sec) 72 C (2 min) 72 C (10 min) 
9 
648  
acrA Complementation 
Forward 
649 
acrA Complementation 
Reverse 
95 C (5 min) 95 C (30 sec) 53 C (30 sec) 72 C (2 min) 72 C (10 min) 
 
Primer information can be found in Table 2.4 
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analyser. The quantity of the PCR construct was determined using the Gene Tools software package 
(Syngene). 
2.2.3 Transformation of the recipient Salmonella strain, L642, with the knockout PCR construct 
A single colony of L642, the salmonella strain containing the λ red recombinase system on the pKD46 
helper plasmid, was inoculated into LB broth, supplemented with 50 µg/ml ampicillin and 10 mM 
arabinose, and grown overnight at 30°C with aeration (shaking at 150 rpm). The arabinose is required 
to induce the λ red recombination system on the pKD46 helper plasmid. 50 ml of pre-warmed SOB 
media containing 50 µg/ml ampicillin and 10 mM arabinose was inoculated with 1 ml of the 
overnight culture and incubated at 30°C with aeration for approximately four hours until an OD600 of 
0.6 was reached (mid logarithmic phase). The cells were harvested from this culture by centrifugation 
at 2250 x g for 10 minutes at 4°C in a Mistral 3000i. The cells were re-suspended in 50 ml of ice cold 
10% glycerol to wash. This washing process was repeated a further three times. After the final 
centrifugation the pellet of competent L642 cells was re-suspended in 250 µl of ice-cold glycerol and 
left on ice. 
Before electroporation a range of quantities (typically 50 ng, 100 ng and 150 ng) of the aph 
containing  PCR construct were added to approximately 45 µl of competent cells to a total volume of 
50 µl and put into a chilled 0.2 cm electroporation cuvette. The samples were electroporated at 
2.5 kV (25 μF, 200 Ω). A negative control was also included which contained 50 µl of competent cells 
and no PCR product. After electroporation the cells were recovered in 1 ml of pre-warmed SOB 
media supplemented with 10 mM arabinose. This was incubated at 37°C with aeration (shaking at 
150 rpm) for two hours at 37°C. Half of the recovery mixture was transferred in 200 μl quantities 
onto selective LB agar plates containing 25 μg/ml kanamycin and incubated overnight at 37°C. The 
remaining cells were left to recover at room temperature overnight and then transferred in 200 µl 
quantities onto selective LB agar plates containing 25 µg/ml kanamycin. This allows for selection of 
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transformants and for loss of the pKD46 helper plasmid as the plates do not contain ampicillin. The 
agar plates were incubated at 37°C for two days and examined for candidate recombinants. 
2.2.4 Verification of gene disruption in candidate colonies by PCR 
All colonies which appeared on the selective media after two days were sub-cultured onto separate 
LB agar plates containing 25 µg/ml kanamycin and incubated overnight at 37°C. Whole cell lysates 
were prepared by putting a loop full of bacterial culture from the agar plate into 100 µl of sterile 
water and heating to 99°C for 10 minutes. 
Primers 570 and 571 were designed to allow the insertion of the aph gene to be checked by PCR 
(Table 2.4). The check primers had 20 bp of homology to regions upstream and downstream of the 
target insertion site for the aph gene. Four PCR reactions were performed from each candidate using 
combinations of the upstream and downstream check primers and primers internal to the aph gene 
(Table 2.4) as an initial screen for successful gene inactivation. The PCR reaction contained 45 µl of 
1.1 x ReddyMix™ PCR master mix (AB-0575-LD, ABgene, UK), 1.5 µl of a 25 µM working stock of each 
primer and 2 µl of the whole cell lysate as the template. Wild-type genomic DNA was used as a 
control. The initial denaturation step of the PCR was five minutes at 95°C. For PCR reactions 2, 6 and 
7 (Table 2.5) 30 cycles of denaturation at 95°C for 30 seconds, annealing at 52°C for 30 seconds and 
elongation at 72°C for 2 minutes were used.  For PCR reaction 8 (Table 2.5) this was followed by 30 
cycles of denaturation at 95°C for 30 seconds, annealing at 51°C for 30 seconds and elongation at 
72°C for 30 seconds. This was followed in both cases by a final elongation stage at 72°C for ten 
minutes. The sizes of the PCR amplimers was analysed by running the samples on a 1 % agarose gel 
along with Hyperladder 1 (Bioline, UK, BIO-33025). This was electrophoresed at 100 volts for one 
hour and viewed on the ‘gene genius’ image analyser. The size of amplimers produced from the 
candidates was compared to the amplimers size produced from SL1344 DNA and the predicted 
amplimers size. Amplimer sizes were predicted by accessing the wild-type sequence (from 
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http://xbase.bham.ac.uk) and calculating the size of the PCR fragment which would be produced 
before and after insertion of the aph gene. 
2.2.5 Sequencing of candidate acrA mutants 
Once transformation had been confirmed by the PCR reactions, the DNA upstream and downstream 
of the inactivated gene was sequenced to guarantee that the gene disruption had occurred as 
predicted. PCR reactions 6 and 7 (Table 2.5) were used to amplify the region to be sequenced in each 
candidate. The PCR products were purified using the QIAquick PCR Purification Kit (QIAGEN, 28106) 
and were eluted in 30 μl of water. The PCR product was separated by electrophoresis at 100 V for 
approximately one hour on a 1 % agarose gel electrophoresis. The amount of DNA was quantified 
using the ‘Gene Tools’ software (Syngene) using HyperLadder I (Bioline) as a reference for quantity. 
The sequencing reaction was performed by the Functional genomics and Proteomics unit at the 
University of Birmingham using the BigDye® Terminator v3.1 Cycle sequencing kit (Applied 
Biosystems Ltd., U.K) following the protocol described by ExGen, Functional Genomics and 
Proteomics Unit (School of Biosciences, University of Birmingham). The sequence data was aligned 
and compared with SL1344 and the expected sequences using the GeneDoc software package. 
2.2.6 Verification that transformants were S. enterica 
To confirm bacterial identity, each of the candidate transformants were sub-cultured onto 
Salmonella-selective XLD agar (Sigma-Aldrich Ltd., UK). The bacteria were all Gram stained and 
subsequently observed microscopically to ensure they were Gram-negative bacilli. API testing, 
(Biomerieux, France) was used according to the manufacturer’s instructions for final confirmation of 
bacterial identity. 
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2.3 P22 transduction of the disrupted region 
The λ red recombinase used during the construction of the gene disrupted mutants is known to 
induce non-specific mutations throughout the genome. To remedy this problem the disrupted region 
containing the aph cassette was transduced back into SL1344 using P22 phage. 
2.3.1 Production of the P22 phage 
A 10 ml overnight culture of the strain containing the aph cassette was grown in LB broth at 37°C 
with shaking. This culture was diluted 1:100 (5 µl in 5 ml) in fresh LB broth supplemented with 
10 mM MgSO4 and 5 mM CaCl2 and grown at 37 C with aeration. After 30 minutes 5 µl of P22 phage 
stock was added to the culture and re-incubated at 37°C with aeration overnight. 1 ml of chloroform 
was added to the bacteria and phage culture and this was vortexed hard for 20 seconds and then 
centrifuged at 2250 x g (Mistral 3000i, MSE) for 10 minutes at 4°C. The supernatant was then 
transferred to a glass universal container. 200 µl of chloroform was added and vortexed briefly. The 
P22 phage stock was then stored at 4°C until needed. 
2.3.2 P22 Transduction 
A 10 ml culture of the recipient strain, SL1344 (L354), was grown overnight in LB broth at 37°C with 
aeration. The culture was centrifuged at 2250 x g (Mistral 3000i, MSE) at room temperature for 
10 minutes. The supernatant was discarded and the pellet re-suspended in 1 ml 10 mM MgSO4 and 
5 mM CaCl2. Six 100 µl aliquots of the cell suspension were set up and into each aliquot a volume of 
phage lysate was added in a range from 0 µl to 100 µl. The transduction reactions were then 
incubated at 37°C for 15 minutes. 100 µl of sodium citrate was added to chelate the divalent cations 
along with 1 ml of LB broth. This was incubated for 45 minutes at 37°C. To select for transductants, 
100 µl from each transduction reaction was spread onto LB agar supplemented with 50 µg/ml 
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kanamycin and incubated at 37°C overnight. Putative transductants were confirmed by PCR 
(Table 2.5, PCR 2, 6 and 7).  
2.4 Removal of the kanamycin resistance gene, aph, using the pCP20 plasmid 
The kanamycin resistance gene, aph, was removed from the gene disrupted mutant L884 (acrA::aph) 
using the ampicillin resistant plasmid, pCP20 (Cherepanov and Wackernagel, 1995; Datsenko and 
Wanner, 2000) (Table 2.3). The plasmid contains the FLP gene whose product will remove the 
FRT-flanked antibiotic resistance cassette in the gene disrupted mutant. It is temperature sensitive 
such that it replicates at 30°C and is cured at 43°C (Datsenko and Wanner, 2000).  
2.4.1 Treatment of L884 with pCP20 
A single colony of the recipient strain, L884 (acrA::aph), was inoculated into 10 ml LB broth and 
grown overnight at 37°C with aeration. 4 ml of the overnight culture was added to 50 ml of 
pre-warmed LB broth (4% inoculum) and grown at 37 C with aeration for approximately 4 hours until 
mid-logarithmic phase (OD600 = 0.6). The cells were harvested by centrifugation at 2250 x g for 
10 min at 4 C (Mistral 3000i, MSE). The cell pellet was re-suspended in 50 ml of ice-cold 10% glycerol 
to wash. The washing process was repeated a further three times to make cells competent. After a 
final centrifugation the pellet of competent L884 cells was re-suspended in 300 µl of ice-cold 10% 
glycerol and left on ice. 5 µl of the isolated pCP20 plasmid was added to 45 µl of competent L884 
cells and this was left on ice for 20 minutes. The cell/plasmid mixture was transferred to a chilled 
electroporation cuvette and electroporation was carried out at 2.5 kV. A negative control with no 
plasmid and a positive control with pUC19 were also included. After electroporation the cells were 
recovered in 1 ml of pre-warmed SOB broth. The recovery mixture was incubated at 30°C for one 
hour. 200 µl of the recovery mixture was spread onto LB agar plates containing 25 µg/ml ampicillin. 
The plates were incubated for 48 hours at 30°C and then inspected for candidate transformants. 
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2.4.2 Curing the plasmid 
Candidate transformants were selected and inoculated into 10 ml of antibiotic free LB broth and 
grown overnight with aeration at 43°C to allow the plasmid to be cured. A loopful of this overnight 
culture was streaked onto antibiotic free LB agar and incubated at 37°C overnight. From this plate 
single colonies were selected and sub-cultured on three plates: antibiotic free LB agar, LB agar 
containing 25 µg/ml ampicillin to screen for loss of the pCP20 plasmid and a plate containing 
25 µg/ml kanamycin to screen for loss of the aph gene. 
2.4.3 Confirmation of removal of the aph gene 
Candidate recombinants that were ampicillin and kanamycin susceptible were selected for further 
analysis. To confirm that the aph insertion had been removed from the acrA gene two PCRs were 
performed. The first PCR allowed assessment of the size of the acrA region (Table 2.5, PCR 2). In the 
wild-type strain (SL1344) this PCR would produce a product of 1528 bp while in L884 (acrA::aph) the 
product would be 2033 bp. If the aph cassette has been successfully removed then the PCR should 
produce a fragment of only 539 bp. A PCR using primers internal to the aph gene was performed to 
ascertain if it was still present (Table 2.5, PCR 8).  The wild-type strain, SL1344, and a strain from 
which the aph gene has been removed should not produce a product in this reaction while a strain 
containing the aph gene (e.g. L884) would produce a product of 471 bp. The amplified products were 
analysed by running the samples on a 1% agarose gel, along with a DNA sizing ladder (Hyperladder I, 
Bioline, BIO-33025). This was electrophoresed at 100 volts for one hour and visualised on the ‘Gene 
genius’ image analyser (Syngene, UK).  
2.5 Complementation of acrA 
To complement the acrA mutants, wild-type acrA was cloned into the well characterised, low copy 
number vector pWKS30 (Wang and Kushner, 1991) (Table 2.3). This vector had been used previously 
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in this laboratory to complement ΔacrB and ΔtolC (Buckley et al., 2006). It contains the ampicillin 
resistance marker and a multiple cloning site (MCS) containing, among others, HindIII and BamHI 
restriction sites. 
2.5.1 Amplification and restriction digest of the wild-type acrA insert  
Primers 648 and 649 were designed to amplify wild-type acrA, along with the region upstream of the 
gene so that the native promoter would be present to drive transcription of the cloned gene allowing 
approximately wild-type levels of acrA to be present in the complemented strain (Table 2.4). 
Restriction sites for HindIII and BamHI (AAGCTT and GGATCC, respectively) which are compatible 
with the MCS of the vector were added the 5’ end of the primers along with two extra bases to allow 
the restriction enzymes to cut. Wild-type acrA was amplified by PCR using primers 648 and 649 
(Table 2.4 and 2.5, PCR 9). Successful amplification was confirmed by running the samples on a 1% 
agarose gel along with a DNA ladder (Hyperladder I, Bioline, BIO-33025). This was electrophoresed at 
100 V for one hour and visualised on the ‘Gene genius’ image analyser (Syngene, UK).  
The amplified acrA fragment was digested with the restriction enzymes BamHI and HindIII (Both 
Promega Corporation, UK). 30 µl of the PCR product was added to 5 µl of the supplied multicore 
buffer, 5 µl HindIII, 5 µl BamHI, 1 µl BSA and 4 µl H2O. This 50 µl reaction was incubated at 37°C for 
one hour and inactivated at 80°C for 20 minutes.  
2.5.2 Isolation and digestion of pWKS30 plasmid 
The pWKS30 plasmid was isolated from E. coli strain I906. One colony of I906 was inoculated into LB 
broth and grown overnight at 37°C with aeration. The plasmid was harvested using the QIAprep® 
Miniprep kit (Qiagen, 27104) following the low copy number protocol to ensure maximum yield. The 
plasmid was then digested with HindIII and BamHI following the same protocol as for the PCR 
fragment digestion (Section 2.5.2). Successful plasmid isolation and digestion was confirmed by gel 
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electrophoresis on a 1% agarose gel which was visualised using the ‘Gene genius’ image analyser 
(Syngene, UK). The plasmid stock was stored at -20°C.  
2.5.3 Ligation of acrA insert and pWKS30 plasmid 
The digested plasmid and insert were ligated using the Bioline Quick Stick Ligase® (Bioline, 27027). 
3 µl of digested acrA insert and 1 µl of digested plasmid were added to 10 µl of ddH2O, 1 µl of Quick 
Stick DNA Ligase and 5 µl 4 x Quick Stick Buffer. The 20 µl reaction was mixed thoroughly by pipetting 
and incubated at room temperature for five minutes. The ligated product was loaded onto a 1% 
agarose gel alongside the digested insert, the digested plasmid and a DNA sizing ladder (Hyperladder 
1, Bioline, BIO-33025) for comparison purposes. The gel was visualised on the ‘Gene genius’ image 
analyser (Syngene, UK). A successful ligation would produce a band of 6.9 Kb. It is also possible that 
bands of 1542 bp representing residual insert and of 5.4 Kb representing residual plasmid will also be 
present. 
2.5.4 Transformation of DH5α cells with the ligated product 
In the first instance the ligated product was electroporated into electro-competent E. coli DH5α cells 
(Invitrogen, UK) because high competence is guaranteed. 5 µl of the ligated plasmid was added to 
45 µl of DH5α cells and this was left on ice for 20 minutes. The cell/plasmid mixture was transferred 
to a chilled electroporation cuvette and electroporation was carried out at 1.25 kV. A negative 
control containing no plasmid was also included. After electroporation the cells were recovered in 
1 ml of room temperature SOB broth. The recovery mixture was incubated at 37°C for one hour. 
200 µl of the recovery mixture was transferred onto LB agar plates containing 25 µg/ml ampicillin. 
The plates were incubated for 48 hours at 37°C and then inspected for candidate transformants. 
All colonies which appeared on the selective media after 48 hours were sub-cultured onto individual 
agar plates containing 25 µg/ml ampicillin and incubated overnight at 37°C. A single colony from each 
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plate was inoculated into 10 ml of LB broth supplemented with 25 µg/ml ampicillin and incubated 
overnight at 37°C with aeration. Plasmid DNA was harvested using the QIAprep® Miniprep kit 
(Qiagen, 27104) following the low copy number protocol to ensure maximum yield. Successful 
plasmid isolation was confirmed by gel electrophoresis on a 1% agarose gel which was visualised 
using the ‘Gene genius’ image analyser (Syngene, UK). 
To verify that the plasmid obtained from the candidate transformants was the complementation 
plasmid constructed, a restriction digest along with a PCR to check for fragment identity were 
performed. The plasmid was digested with HindIII and BamHI as previously described (Section 2.5.2) 
to see whether fragments of the predicted size were produced. The entire restriction digest reaction 
was loaded onto a 1% agarose gel. After electrophoresis, at 100 V for one hour, the gel was visualised 
using the ‘Gene genius’ image analyser (Syngene, UK). Fragments of 5.4 Kb and 1.5 Kb were 
expected, representing the plasmid and insert, respectively. The band representing the insert was 
excised and the DNA isolated using the QiaQuick Gel Extraction Kit (Qiagen, 28704). To confirm that 
this band contained the acrA insert a PCR was performed using primers upstream and downstream 
of acrA (Table 2.4, Primers 570 and 571 and Table 2.5, PCR 1). Successful amplification was confirmed 
by gel electrophoresis on a 1% agarose gel which was electrophoresed at 100 V for one hour and 
visualised using the ‘Gene genius’ image analyser (Syngene, UK). The production of an amplimer of 
1528 bp would indicate that the plasmid in the candidate transformant contained the acrA insert.  
2.5.5 Transformation of L884 (acrA::aph) with pWKS30acrA 
The transformed E. coli I750 strain containing the pWKS30acrA plasmid was grown overnight in LB 
broth containing 25 µg/ml ampicillin at 37°C with aeration. The plasmid was harvested using the 
QIAprep® Miniprep kit (Qiagen, 27104) following the low copy number protocol to ensure maximum 
yield. Successful plasmid isolation was confirmed by gel electrophoresis on a 1% agarose gel and 
visualization using the ‘Gene genius’ image analyser (Syngene, UK).  
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A single colony of the recipient strain, L884 (acrA::aph), was inoculated into 10 ml LB broth and 
grown overnight at 37°C with aeration. 4 ml of the overnight culture was added to 50 ml of pre-
warmed LB broth (4% inoculum) and grown at 37 C with aeration for approximately 4 hours until 
mid-logarithmic phase (OD600 = 0.6). The cells were harvested by centrifugation at 2250 x g for 10 
minutes at 4 C (Mistral 3000i, MSE). The cell pellet was re-suspended in 50 ml of ice-cold 10% 
glycerol to wash. The washing process was repeated a further three times. After a final centrifugation 
the pellet of competent L884 cells was re-suspended in 300 µl of ice-cold 10% glycerol and left on ice. 
5 µl of plasmid DNA was added to 45 µl of the competent L884 cells and left on ice for 20 minutes. 
The cell/plasmid mixture was transferred to a chilled electroporation cuvette and electroporation 
was carried out at 2.5 kV. A negative control containing no plasmid was also included. After 
electroporation the cells were recovered in 1 ml of room temperature SOB broth. The recovery 
mixture was incubated at 37°C for one hour. 200 µl of the recovery mixture was transferred onto LB 
agar plates containing 25 µg/ml ampicillin. The plates were incubated for 48 hours at 37°C and then 
inspected for candidate transformants. 
All colonies which appeared on the selective media after 48 hours were sub-cultured onto individual 
agar plates containing 25 µg/ml ampicillin and incubated overnight at 37°C. A single colony from each 
plate was inoculated into 10 ml of LB broth supplemented with 25 µg/ml ampicillin and incubated 
overnight at 37°C with aeration. Plasmid DNA was harvested using the QIAprep® Miniprep kit 
(Qiagen, 27104). Successful plasmid isolation was confirmed by gel electrophoresis on a 1% agarose 
gel and visualised using the ‘Gene genius’ image analyser (Syngene, UK). Identity of the plasmid was 
confirmed by performing a restriction digest and PCR of the insert to check for fragment identity as in 
Section 2.6.7. 
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2.6. Measuring transcription and translation of acrA/AcrA and acrB/AcrB 
Reverse transcriptase (RT) PCR was used to measure the transcription of the acrA and acrB genes and 
Western Blotting was used to measure the level of AcrA and AcrB proteins. 
2.6.1 Determination of acrA and acrB transcription 
2.6.1.1 RNA extraction 
To give three biological and three technical replicates of each strain, on three separate occasions 
single colonies of the strains to be tested were each inoculated into 10 ml LB broths and incubated 
overnight at 37°C with aeration. 1 ml of overnight culture was inoculated into 24 ml of pre-warmed 
minimal media (Teknova, US) and incubated at 37°C with aeration until mid-logarithmic phase (OD600 
of 0.6). 5 ml of culture was added to 1 ml of a 95% ethanol, 5% phenol mixture and left on ice for 30 
minutes. The samples were centrifuged at 2250 x g (Mistral 3000i, MSE), 4°C for 10 minutes and the 
supernatant discarded. The pellets were re-suspended in 100 µl of TE buffer containing 50 mg/ml 
lysozyme and incubated at room temperature for 5 minutes. After lysozyme treatment the Promega 
SV Total RNA Purification Kit was used (Promega Corporation, UK, Z3100), according to 
manufacturer’s instructions. The isolated RNA was loaded onto a 1% agarose gel along with a DNA 
sizing ladder (Hyperladder I, Bioline, BIO-33025) and electrophoresed at 100 volts for one hour and 
visualised on the ‘Gene genius’ image analyser (Syngene, UK) to see whether RNA was visible.  A PCR 
was performed to see whether any residual DNA was present in the sample (Table 2.5, PCR 4). Any 
residual DNA was removed by digestion with Promega RNase free DNase (Promega Corporation, UK, 
M6101) according to the manufacturer’s instructions. 
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2.6.1.2 cDNA synthesis 
cDNA was synthesised using Invitrogen Superscript III Reverse Transcriptase (Invitrogen, UK). For first 
strand DNA synthesis 1 µg of RNA was added to 1 µl of 50 ng/µl Random Primers, 1 µl dNTP mix and 
this was made up to 10 ml with RNase free sterile water in nuclease free microcentrifuge tubes. The 
reaction was incubated at 65°C for five minutes and then on ice for one minute. 10 µl of the RNA mix 
was added to 10 µl of cDNA synthesis mix consisting of 2 µl of 5 x first strand buffer, 4 µl of 25 mM 
MgCl2, 2 µl 0.1 M DTT, 1 µl  40 U/µl RNase Out and 1 µl of 100 U/µl Superscript III reverse 
transcriptase. This was incubated at 25°C for 10 minutes and then at 50°C for 50 minutes. The 
reaction was terminated at 85°C for five minutes. The cDNA was stored at -20°C. 
2.6.1.3 RT-PCR  
PCRs for acrA, acrB and 16s (Table 2.5, PCRs 3, 4, and 5) were set up using the cDNA as a template. 
For the 16s PCR cDNA was used at a 1:1000 dilution while for both acrA and acrB PCRs the cDNA was 
used at a dilution of 1:5 (Eaves et al., 2004). The products of all PCR reactions were loaded onto a 1% 
agarose gel along with a DNA sizing ladder (Hyperladder I, Bioline, BIO-33025) and electrophoresed 
at 100 V for approximately one hour. The gel was visualised on the ‘Gene genius’ image analyser 
(Syngene, UK) and inspected for presence or absence of amplified products. PCR products were then 
loaded onto a dHPLC column (Transgenomic Ltd, UK). 
2.6.1.4 PCR product quantification using Denaturing High Pressure Liquid Chromatography (DHPLC) 
The PCR products were quantified using DHPLC and the WAVE DNA fragment analysis system 
(Transgenomic Inc.). The method used was as published by Eaves et al (2004). This system separates 
fragments by size using heat (50°C) and ion-pair chromatography. PCR products were loaded onto 
the machine in open topped 0.2 ml tubes and from here 15 μl of each PCR product was loaded onto 
the column (DNASepCartridge, Transgenomic Inc.) with 55% buffer A (0.1M 
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triethylammoniumacetate, TEAA) and 45% buffer B (0.1M TEAA in 25% acetonitrile). A buffer 
gradient from 50% buffer B to 65% buffer B was created over 15 minutes with a flow rate of 
approximately 0.9ml/min to allow separation of the products. The column was then washed with 
100% buffer B for 30 seconds. The elution profiles of each sample were quantified according to their 
peak areas with the NAVIGATOR software (version 1.4) (Transgenomic Inc.). 
Average transcription for the genes of interest were calculated from each cDNA synthesis reaction. 
The level of 16s rRNA transcription has previously been shown to be invariant in the conditions 
(Eaves et al., 2004; Bailey, 2007). Therefore, the level of 16s transcription was used to normalise the 
transcription level of each test gene as previously described (Eaves et al., 2004; Bailey, 2007). After 
normalisation, the mean and standard deviation of transcription levels were calculated and 
converted to fold change compared to SL1344. Student’s t-tests were calculated to compare 
transcription of genes relative to SL1344. 
2.6.2 Western Blotting  
2.6.2.1 Isolation of membrane proteins 
Single colonies of the bacterial strains to be tested were each inoculated into 10 ml LB broths and 
incubated overnight at 37°C with aeration. 1 ml of overnight culture was inoculated into 50 ml of 
pre-warmed LB broth and incubated at 37°C with aeration until mid-logarithmic phase (OD600 of 0.6). 
Cultures were centrifuged at 2250 x g for 15 minutes at 4°C and the cells re-suspended in 1 ml of 
10 mM Tris-EDTA buffer, pH 8.5 (Fluka, 93283). Lysozyme was added to a final concentration of 
100 µg/ml and incubated on ice for 30 minutes. Cells were disrupted by sonication on ice; three 
pulses of 30 seconds, with 30 seconds rest in between. Unbroken cells were removed by 
centrifugation at 2250 x g and the supernatant was centrifuged at 100,000 x g for 1 hour at 4°C. The 
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pellet, containing the total membrane proteins, was re-suspended in 200 µl of 10 mM Tris-EDTA 
buffer, pH 8.5. 
The protein content of each membrane preparation was determined using a Bradford assay. 20 µl of 
each membrane preparation was added to 980 µl of Bradford reagent (Sigma Aldrich, UK, B6916) and 
the OD595 was measured. 1 ml of Bradford agent alone was used as the blank. Protein content was 
calculated by comparison to a curve produced using Bradford reagent and known protein standards. 
2.6.2.2 Western blotting  
The volume of each membrane protein preparation required to give 3 µg of protein in each lane was 
calculated, mixed with NuPAGE® LDS sample buffer (Invitrogen, NP0007) and loaded onto a 
NuPAGE®  10% Bis-Tris gel (Invitrogen, NP0303BOX) along with a molecular weight marker (Magic 
Mark XP Western Standard, Invitrogen, LC5602). This was electrophoresed at 4°C in MOPs 1 x SDS 
Running Buffer (Invitrogen, NP0001) (50 ml of 20 x MOPS SDS running buffer in 950 ml water) at 
~100v until the dye front reached the bottom of the gel. For each new set of protein preparations the 
first SDS-PAGE gel was stained with Safestain® (Invitrogen, LC6060), a coomasie blue like stain, to 
ensure that the protein preps were adequate and that an equivalent amount of protein was present 
in each well. 
For subsequent immunoblotting the proteins were transferred to a PVDF membrane (GE Healthcare, 
RPN1416LFP) by electrophoresis at 50v for three hours at 4°C in an electro-blotting unit (Scie-Plas, 
UK, EB10) filled with transfer buffer. Transfer buffer was made by adding 100 ml of methanol to 5.8 g 
Glycine (Fluka, 50046) and 11.6 g Trizma base (Sigma, T1503). This was then made up to 2 L and the 
pH adjusted to 8.3 with HCl. After transfer the membrane was washed twice for five minutes each 
with ~40 ml of 1 x Tris-Buffered Saline (TBS) with vigorous shaking. 10 x TBS was prepared by adding 
24.2 g of Trizma base and 80 g of NaCl to 800 ml of distilled water. The pH was adjusted to 7.6 with 
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HCl and the volume was made up to 1 L with distilled water. This solution was diluted 1:10 before 
use. The membrane was blocked by incubation with ~40ml blocking buffer (1 x TBS with 0.1% Tween-
20 ( Sigma, P5927) and 5% w/v skimmed milk powder (Sigma 70166)) for one hour at room 
temperature and then washed three times for 5 minutes with TBS/T(1 x TBS with 0.1% Tween-20). 
The blocked membrane was then washed three times for 5 minutes with TBS/T and incubated 
overnight at 4°C with either AcrA, AcrB or TolC primary antibody diluted 1:60,000 with blocking 
buffer (kindly provided by Helen Zgurskaya, Elena Tikhonova and Vassilis Koronakis). The membrane 
was then washed three times for five minutes with ~40 ml of TBS/T with vigorous shaking and then 
incubated for a further hour with Anti-Rabbit IgG, HRP-linked secondary antibody raised in donkey 
(GE healthcare, NA934V). After a further three washes the blot was flooded with mixed ECL western 
blotting detection system (GE Healthcare, RPN2132) on the protein side for 5 minutes. The excess 
detection fluid was drained from the membrane and the membrane placed protein side down on 
saran wrap which is wrapped around the blot. To visualise the blot the wrapped membrane was 
exposed to a sheet of chemi-luminescence autoradiography film (Amersham Hyperfilm ECL 
28906836) for between 2 and 30 minutes. The film was developed immediately using Kodak 
developer and fixer (Kodak, 190 0943 and 190 1875, respectively). 
2.7 Phenotypic Characterisation of S. Typhimurium acrA::aph  
To determine the effect of inactivating the acrA gene the characteristics of the acrA mutant strains 
were compared to that of the wild-type (SL1344) and other efflux mutants L109 (tolC::aph) and L110 
(acrB::aph) in a series of phenotypic tests. 
2.7.1 Bacterial growth kinetics 
Each strain was grown overnight at 37°C in LB broth containing appropriate antibiotics where 
needed. The overnight cultures were diluted 1:100 into LB broth. 100µl of this diluted culture was 
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added to each well of a 96 well plate. Optical density at 600nm was measured every ten minutes for 
12 hours in the BMG FLUOstar optima (BMG, UK). All growth experiments were conducted at 37°C. 
Each experiment was repeated three times and each repeat included eight technical repeats of each 
strain. The FLUOstar is sensitive to an OD600 of between 0.0 and 4.0 and reproducibility is ±0.010 for 
the OD range of 0.0-2.0 (www.bmglabtech.com). 
2.7.2 Determination of the Minimum Inhibitory Concentration (MIC) of antibiotics 
The MIC of a series of antibiotics, dyes and detergents (Table 2.2) were determined using the agar 
doubling dilution method as described by the British Society for Antimicrobial Chemotherapy (BSAC) 
(Andrews, 2006). All antibiotics used in this study are shown in Table 2.2. Fresh stock solutions of 
each antibiotic were made on the day of use. Appropriate volumes of the antimicrobial stock were 
dispensed into sterile plastic universal containers to which 20 ml of cooled, molten, Iso-sensitest agar 
(Oxoid, UK) was added aseptically with a peristaltic pump dispenser (Jencons Scientific Ltd., UK). The 
antimicrobial and agar were mixed and poured into labelled tri-vented petri dishes and allowed to 
set. The plates were dried for approximately 15 minutes at 50°C in an oven. Overnight cultures of 
each bacterial strain to be tested were diluted 1:100 to give approximately 107 CFU/ml.  Each agar 
plate was inoculated with 1 µl of diluted culture giving approximately 104 CFU/spot. Inoculation was 
carried out using a 21 pin multipoint inoculator (AQS manufacturing, UK). The plates were incubated 
overnight at 37°C. The MIC is defined by BSAC as the lowest concentration of a drug that that will 
inhibit the visible growth of an organism after overnight incubation (Andrews, 2006). MICs were 
determined as the modal value from at least three independent experiments. 
2.7.3 Accumulation of Hoechst 33342 (Bis-benzamide) 
Hoechst, H33342 (bis-benzamide) fluoresces when bound to DNA and therefore its accumulation can 
be used to assess the relative level of active efflux in the mutants (Webber et al., 2008; Webber and 
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Coldham, In Press).  To give three biological replicates of each strain, on three separate occasions 
single colonies of the strains to be tested were each inoculated into 10 ml LB broth and incubated 
overnight at 37°C with aeration. 1 ml of overnight culture was inoculated into 10 ml of pre-warmed 
LB broth and incubated at 37°C with aeration until mid-logarithmic phase (OD600 of 0.6). Cells were 
harvested by centrifugation at 2250 x g and re-suspended in Phosphate Buffered Saline (PBS) to an 
optical density of 0.1 at a wavelength of 600 nm. 200 µl of diluted culture was added to each well of 
a black flat bottomed 96 well plate (Greiner CN 655076). A 25 µm Hoechst H33342 stock was 
prepared and loaded into the FLUOstar OPTIMA (BMG labtech) for injection after an initial reading, 
to a final concentration of 2.5 μM. Fluorescence intensity was measured over 30 minutes at 
excitation and emission wavelengths of 350 and 461 nm, respectively in a FLUOstar OPTIMA (BMG 
labtech). Student’s t-tests were performed to compare the accumulation of each strain to that of the 
parental wild-type strain, SL1344; P values <0.05 were taken as significant. 
2.7.4 Electron microscopy of SL1344 and strains lacking AcrA, AcrB and TolC 
The strains SL1344, L109, L110 and L884 were grown and given to Bill Cooley at the veterinary 
laboratories agency, Weybridge, Surrey for transmission electron microscopy studies. Briefly, 
samples were fixed using 2.5% gluteraldehyde in phosphate buffer and then 1% osmium tetroxide. 
Samples were dehydrated through a graded ethanol series then embedded in epoxy resin. Sections 
were cut at 70-90 nm thickness and stained with uranyl acetate and Reynolds lead citrate. 
2.8 Investigating the Role of AcrAB-TolC in Adhesion and Invasion 
The ability of the acrA mutant strains to adhere and invade to two tissue culture cell lines in vitro was 
determined and compared to that of the wild-type strain (SL1344) and two other efflux mutants 
(L109 and L110). The cell lines used were human embryonic intestine cells (INT-407) and mouse 
macrophages (RAW 264.7) as used previously by this team (Buckley et al., 2006). The protocols used 
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for the adhesion and invasion assays were based upon those described by Dibb-Fuller and colleagues 
(Dibb-Fuller et al., 1999). Each assay was repeated a minimum of three times and each repeat 
contained four technical repeats. Both the INT-407 and RAW 264.7 cell lines were kindly supplied by 
R. La Ragione at the Veterinary Laboratories Agency (VLA), Addlestone, Surrey. 
2.8.1 Tissue culture 
Monolayers of each cell type were grown in 250ml tissue culture flasks (BD Falcon™, 353136) in 
complete tissue culture medium. INT-407 cells required Minimum Essential Medium (MEM) (Sigma-
Aldrich, UK, M2279) while RAW cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
(Sigma-Aldrich, UK, D5671). The complete tissue culture medium contained the appropriate medium 
for the cell type supplemented with 10% heat inactivated foetal calf serum (Invitrogen, UK, 10108-
165), 1% non-essential amino acids (NEAA) (Sigma, UK, M7145), 1% L-glutamine (Sigma, UK, G7513) 
and 50µg/ml gentamicin (Sigma, UK, G1397). For the assays monolayers of each cell line were 
prepared in 24 well plates (Falcon). Each well was seeded with approximately 105 cells and incubated 
for 48 hours at 37°C and 5% CO2. Before the assays were performed each well was washed with 1 ml 
pre-warmed Hanks Balanced Salt Solution (HBSS) (Sigma, UK, H9269) by pipetting 1 ml into each well 
and then removing it. This was done three times for each well to remove residual medium and 
antibiotic.  
2.8.2 Preparation of bacterial strains for infection assays 
All the bacterial strains were grown overnight at 37°C in LB broth containing appropriate antibiotics 
where necessary. The cells were harvested from the culture by centrifugation at 2250 x g for 10 
minutes at 4°C in a Mistral 3000i. The supernatant was discarded and the cells were re-suspended in 
10ml of sterile PBS to wash and re-centrifuged. The supernatant was once more discarded and the 
cells were re-suspended in approximately 10 ml of sterile PBS and adjusted to an optical density of 
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1.23 at 540 nm with further PBS (approximately 1 x 107 CFU/ml). The bacterial cultures were then 
diluted 1:20 in appropriate inoculation medium and viable counts were performed on this diluted 
bacterial culture. Inoculation media consisted of the appropriate medium for the intended cell type 
(MEM or DMEM) supplemented with 1% L-glutamine (Sigma, UK) and 1% NEAA (Sigma, UK).  
2.8.3 The Association Assay  
To quantify the number of bacteria which associated with the eukaryotic cell monolayer 1 ml of the 
diluted bacterial suspension was inoculated into each well and incubated for two hours at 37°C and 
5% CO2 as described previously (Dibb-Fuller et al., 1999; Buckley et al., 2006). The supernatant was 
then removed and the monolayers were washed six times with 1 ml of pre-warmed HBSS to remove 
all non-adherent bacteria. The monolayers were disrupted by adding 1 ml of sterile 1% Triton-X 100 
and a magnetic flea to each well. The plate was put onto a magnetic stirrer for 10 minutes. A series of 
1:10 dilutions were made from each well of the tissue culture plate and three 20 µl drops of each 
dilution were plated onto LB agar (Miles et al., 1938). The agar plates were incubated overnight at 
37°C. The colonies from those dilutions that gave separate colonies were counted and used to 
determine the number of colony forming units (CFU) per millilitre.  
2.8.4 The Invasion Assay  
To determine the number of bacteria which invaded the eukaryotic cell monolayer 1 ml of bacterial 
suspension diluted 1:20 in inoculation media was added to each well and incubated for two hours at 
37°C and 5% CO2. The supernatant was then removed and the monolayers were washed three times 
with 1 ml of pre-warmed HBSS to remove all non-adherent bacteria. Two millilitres of media 
containing 100 µg/ml of gentamicin was added to each well and the plate was incubated for a further 
two hours at 37°C and 5% CO2. This step kills all external bacteria without damaging or entering the 
eukaryotic cells, so leaving the internal bacteria unharmed. The antibiotic containing media was then 
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removed and the monolayers were washed six times with 1 ml of pre-warmed HBSS. The monolayers 
were disrupted by adding 1 ml of 1% Triton-X 100 and a magnetic flea to each well. The plate was put 
onto a magnetic stirrer for 10 minutes. A series of 1:10 dilutions were made from each well of the 
tissue culture plate and three 20 µl drops from each dilution were plated onto LB agar (Miles et al., 
1938). The agar plates were incubated overnight at 37°C. The colonies from those dilutions that gave 
separate colonies were counted and used to determine the number of colony forming units (CFU) per 
millilitre. 
2.8.5 Statistical Analyses 
2.8.5.1 Mean and standard deviation 
The mean and standard deviation CFU/ml was calculated for association and invasion for each 
biological replicate. Each experiment was performed a minimum of three times and the overall mean 
CFU/ml for each strain was calculated as the mean of the values for each biological replicate. These 
values were plotted on a graph in the Excel software (Microsoft, 2007) with error bars ± one standard 
deviation. 
2.8.5.2 Determining the level of Adhesion 
The level of adhesion was determined by subtracting the mean CFU/ml for invasion from the mean 
CFU/ml for association. These values were plotted on a graph in the Excel software (Microsoft, 2007) 
with error bars ± one standard deviation. 
2.8.5.3 Student’s t-Test 
A Student’s t-test was performed to compare the adhesion and invasion values of each strain to wild-
type values. The test was performed using the t-test function of the Excel software (Microsoft, 2007). 
P values of ≤0.05 were deemed to be statistically significant. 
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2.8.5.4 Calculating the confidence interval for the association level of SL1344  
The confidence interval at the 0.05 (95%) level of significance was calculated from the mean and 
standard deviation of all values obtained for association of SL1344 with INT-407 cells. 
95% confidence interval = sample mean ± (t-crit x SE of the mean), 
Where the SE of the mean =    ( ) 
Data from all future assays was only accepted if the SL1344 association values fell within the 
calculated range. 
2.8.5.5 Multiplicity of Exposure  
For each assay the multiplicity of exposure (MOE) was calculated. This is a measure of the number of 
bacterial cells present compared to the number of eukaryotic cells and is calculated by dividing the 
viable counts for each bacterial strain by the estimated number of eukaryotic cells per well. The 
number of eukaryotic cells per well was estimated by removing the tissue culture cells from 
monolayers in 10 wells by trypsinisation. The cells suspended in trypsin were added to 10 ml of 
complete tissue culture medium and centrifuged at 250 x g for 5 minutes (Mistral 3000i, MSE). The 
cells were then re-suspended in a known volume of media and counted using a haemocytometer. 
The estimated number of cells per well could then be calculated. The bacterial viable counts were 
performed by plating out serial dilutions of the diluted bacterial suspensions. 
To check that the number of viable eukaryotic cells did not change during the assay cell counts using 
trypan blue were performed before and after infection. The number of viable eukaryotic cells per 
well was estimated by removing the tissue culture cells from monolayers in 4 wells by trypsinisation. 
The cells suspended in trypsin were added to 10 ml of complete tissue culture medium and 
centrifuged at 250 x g for 5 minutes (Mistral 3000i, MSE). The cells were re-suspended in a known 
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volume of complete media and trypan blue added for 5 minutes before being counted using a 
haemocytometer.  Dead cells take up the stain so appear blue while viable cells do not and are 
colourless. 
2.9 Competition assays 
10 ml bacterial cultures of the two strains to be tested were grown overnight at 37°C. 1ml of each 
culture was diluted in 5 ml PBS and the optical density at a wavelength of 600 nm was measured.  
The OD of the culture with the highest starting value was adjusted to be equal to that of the other 
culture by addition of further PBS. 20 µl was taken from each culture, serially diluted and pipetted 
out using the method described by Miles and Misra (Miles et al., 1938). Equal volumes of the two 
solutions were then combined, and another 20 µl sample was taken, serially diluted and pipetted in 
the same manner. The mixed culture solution was centrifuged at 2250 x g for 10minutes at 4oC. As 
described in section 2.8.2 the supernatant was discarded and the pellet re-suspended in PBS. The OD 
of this re-suspended pellet was then adjusted to 1.23. 
Association and invasion assays were performed as described in section 2.8.3 and 2.8.4. Each strain 
was tested alone as well as in competition. At the end of the assay the LB agar plates were incubated 
overnight at 37°C as normal. Replica plating onto LB agar containing 50 µg/ml of kanamycin allowed 
SL1344 and the kanamycin resistant mutant (containing the aph gene) to be distinguished. The 
colonies from those dilutions that gave separate colonies were counted and used to determine the 
number of colony forming units (CFU) per millilitre. 
2.10 Does AcrAB-TolC export a molecule required for invasiveness? 
Experiments were performed to ascertain whether the invasiveness of L109 (tolC::aph) in vitro could 
be restored by the addition of culture supernatant from INT-407 cells infected with wild-type 
Salmonella, SL1344. 
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2.10.1 The effect of addition of culture supernatant, INT-407 conditioned media or SL1344 
conditioned media on the invasive abilities of mutants 
The adhesion and invasion assays were performed as described in sections 2.8.3 - 2.8.5. Bacterial 
suspensions were prepared as described in section 2.8.2 except that the bacteria were diluted 1:20 in 
either inoculation media (MEM supplemented with 1% L-glutamine and 1% NEAA), culture 
supernatant from INT-407 cells infected with SL1344 (section 2.10.11), INT-407 conditioned media 
(section 2.10.12) or SL1344 conditioned media (section 2.10.13). 
2.10.1.1 Generation of culture supernatant from SL1344 infected INT-407 cell monolayers 
Each well of a 24 well plate of confluent INT-407 monolayers was washed three times with 1 ml of 
pre-warmed HBSS (Sigma, UK, H9269). An overnight broth culture of SL1344 was diluted in 
inoculation media as described (Section 2.8.2) and 1 ml of diluted culture was added to each well. 
The plates were then incubated for 30 minutes, two hours or 18 hours at 37°C and 5% CO2. After 
incubation the supernatant was collected and filter sterilised using a either a single use Millex® GP 
0.45µm filter unit or a single use low protein binding 0.45 µm filter (Millex®HV, Durapore® PVDF 
membrane). The sterile culture supernatant was diluted 1:2 and 1:20 in inoculation media and then 
used to dilute the bacterial suspension 1:20. For the control, without supernatant, the bacterial 
suspension was diluted 1:20 in inoculation media alone. 
2.10.1.2 Generation of INT-407 conditioned media 
Each well of a 24 well plate of confluent INT-407 monolayers was washed three times with 1 ml of 
pre-warmed HBSS (Sigma, UK, H9269). 1 ml of sterile inoculation media was added to each 
monolayer and incubated for 30 minutes at 37°C and 5% CO2. This media was then removed and 
filter sterilised using a single use low protein binding 0.45 µm filter (Millex®HV, Durapore® PVDF 
membrane). The sterile media was diluted 1:2 in inoculation media and then used to dilute the 
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bacterial suspension 1:20 (Section 2.8.2). For the control, without INT conditioned media, the 
bacterial suspension was diluted 1:20 in inoculation media alone. 
2.10.1.3 Generation of SL1344 and L109 (tolC::aph) conditioned media 
A 10 ml overnight LB broth culture of SL1344 was centrifuged at 2250 x g for 10 minutes at 4°C 
(Mistral 3000i, MSE) to pellet the bacteria and then filter sterilised using a single use low protein 
binding 0.45 µm filter (Millex®HV, Durapore® PVDF membrane). The SL1344 conditioned media was 
diluted 1:2 in inoculation media and then used to dilute the bacterial suspension 1:20 (Section 2.8.2). 
For the control, without SL1344 conditioned media, the bacterial suspension was diluted 1:20 in 
inoculation media alone. As another control, the bacterial suspension was also diluted in fresh LB 
media mixed 1:2 with inoculation media to ensure addition of LB broth had no effect. 
2.10.1.4 Generation of boiled and proteinase K treated bacterially conditioned medium 
The bacterially conditioned medium was boiled to determine whether this would affect its ability to 
restore the invasive ability of efflux mutants (L109, L110 or L884). The bacterially conditioned media 
was generated in exactly the same way as in section 2.10.1.3 but before dilution the media was put 
into a boiling water bath for 10 minutes. After being left to cool, the media was diluted 1:2 in 
inoculation media and used in the infection assays as described. 
To determine whether the active component of the SL1344 conditioned media was proteinaceous, 
the bacterially conditioned media, which was generated as described in section 2.10.1.3, was treated 
with proteinase K. Proteinase K (Promega) was added to the conditioned media to a final 
concentration of 100 µg/ml and at 37 °C for one hour. The proteinase K was inactivated using by 
addition of EGTA to a final concentration of 10 mM. After inactivation, the proteinase K treated 
media was diluted 1:2 in inoculation media and used in the infection assays as described. 
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2.11 Imaging of infected INT-407 cells 
2.11.1 Constructing Green Florescent Protein (GFP) marked strains  
The pUA66pacpP plasmid was a gift from Neil Burton at the University of Birmingham and encodes a 
constitutively transcribed gfp gene. Briefly, the parent vector was pUA66 into which the pacpP 
promoter was cloned upstream of GFPmut2. This vector also contains the aph gene coding for 
kanamycin resistance. 
A single colony of the recipient strain (SL1344, L109, L110 and L884) was inoculated into 10 ml LB 
broth and grown overnight at 37°C with aeration. 4 ml of the overnight culture was added to 50 ml of 
pre-warmed LB broth (4% inoculum) and grown at 37 C with aeration until mid-logarithmic phase 
(OD600 = 0.6). The cells were harvested by centrifugation at 2250 x g for 10 minutes at 4 C (Mistral 
3000i, MSE). The cell pellet was re-suspended in 50 ml of ice-cold 10% glycerol to wash. The washing 
process was repeated a further three times. After a final centrifugation the pellet of competent cells 
was re-suspended in 300 µl of ice-cold 10% glycerol and left on ice. 
5 µl of plasmid DNA was added to 45 µl of the competent recipient strain and left on ice for 
20 minutes. The cell/plasmid mixture was transferred to a chilled electroporation cuvette and 
electroporation was carried out at 2.5 kV. A negative control containing no plasmid was also 
included. After electroporation the cells were recovered in 1 ml of room temperature SOB broth at 
37°C for one hour. 200 µl of the recovery mixture was transferred onto LB agar plates containing 
50 µg/ml kanamycin. The plates were incubated for 48 hours at 37°C and then inspected for 
candidate transformants. 
All colonies which appeared on the selective media after 48 hours were sub-cultured onto individual 
agar plates containing 25 µg/ml kanamycin and incubated overnight at 37°C. A single colony from 
each plate was inoculated into 10 ml of LB broth supplemented with 25 µg/ml kanamycin and 
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incubated overnight at 37°C with aeration. Plasmid DNA was harvested using the QIAprep® Miniprep 
kit (Qiagen, 27104). Successful plasmid isolation was confirmed by electrophoresis of a 1% agarose 
gel and visualised using the ‘Gene genius’ image analyser (Syngene, UK).  
To confirm successful transformation of the strains with pUA66pacpP the fluorescence of putative 
transformants was measured. GFP has a major excitation peak at a wavelength of 395 nm with 
emission at 509 nm. 
Cultures of SL1344 and the putative transformants were grown in LB broth overnight at 37°C. The 
cultures were diluted 1:100 in sterile PBS (Invitrogen) and 3 ml of the diluted culture was loaded into 
a clean glass cuvette. The cuvette was loaded into the Perkin Elmer Fluorescence spectrophotometer 
(Perkin Elmer, LS 45). The excitation was set at 395 nm and a scan of emission wavelengths was run. 
As a control the emission of PBS alone and SL1344 in PBS was also measured. 
2.11.2 Preparing infection plates, staining and imaging 
For INT-407 infections a sterile circular glass slide was placed into each well of a 24 well plate 
(Falcon). INT-407 cells were then seeded into the 24 well tissue culture plate, on top of the glass 
slides, as described in section 2.8.1. For Caco2 infections, the cells were maintained in DMEM with 
20% serum as described for INT-407 and RAW cells in section 2.8.1. For infection assays the cells 
were seeded onto transwell polyester membranes in 6 well plates (Costar). The media was replaced 
every two to three days for 12-14 days until infection. The INT-407 cells were infected as described in 
section 2.8.3. For the Caco2 cells the media was removed from the top portion of the transwell 
system and replaced with 1.5 ml of diluted bacterial culture, prepared as described in section 2.8.2. 
All infected cells were incubated at 37°C, 5% CO2 for 2 hours. After this all spent media was removed 
and the infected eukaryotic cells washed with HBSS as described previously. For the INT cells, 1 ml of 
1% formalin was added to each well, for the Caco2 cells 3 ml of 1% formalin was added to the 
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bottom chamber of the transwell system and 1.5 ml was added to the top compartment. Fixed plates 
were kept at 4°C until needed. 
Staining and imaging of the fixed infected plates was kindly performed by Robert Shaw (University of 
Birmingham). Briefly, the plates were counterstained with the F-actin specific molecule phalloidin 
conjugated to the Rhodamine dye, so the eukaryotic cells stained red. Confocal z-stack images of the 
plates were then taken in the xzy (vertical) and xzy (transverse) planes. 
2.11.3 Test to see whether the strains aggregate in broth culture 
Strains were grown overnight in LB broth at 37°C with shaking at 150 rpm. Cultures were then left on 
the bench for eight hours to settle. At the beginning of the experiment and every hour thereafter 
100 µl of culture was taken from the very surface of the culture. This was diluted in 900 µl of fresh 
broth and the optical density at 600 nm was recorded. 
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Chapter 3. Construction and Characterisation of mutants lacking AcrA 
3.1 Background 
It has previously been shown that inactivation of either acrB or tolC of Salmonella 
Typhimurium results hypersusceptibility to a range of antibiotics, dyes and detergents and 
an impaired ability to cause infection (Eaves et al., 2004; Buckley et al., 2006; Nishino et al., 
2006).  
3.2 Aims and hypothesis  
The initial aim was to inactivate the final component of the AcrAB-TolC efflux system, the 
periplasmic adaptor, acrA, while retaining transcription and translation of acrB/AcrB and 
tolC/TolC, respectively. The hypothesis was that inactivation of acrA would also lead to 
hyper-susceptibility to a range of antimicrobials by impairing pump function. In order to test 
this hypothesis, the mutant phenotype was characterised by studying the mutant growth 
kinetics, determining the minimum inhibitory concentrations (MIC) of a range of 
antimicrobials and measuring efflux activity in the mutant strain. 
3.3 Disruption of acrA 
The acrA gene was inactivated using the method published by Datsenko and Wanner in 2000 
(Datsenko and Wanner, 2000). This method allows disruption of chromosomal genes by 
homologous recombination with PCR products containing the aph gene whose product 
provides kanamycin resistance. This relies on the plasmid encoded λ red recombination 
system. In the first instance the aph gene was amplified by PCR using primers that also have 
homology to the gene of interest. The recipient strain, containing the pKD46 plasmid, is 
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transformed with the PCR construct and homologous recombination follows, mediated by 
the λ red recombinase system, to leave a mutant with the chromosomal gene of interest 
disrupted by the kanamycin resistance gene, aph.  
3.3.1 Verification of Gene Disruption  
Following electroporation with the PCR amplified aph gene, potential recombinants were 
selected on LB agar with 50 μg/ml kanamycin. After 48 hours two putative recombinants 
were present on the selective agar both of which were checked for the insertion of the 
kanamycin resistance gene (aph) by four PCR reactions (Table 2.5, PCR numbers 8, 2, 6 and 
7) (Primer positions shown in Appendix 1, Figure 1). Following the PCR reactions, the 
amplimers were electrophoresed and visualised on the Gene genius ™ image analyser. Both 
candidates produced amplimers of the size predicted for an acrA disrupted mutant in all four 
of the PCR reactions (Figure 3.1).  
To confirm insertion of the aph gene in the correct location, the PCR amplimers obtained 
using a primer that annealed in the acrA gene and one that annealed in the aph gene were 
sequenced (Table 2.5, PCRs 6 and 7). The sequence was aligned with the predicted sequence 
for an acrA::aph mutant (Appendix 1). The sequence from both the candidates was 
homologous to the predicted sequence showing that the aph gene had inserted as predicted 
between base pairs 297 and 1326 (Appendix 1, Figures 3 and 4). 
To confirm that transformants were S. Typhimurium two putative gene disrupted mutants 
were cultured on XLD agar for 48 hours at 37°C and produced colonies with black centres. 
Furthermore they both produced white/colourless colonies on MacConkey agar. Both 
candidates were Gram-negative rod shaped bacteria when Gram stained and observed  
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Figure 3.1 Verification of gene disruption by PCR 
 
 
a           b             c                      d 
 
    1   2   3  4     1   2   3   4        1   2   3  4         1  2   3   4 
 
 
For each PCR (a-d): 
Lane 1 = Candidate 1 
Lane 2 = Candidate 2 
Lane 3 = Positive control (a = L109 and b,c,d = SL1344)  
Lane 4 = Negative control 
 
 
 
PCR number 
(see Table 2.5) 
Description Lane 
Predicted 
Fragment Size 
(bp) 
Actual Fragment  
Size (bp) 
a 8 Internal aph check 1 471 ~500 
2 471 ~500 
3 471 ~500 
4 0 0 
b 2 External acrA 
check 
1 2033 ~2000 
2 2033 ~2000 
3 1528 ~1500 
4 0 0 
c 6 acrA aph check 1 795 ~800 
2 795 ~800 
3 0 0 
4 0 0 
d 7 aph acrA check 1 1148 ~1100 
2 1148 ~1100 
3 0 0 
4 0 0 
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800bp 
10000b
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2033b
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microscopically. Finally, Analytical profile indexing (API, Biomerieux, France) gave the 
identity of the bacteria to be Salmonella spp. with a probability of 98.9%. One acrA::aph 
mutant was retained for further study and given the laboratory code L823. 
3.3.2 P22 transduction of the disrupted region 
The λ red recombinase used during the construction of the gene disrupted mutants is known 
to induce non-specific mutations throughout the genome, albeit at a low frequency. To 
minimise this risk the disrupted region containing the aph cassette was transduced with P22 
phage into the wild-type SL1344 background.  
Following transduction with the P22 phage, two colonies were present on the kanamycin 
containing agar onto which the transduction reaction containing 50 µl of P22 phage had 
been plated. Cell lysates were prepared from each putative transductant and in the first 
instance a PCR to assess the size of the acrA region was performed (Table 2.5, PCR 2). Both 
putative transformants produced an amplimers of approximately 2000 bp while the 
wild-type control, SL1344, produced an amplimer of approximately 1500 bp. Data for the 
transductants indicated that the disrupted region, containing the aph cassette, had been 
transduced from L823 into SL1344. Two further PCRs which combined external check 
primers with primers internal to the aph cassette produced amplimers of the predicted size 
confirming that the transduction had been successful (Table 2.5, PCRs 5 and 6) (Figure 3.2). 
One candidate was chosen and designated L884. 
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Figure 3.2 Confirmation of successful transduction of the disrupted acrA::aph region.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three PCR checks were performed on two candidate transductants and SL1344 was included 
as a control. Lane 10 contains a negative control and lane 11 contains a DNA sizing ladder 
which is labelled to the left hand side. The details of the PCR reactions are given in Table 2.5. 
  
Lane Strain PCR 
number  
(see 
Table2.5) 
Predicted 
Fragment 
Size (bp) 
Actual 
Fragment 
Size (bp) 
Result Conclusion 
1  
Candidate 1  
1  2033  2033  acrA disrupted 
by aph  
The acrA::aph region 
has been successfully 
transduced in L354  2  5  1355  1355  aph is present 
within acrA  
3  6  1148  1148  aph is present 
within acrA  
4  
Candidate 2  
1  2033  2033  acrA disrupted 
by aph 
The acrA::aph region 
has been successfully 
transduced in L354  5  5  1355  1355  aph is present 
within acrA  
6  6  1148  1148  aph is present 
within acrA  
7  
 
SL1344 
1  1528  1528  Wild type acrA  The wild type control 
behaved as expected  
8  
 
5  0  0  aph is not 
present  
9  
 
6  0  0  aph is not 
present  
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3.3.3 Removal of the aph cassette using the pCP20 plasmid 
Removal of the aph gene from the gene disrupted mutant L884 (acrA::aph) was necessary to 
ensure that there were no polar effects from the insertion of this gene.  
After L884 was transformed with pCP20, multiple large colonies appeared on all plates while 
the negative control, to which no plasmid was added, produced no colonies. After the 
plasmid was cured by overnight growth at 43°C all colonies grew well on antibiotic free LB 
agar. No growth was observed on LB agar containing ampicillin, confirming the plasmid had 
been lost. There was also no growth on LB agar containing kanamycin, indicating that the 
aph cassette had been successfully removed.  
Three candidate transformants were selected. In a PCR to assess the size of the acrA region 
in each candidate (Table 2.5, PCR 2), candidates two and three produced amplimers of 
approximately 500 bps indicating the antibiotic resistance cassette had been removed while 
candidate one produced a fragment of 2033 bp indicating that the aph gene was still present 
(Figure 3.3 a and b). Finally, in a PCR using primers internal to the aph cassette (Table 2.5, 
PCR 7) an amplimer of approximately 500 bps was produced from L884 (acrA::aph) and 
candidate one, but no product was produced from candidates two or three confirming 
neither of them retain the aph cassette (Figure 3.3). Candidate two was selected and 
designated L976 (ΔacrA). 
3.4 Complementation of acrA in the acrA::aph mutants 
To ensure that the phenotypic changes in the acrA mutants (L823 and L884) were due to 
inactivation of acrA, the non-functional gene was complemented with the wild-type version  
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Figure 3.3 Confirmation of the removal of the aph cassette after treatment with the pCP20 plasmid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lane  Strain  Predicted 
Fragment 
Size (bp)  
Actual 
Fragment 
Size (bp)  
Conclusion    Lane  Strain   Predicted 
Fragment 
Size (bp)  
 Actual 
Fragment 
Size (bp)  
 Conclusion  
2  SL1344  1528  1528  Wild type acrA    2   SL1344   0  0   Does not contain aph  
3  L110 (acrB::aph)  1528  1528  Wild type acrA    3   L110 (acrB::aph)  471   471   Contains the aph gene  
4  L823 (acrA::aph)  2033  2033  acrA disrupted by aph    4   L823 (acrA::aph)  471   471   Contains the aph gene  
5  Candidate 1  539  2033  acrA disrupted by aph    5   Candidate 1   0   471   Contains the aph gene  
6  Candidate 2  539  539  aph removed.    6   Candidate 2   0   0   aph removed.  
7  Candidate 3  539  539  aph removed.    7   Candidate 3   0   0   aph removed.  
8  Negative 
Control  
0  0  Negative    8   Negative Control  0   0   Negative  
b. PCR to confirm presence or absence of aph gene (Table 2.5, PCR 7). a. PCR to assess the size of the acrA region (Table 2.5, PCR 2). 
Lane 1 contains a DNA sizing ladder 
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in the gene disrupted mutants. This was done using the low copy number vector pWKS30 to 
try to achieve approximately wild-type levels of acrA expression (Wang and Kushner, 1991; 
Buckley et al., 2006). After complementation, reversion to the wild-type phenotype would 
indicate that the inactivation of the target gene, acrA, and not polar effects, was responsible 
for the phenotypic change. 
3.4.1 Construction of the complementation plasmid 
Wild-type acrA, along with its native promoter, was amplified by PCR (Table 2.5, PCR 8) 
producing an amplicon of approximately 1500 bp. This product was digested with HindIII and 
BamHI (Figure 3.4, lane 2). The pWKS30 vector (Wang and Kushner, 1991) was successfully 
isolated from E. coli I906 and after digestion with HindIII and BamHI a linear product of 
5.4 Kb was produced (Figure 3.4, lane 3). The plasmid and insert were successfully ligated 
producing a band of 6.9 Kb after agarose gel electrophoresis (Figure 3.4, lane 4). Bands of 
5.4 Kb and 1542 bp were also present representing residual plasmid and insert which had 
not been incorporated into the ligated product (Figure 3.4, lane 4).  
3.4.2 Transformation of strains with pWKS30acrA 
After the ligated product was electroporated into E. coli DH5-α cells, three large colonies 
were produced on LB agar containing 50 µg/ml ampicillin. Plasmid was recovered from all 
three putative transformants. After digestion with HindIII and BamHI only candidate two 
produced bands of 5.4 Kb and 1542 bp representing plasmid and insert respectively (Figure 
3.5). A PCR for acrA (Table 2.5, PCR 2), using DNA isolated from the band representing the 
insert from candidate two as the template, produced an amplimer of approximately 1.5 Kb 
confirming the plasmid insert was acrA (Figure 3.6).  The E. coli strain containing the  
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Figure 3.4 Construction of the acrA complementation plasmid by insertion of wild type 
acrA into the pWKS30 vector: ligation of digested insert and digested plasmid to give the 
ligated product, pWKS30acrA 
 
 
 
Lane  Description  Expected 
fragment size (bp)  
Actual fragment 
size (bp)  
1  DNA sizing ladder (Bioline)  -  -  
2  Digested Insert  1542  1542  
3  Digested Plasmid  5400  5400  
4  Ligation reaction 6900  6900  
 
Lane one contains a DNA sizing ladder. In lane four, containing the ligation reaction, the 
ligated product is visible (6.9 Kb). Residual plasmid (5.4 Kb) and insert (1542 bp) are also 
visible which were not incorporated into the ligated product.  
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Figure 3.5 Confirmation of successful transformation of I750 with pWKS30 acrA plasmid: 
Undigested and digested plasmid recovered from three candidate transformants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lane  Description  Predicted 
Fragment Size 
(bp)  
Actual 
Fragment 
Size (bp)  
Conclusion  
1  DNA sizing ladder  -  -  -  
2  Candidate 1 Undigested 
plasmid  
-  -  Plasmid isolated  
3  Candidate 1 digested 
plasmid  
5400 and 1542  No products  No bands after digestion  
4  Candidate 2 Undigested 
plasmid 
-  -  Plasmid isolated  
5  Candidate 2 digested 
plasmid 
5400 and 1542 5400 and 
1542 
Plasmid and insert visible 
after digestion  
6  Candidate 3 Undigested 
plasmid 
-  -  Plasmid isolated  
7  Candidate 3 digested 
plasmid 
5400 and 1542 No products  No band after digestion  
 
Only the plasmid isolated from candidate two gave two bands of expected size after 
digestion. No expected fragment sizes are listed for the undigested plasmid as they cannot 
be accurately sized until linearised. The gel is shown as black bands on a white background 
as the bands were difficult to see.  
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Figure 3.6 Confirmation by PCR that the insert in pWKS30 is acrA 
 
 
 
 
 
 
 
 
Lane  Description  Predicted 
Fragment Sizes 
(bp)  
Actual 
Fragment Sizes 
(bp)  
Conclusion  
1, 5  DNA sizing ladder  -  -  -  
2  Candidate 2  1528  1528  acrA amplified from purified 
plasmid insert  
3  SL1344  1528  1528  acrA amplified  
4  Negative control  0  0  Negative  
 
After isolation and digestion of the plasmids (Figure 3.5) the band representing the plasmid 
insert was excised and the DNA isolated. This DNA was used as the template in this PCR 
reaction. The band of around 1500bp from candidate two produced the same size product as 
the positive control, SL1344, so contains the acrA insert.   
120 
 
pWKS30acrA plasmid was designated I750. The pWKS30acrA plasmid was successfully 
recovered from I750 and electroporated into L823 (acrA::aph), L884 (transduced acrA::aph), 
and SL1344. Transformation was confirmed by isolation and digestion of the plasmid with 
HindIII and BamHI followed by a PCR for acrA to confirm insert identity. These strains were 
designated L975, L979, and L980, respectively.  
3.5 Expression of acrB/AcrB in mutants lacking acrA 
The acrA and acrB genes exist together in a single operon. To determine the role of AcrA 
alone it is crucial that expression of acrB/AcrB was un-affected by the disruption of the acrA 
region. Reverse transcriptase PCR was used to confirm acrB transcription and Western 
Blotting was used to confirm the presence of the AcrB protein. 
3.5.1 Reverse transcriptase (RT) PCR to measure acrA and acrB transcription  
After RNA isolation all samples were electrophoresed on a 1% agarose gel confirming RNA 
had been successfully isolated from all three biological replicates of SL1344, L884 
(acrA::aph), L976 ( acrA), L979 (L884 with pWKS30acrA) and L110 (acrB::aph),  respectively. 
A PCR for 16s was performed to determine whether any was DNA present (Table 2.5, PCR 5). 
No product was produced from any of the samples indicating that no DNA was present. 
After cDNA was synthesised from the isolated RNA, PCRs using primers internal to the genes 
of interest, acrA and acrB, were set up along with a control PCR using primers internal to 16s 
(Table 2.5, PCRs 3, 4, and 5). The levels of the PCR products were quantified according to 
their peak areas after denaturing high-pressure liquid chromatography (dHPLC) on the WAVE 
DNA fragment analysis system and subsequent analysis with the NAVIGATOR (version 1.4) 
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software (Transgenomic Inc.) as described by Eaves et al., (2004). Expression levels of each 
gene were normalised against levels of 16s in each sample. 
The acrA transcript was detected in SL1344 but was absent in L884 (acrA::aph) (Figure 3.7 a). 
A small amount of transcript was detected in L976 ( acrA) but this was significantly lower 
than in SL1344 and was not significantly different from L884 (acrA::aph). The acrA transcript 
was slightly over-expressed in the complemented strain L979 (acrA::aph, pWKS30acrA) 
(Figure 3.7 a). 
The level of acrB detected in the acrA mutants (L884 and L976) was not significantly 
different to the level detected in SL1344 (Figure 3.7 b). No acrB expression could be 
detected in L110 (acrB::aph) (Figure 3.7 b). 
3.5.2 Western Blotting to detect the presence of AcrA, AcrB and TolC proteins  
Western blotting with anti-AcrA antibody confirmed the expression of the AcrA protein in 
SL1344 and L110 (acrB::aph) with a band present at ~42 kDa. Expression was absent in both 
AcrA mutants (L884 (acrA::aph) and L976 (ΔacrA)) and was over-expressed by 3.2 fold in the 
complemented strain (L979). Surprisingly, the AcrA protein could not be detected in the tolC 
mutant (L109) (Figure 3.8a). 
Western blotting with anti-AcrB antibody confirmed the expression of the AcrB protein in 
SL1344, L884 (acrA::aph) and L109 (tolC::aph) with a band present at ~110-120 kDa 
representing the AcrB monomer. Expression was absent in the acrB mutant (L110) (Figure 
3.8b). 
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Figure 3.7 RT-PCR to measure acrA and acrB expression 
a. Expression of acrA in SL1344, L884 (acrA::aph), L976 ( acrA) and L979 
(acrA::aph, pWKS30acrA) 
 
b. Expression of acrB in SL1344, L884 (acrA::aph), L976 ( acrA), L110 (acrB::aph) and L979 
(acrA::aph, pWKS30acrA) 
 
 
 
Data shown are presented as fold change compared to SL1344 +/- standard deviation and 
are the mean of three independent experiments. Results that were significantly different 
from SL1344 are denoted by *. 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
SL1344 L884 L976 L979
Fo
ld
 C
h
an
ge
0
0.2
0.4
0.6
0.8
1
1.2
1.4
SL1344 L884 L976 L110 L979
Fo
ld
 c
h
an
ge
* 
* 
123 
 
Figure 3.8 Western Blotting for AcrA, AcrB and TolC in SL1344 and efflux mutants thereof. 
 
 
 
 
a. AcrA 
 
 
 
 
b. AcrB 
 
 
 
 
c. TolC 
 
 
 
Membrane protein preparations were blotted with anti-AcrA, anti–AcrB or anti-TolC 
antibodies. 
 
SL1344      L109              L110           L884          L976      L979 
   WT        tolC::aph    acrB::aph   acrA::aph   ΔacrA    acrA::aph,  
           pWKS30acrA 
SL1344                          L109                    L110                   L884           
                   tolC::aph            acrB::aph                acrA::aph      
         
SL1344         L109             L110            L884           L976     L979 
   WT      tolC::aph        acrB::aph    acrA::aph     ΔacrA   acrA::aph +  
               pWKS30acrA 
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Western blotting with anti-TolC antibody confirmed the expression of the TolC protein in 
SL1344, the acrB mutant (L110), the acrA mutants (L884, L976) and the acrA complemented 
strain (L979) with a band present at ~150 kDa representing the TolC trimer. Expression was 
absent in the tolC mutant (L109) (Figure 3.8c). 
3.6 Phenotypic Characterisation of S. Typhimurium mutants lacking AcrA 
3.6.1 Bacterial growth kinetics in LB broth 
There was no significant difference between the generation times or the final optical density 
at stationary phase for SL1344, L109 (tolC::aph), L110 (acrB::aph), L884 (acrA::aph), L976 
( acrA) or L979 (acrA::aph with pWKS30acrA) in LB broth (Figure 3.9). However, it has also 
been shown by this laboratory that mutants lacking acrA or acrB are impaired in their ability 
to grow in anaerobic conditions after both 8 and 24 hours compared to SL1344. The ability of 
the mutant lacking tolC to grow anaerobically was not affected(Webber et al., 2009). 
3.6.2 Hoechst 33342 (Bis-benzamide) accumulation 
Hoechst H33342 is a dye which fluoresces when bound to DNA and therefore its 
accumulation can be used to assess relative levels of active efflux (Webber et al., 2008; 
Webber and Coldham, In Press). Accumulation of Hoechst H33342 in the acrA mutant was 
determined and compared to that of SL1344. Inactivation of acrA conferred a two-fold 
increase in accumulation compared to the wild-type strain SL1344 (P = 0.04). This phenotype 
was abolished in the complemented strain (L979). The acrB mutant accumulated 2.9 fold 
more Hoechst H33342 (P = 0.005), while the tolC mutant accumulated 3.6 fold more (P = 
0.003) (Figure 3.10).  
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Figure 3.9 (a) Growth kinetics of SL1344 and efflux mutants thereof in LB broth at 37 °C for 
12 hours 
 
(b) Generation Times and Optical Density at Stationary Phase (± standard deviation) 
Strain Mean Generation 
Time (minutes) 
T-test (P) OD 600 at 
Stationary Phase 
T-test (P) 
SL1344 47.38 ± 0.65 
 
- 0.749 ± 0.585 - 
L109 
(tolC::aph) 
46.15 ± 0.71 0.09 0.721 ± 0.557 0.31 
L110 
(acrB::aph) 
44.41 ± 1.34 0.06 0.702 ± 0.538 0.17 
L884 
(acrA::aph) 
46.53 ± 3.36 0.69 0.637 ± 0.473 0.06 
L976 
( acrA) 
47.46 ± 2.55 0.96 0.704 ± 0.540 0.14 
L979 
(acrA::aph, 
pWKS30 acrA) 
48.08 ± 2.06 0.60 0.630 ± 0.466 0.06 
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Figure 3.10 Accumulation of Hoechst H33342 (Bis-benzamide) by SL1344, L884 (acrA::aph), 
L979 (acrA::aph, pWKS30acrA), L110 (acrB::aph) and L109 (tolC::aph) 
 
 
 
 
a. The accumulation of Hoechst H33342 in L884 (acrA::aph) and SL1344 over time 
 
b. The fold change in accumulation of Hoechst H33342 in SL1344, the acrA mutant (L884), 
the acrA complemented strain (L979), the acrB mutant (L110) and the tolC mutant (L109).  
The data presented is the mean of three separate experiments, each performed in duplicate. 
Data in b is presented as fold change compared to SL1344 at the end point of the time 
course shown in a +/- standard deviation. Student’s t-tests were performed to compare the 
accumulation of each strain to that of SL1344 and those returning P values of less than 0.05 
are indicated by * 
* 
* 
* 
a. 
b. 
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3.6.3 Antimicrobial Susceptibility   
S. Typhimurium SL1344 was susceptible to all 13 agents tested (Table 3.1). These agents 
were chosen as they are known substrates of AcrAB-TolC and represent different antibiotic 
classes as well as the dyes and detergents. 
3.6.3.1 Antimicrobial Susceptibility of the acrA mutant, the transduced acrA mutant strain 
(L884) and the acrA mutant with aph removed (L976) (Table 3.1). 
L823 (acrA::aph) and L884 (transduced acrA::aph) showed the expected increase in 
kanamycin resistance to >256 µg/ml due to incorporation of the aph gene. L976 (  acrA) was 
susceptible to kanamycin due to the removal of the aph gene.  The MICs for the acrA mutant 
(L823), the transduced acrA mutant (L884) and the acrA mutant from which the aph gene 
has been removed (L976) were all within one dilution of each other. 
MIC values for L109 and L110 were within one dilution of previously published data from this 
laboratory (Eaves et al., 2004; Buckley et al., 2006).  Inactivation of acrA resulted in 
increased susceptibility to almost all agents tested except tetracycline, bile, SDS and Triton 
X-100. Inactivation of either acrA, acrB or tolC gave a similar increase (+/- one dilution) in 
susceptibility to ampicillin, nalidixic acid and chloramphenicol. However, the 
hypersusceptibility profiles produced by strains lacking acrA were distinct from those for the 
acrB or tolC mutants. Strains lacking acrA (L823, L884 and L976) were also as susceptible (+/- 
one dilution) as the acrB mutant (L110) to ethidium bromide and Triton X-100, but were 
more susceptible than L110 (acrB::aph) to ciprofloxacin, triclosan, acriflavine and fusidic 
acid. The acrA mutants (L823, L884 and L976) were also as susceptible (+/- one dilution) as 
L109 (tolC::aph) to acriflavine and fusidic acid while the tolC mutant was more susceptible to  
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Table 3.1 MICs of a range of antibiotics, dyes and detergents for the acrA, acrB and tolC mutants (L823, L110 and L109), the transduced acrA 
mutant strain (L884) and the acrA mutant with aph gene removed (L976) compared to SL1344. 
  MIC · (μg/ml) 
 
Genotype Kan Amp Nal Cip Chl Tet Tric EthBr Acr Fus Bile SDS 
Triton 
X-100 
SL1344 
 
 8 1 4 0.015 4 1 0.06 >256 256 >512 2048 >512 
>2000
0 
L823 
 
 acrA::aph >256 0.25 0.5 0.002 0.5 0.5 0.008 64 16 4 2048 256 
>2000
0 
L884 
 
Transduced 
L823 
>256 0.25 0.5 0.002 0.5 0.5 0.008 64 16 4 2048 256 
>2000
0 
L976 
 
Δ acrA 8 0.25 0.5 0.002 0.5 0.5 0.008 64 16 4 2048 256 
>2000
0 
L109 
 
tolC::aph 256 0.25 1 0.015 1 0.5 0.015 16 16 4 256 64 1200 
L110 
 
acrB::aph 256 0.25 1 0.015 1 1 0.03 64 64 16 1024 128 
>2000
0 
 
Red text indicates a ≥ 2 fold decrease in MIC value compared with SL1344. 
 
Kan, kanamycin; amp, ampicillin; Nal, nalidixic acid; Cip, ciprofloxacin; Chl, chloramphenicol; Tet, tetracycline; Tric, triclosan; EtBr, ethidium 
bromide; Acr, acriflavine; Fus, fusidic acid, SDS, sodium dodecylsulphate; Triton, triton X-100. 
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ethidium bromide, bile, SDS and Triton X-100. The acrA mutant was more susceptible than 
L109 (tolC::aph) to ciprofloxacin and triclosan.  
3.6.3.2 Antimicrobial Susceptibility of the strains containing the pWKS30 vector alone 
(L917, L918 and L996) and strains containing pWKS30 acrA (L980, L975 and L979) (Table 
3.2).  
SL1344, L823 (acrA::aph) and L884 (acrA::aph) were transformed with the pWKS30 vector 
giving strains L917, L918 and L996, respectively and with pWKS30acrA giving strains L980, 
L975 and L979, respectively. Strains containing either the pWKS30 plasmid (L917, L918 and 
L996) or the pWKS30 acrA plasmid (L980, L975 and L979) were ampicillin resistant (MIC = 
>128 µg/ml) due to the presence of the ampicillin resistance gene on the pWKS30 plasmid. 
Apart from ampicillin, the MICs of antibiotics, dyes and detergents for L917 (SL1344 with 
pWKS30), L918 (L823 with pWKS30 vector) and L996 (L884 with pWKS30 vector) were all 
within one dilution of those for the parent strain without the plasmid showing that 
possession of the pWKS30 plasmid had no inherent effects on antimicrobial susceptibility. 
The MICs of antibiotics, dyes and detergents for L980 (SL1344 with pWKS30acrA) were all 
within one dilution of those for SL1344 without the plasmid. Except for kanamycin and 
ampicillin, the MICs for the acrA mutants carrying the complementation plasmid (L975  and 
L979) were all within one dilution of those for the wild-type SL1344 showing that 
complementation of acrA has restored the antimicrobial susceptibility profile of the mutants 
to wild-type levels. 
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Table 3.2 MICs of a range of antibiotics, dyes and detergents for the acrA mutant and transduced mutant (L823 and L884), strains containing 
the pWKS30 vector alone (L917 and L918) and strains containing pWKS30 acrA (L980, L975 and L979) 
  MIC · (μg/ml) 
 Genotype Kan Amp Nal Cip Chl Tet Tric EthBr Acr Fus Bile SDS 
SL1344 
 
 WT 8 1 4 0.015 4 2 0.06 >256 256 >512 >1024 >512 
L917 
 
 SL1344 with 
pWKS30 vector 
8 >128 4 0.015 2 2 0.06 >256 256 512 >1024 >512 
L980 
 
SL1344with 
pWKS30 acrA 
8 >128 4 0.015 4 2 0.06 >256 256 512 >1024 >512 
L823 
 
acrA::aph >256 0.25 0.5 0.008 1 0.5 0.008 64 16 4 2048 512 
L918 
 
 L823 with 
pWKS30 vector 
>256 >128 1 0.008 0.5 0.5 0.015 64 16 4 >1024 256 
L975 
 
 L823 with 
pWKS30 acrA 
>256 >128 4 0.03 4 2 0.06 >256 256 512 >1024 >512 
L884 
 
 Transduced 
L823 
>256 0.25 0.5 0.008 0.5 0.5 0.008 64 16 4 >1024 256 
L996 
L884 with 
pWKS30 vector 
>256 >128 0.5 0.008 0.5 0.5 0.008 64 16 4 >1024 256 
L979 
 
L884 with 
pWKS30 acrA 
>256 >128 4 0.03 4 2 0.06 >256 256 512 >1024 >512 
Red text indicates a ≥ 2 fold decrease in MIC value compared with SL1344. Kan, kanamycin; Nal, nalidixic acid; Cip, ciprofloxacin; Chl, 
chloramphenicol; Tet, tetracycline; Tric, triclosan; EtBr, ethidium bromide; Acr, acriflavine; Fus, fusidic acid, SDS, sodium dodecylsulphate; 
Triton, triton X-100. 
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3.6.4 Transmission electron microscopy  
SL1344 and the acrA, acrB and tolC mutants were grown overnight in LB broth before being 
washed, fixed with 2.5% gluteraldehyde  and viewed by transmission electron microscopy by 
Bill Cooley at the Veterinary Laboratories Agency, Weybridge, Surrey. The size and 
appearance of the acrA mutant (L884) was not significantly different to the wild-type SL1344 
(Figure 3.11 a and b).  
3.7 Discussion  
The acrA gene of Salmonella Typhimurium, was successfully inactivated by insertion of the 
aph gene (L823) and this mutation was successfully transduced (L884), the aph gene 
removed (L976) and the mutation complemented (L979). RT-PCR confirmed that acrA was 
not transcribed in any of the acrA mutants and was transcribed at slightly higher than wild-
type levels in the complemented strain (L979). Western blotting showed the same pattern of 
expression for the AcrA protein. Importantly, RT-PCR and Western blotting showed that acrB 
and AcrB, respectively were expressed in the acrA mutants at the same level as in the wild-
type strain and TolC was present in all strains except the tolC mutant. This is crucial as it 
shows, that although acrA and acrB are in the same operon, that inactivation of acrA has not 
adversely affected acrB expression so the loss of the periplasmic adaptor component alone 
can be studied. 
An interesting result from the Western Blotting was that AcrA was not detected in the TolC 
mutant although previous work in this laboratory has shown that acrA transcription was not 
affected by inactivation of tolC (Webber et al., 2009). The complete structure of the 
assembled  E. coli AcrAB-TolC system was recently published and this shows the structural  
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Figure 3.11 Transmission Electron Microscopy to examine bacterial structure 
a. SL1344 
 
 
 
 
 
 
 
 
 
b. L884 (acrA::aph) 
 
 
 
 
 
 
 
 
 
Images taken by Bill Cooley at the Veterinary Laboratories Agency, Weybridge, Surrey 
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importance of the AcrA protein in stabilising the complex between the weakly interacting 
inner and outer membrane components, AcrB and TolC (Symmons et al., 2009). A further 
study has confirmed the importance of E. coli  AcrA, in particular the C-terminal domain, in 
assembly of the efflux pump (Ge et al., 2009). Symmons and colleagues suggest that AcrA 
may bind to AcrB and that this complex then recruits the outer membrane component, TolC. 
One hypothesis for the unusual observation in the TolC mutant in this study is that if the 
AcrAB complex is unable to recruit the outer membrane component (because it is absent) 
then the periplasmic component may be degraded by periplasmic proteases. The study by 
Ge et al., (2009) provides some evidence for this as the C-terminus of AcrA is readily cleaved 
by trypsin when either AcrB or TolC is absent, or when AcrA is linked to either AcrB or TolC 
alone in a bi-partite complex, but is protected from proteolysis by assembly of the tri-partite 
system (Ge et al., 2009). It is therefore possible that, in vivo, assembly of the tri-partite 
system protects AcrA from degradation by periplasmic proteases but when TolC is not 
present, meaning that the complex cannot form, that AcrA is degraded. In wild-type cells 
degradation of un-complexed AcrA is probably important in preventing periplasmic 
overcrowding as over-expression of AcrA in mutants lacking AcrEF is toxic, and results in cell 
division defects (Lau and Zgurskaya, 2005). Although this is not a specific effect of AcrA per 
se but an effect of periplasmic overcrowding in this mutant, it suggests that prevention of 
periplasmic over-crowding by proteolysis of unused proteins is probably important in 
maintaining normal cellular function. Further study is required to explore this hypothesis and 
to explain the lack of AcrA detected in the TolC mutant and this is discussed in section 3.8.  
Inactivation of acrA, acrB or tolC did not affect the growth of S. Typhimurium in LB broth in 
aerobic conditions but a separate study from this laboratory showed that growth of the acrA 
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and acrB mutants was impaired in anaerobic conditions (Webber et al., 2009). In the acrB 
mutant this impaired anaerobic growth has been linked to reduced transcription of the nir, 
nar and nap operons which encode genes known to be involved in anaerobic respiration. In 
contrast, these genes were shown to be transcribed at higher levels in the acrA mutant than 
in SL1344 so the reason for the defect in anaerobic growth in this strain is not known 
(Webber et al., 2009). 
The method used to study the growth of the efflux mutants compared to SL1344 (described 
in 2.7.1) is an automated system allowing high throughput and generation of multiple 
biological and technical replicate data sets. However, this method has limitations. For 
example, optical density was used to measure growth rather than the more accurate 
method of using viable counts. This is a notable limitation of the study. However, previous 
work in this laboratory has confirmed the same findings for these strains by viable counting 
and by estimation of total protein content (Mark Webber, unpublished work; Webber et al., 
2009 supplementary material). A further limitation of the method is that no initial lag phase 
was seen before entry into the logarithmic phase of growth due to the high initial inoculum. 
Therefore, while there was no significant difference in generation time or final optical 
density, it is not possible to comment whether the efflux mutants have a lag phase which is 
significantly different from that of the wild-type strain, SL1344. In addition, the growth 
experiments described in section 3.6.1 were performed in LB broth while later experiments 
used the tissue culture media MEM and DMEM so the results discussed here cannot 
necessarily be extrapolated to be relevant during later experiments. 
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Inactivation of acrA in Salmonella Typhimurium SL1344 led to increased susceptibility to a 
range of antibiotics, dyes and detergents compared with the parental strain S. Typhimurium 
SL1344. This hypersusceptibility phenotype was abolished by complementation with 
pWKS30acrA. When the susceptibility of the acrA mutant was compared with data for 
SL1344 in which acrB or tolC had been inactivated subtle gene dependant differences in 
phenotype were seen. The susceptibility of the acrA mutant (L884) to the antimicrobials 
tested was similar to the acrB mutant for 5 of the 13 agents tested although the acrA mutant 
was more susceptible than L110 to ciprofloxacin, triclosan, acriflavine and fusidic acid. The 
greatest overall increase in susceptibility was seen with the inactivation of tolC, particularly 
to fusidic acid, nalidixic  acid and Triton X-100, as previously reported for both Salmonella 
and E. coli (Nishino et al., 2003; Buckley et al., 2006; Nishino et al., 2006). Interestingly, the 
acrA mutant was more susceptible to ciprofloxacin and triclosan than the tolC mutant. This 
shows that AcrA plays an important role in efficient efflux of these antimicrobials. 
The greater susceptibility of the acrA mutants to some agents may be partially explained by 
the reported promiscuity of the AcrA protein with other efflux proteins of the RND family of 
efflux pumps including AcrD and AcrF (Kobayashi et al., 2001a; Elkins and Nikaido, 2002, 
2003). It may also associate with efflux pumps of other families which can also transport 
ciprofloxacin and triclosan. The TolC protein is also promiscuous and acts as the outer 
membrane component for many efflux systems including other RND pumps (Nagakubo et 
al., 2002; Hirakawa et al., 2003; Nishino et al., 2003; Nishino et al., 2006) as well as members 
of the MFS (Nishino and Yamaguchi, 2002) and ABC transporter families (Kobayashi et al., 
2001b) therefore, disruption of TolC will not only affect the ability of the AcrAB pump to 
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function but will interfere with other export pathways possibly explaining its generally 
greater susceptibility. 
Another possible explanation for the magnitude of susceptibility in the AcrA mutant is that 
AcrA may have some role in recruiting substrates into the pump from the periplasm 
(Zgurskaya et al., 2008; Symmons et al., 2009). The recently published structure of the 
assembled pump shows that, while AcrA does not make any contact with the binding cleft 
between PC1 and PC2 subdomains of AcrB, the newly modeled membrane proximal domain 
of AcrA binds very close to the binding pocket identified between the PN2 and PC1 
subdomains of AcrB. The suggestion is that AcrA could therefore have a role in facilitating 
recruitment of hydrophobic substrates into this binding pocket (Symmons et al., 2009). It has 
not been confirmed that the mutants produce typical LPS and therefore, the possibility that 
pleiotropic effects of an atypical LPS are contributing to the susceptibility phenotype cannot 
be ruled out.  
Interestingly, a comprehensive study of multiple efflux pump mutants by Nishino and 
colleagues (2006) showed that a mutant lacking both AcrA and AcrB was hypersusceptible to 
antibiotics, dyes and detergents but to the same level as a strain lacking only AcrB. This is 
interesting as the results from this study suggest that lack of AcrA has a distinct susceptibility 
phenotype to loss of AcrB. However, this discrepancy is probably explained by the different 
agents tested in the two studies and, as the susceptibility is substrate specific, the difference 
between the single acrB mutant and the acrAB mutant may be detected if more agents were 
tested.  
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Accumulation of the fluorescent dye Hoechst 33342 was increased two fold in the acrA 
mutant (L884 acrA::aph) and to a greater extent in the acrB and tolC mutants showing a 
significant decrease in efflux.  These data suggest that the PAP is required for efficient efflux. 
The observed decrease in efflux goes some way to explain the increase in susceptibility of 
strains lacking components of AcrAB-TolC to the antimicrobials tested. The decreased efflux 
means that toxic compounds are not extruded as efficiently and therefore accumulate inside 
the cell and are lethal at lower total concentration. However, the effect is substrate specific 
as the acrA mutant was the most susceptible to triclosan while it did not have the most 
attenuated efflux level. 
Loss of functional acrA significantly affected the efflux activity and antibiotic susceptibility of 
SL1344 and importantly the mutant phenotype was distinct from strains lacking either AcrB 
or TolC. This suggests a key role for AcrA in efficient operation of this pump which is 
separate and distinct from that of AcrB (or other protein partners) or TolC. This is 
complementary to the growing body of structural data showing that AcrA physically interacts 
with both AcrB and TolC (Husain et al., 2004; Tikhonova and Zgurskaya, 2004; Bavro et al., 
2008) and is structurally important in assembly of the complex (Symmons et al., 2009). The 
extent of the change in phenotype is probably augmented by the promiscuity of AcrA such 
that disruption of acrA will also cause the function of other RND pumps to be impaired 
(Kobayashi et al., 2001a; Elkins and Nikaido, 2002, 2003; Hirakawa et al., 2003; Nishino et al., 
2003).  
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3.8 Further work 
Limitations of the method used to measure growth of SL1344 and the efflux mutants have 
been discussed. To overcome these limitations the findings the experiments should first be 
confirmed by viable counts. A more dilute bacterial suspension or a range of dilutions could 
be used to study the effect of inactivation of these efflux proteins on the lag phase of growth 
and finally the experiments should be repeated in all media types relevant to the study 
including both MEM and DMEM. 
Strains which over-express each of the components of AcrAB-TolC will be constructed along 
with a strain which over-expresses all three components of the efflux system. The hypothesis 
is that over-expression of single components or the entire efflux system may confer multi-
drug resistance as over-expression of efflux pumps has been found to confer MDR in clinical 
isolates (Piddock et al., 2000; Baucheron et al., 2004). 
Previous work by Nishino et al., (2006) has included characterisation of a Salmonella 
Typhimurium strain lacking both AcrA and AcrB. Further work could include constructing 
mutants with inactivations in various combinations of RND pump genes including a strain 
that lacks all three components of AcrAB-TolC. In addition a strain which lacks AcrA and the 
other major RND periplasmic adaptor protein, AcrE could be constructed. It is postulated 
that the efflux activity of strains lacking multiple components of the RND efflux systems will 
be even more impaired and this would allow investigation of the level of redundancy in 
these systems.  
The RND efflux pump AcrD is involved in the transport of aminoglycoside antibiotics 
(Rosenberg et al., 2000; Aires and Nikaido, 2005). The genetic organisation of AcrD is 
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different from other RND systems in that it is not encoded alongside its own periplasmic 
adaptor protein but requires AcrA for proper function (Aires and Nikaido, 2005). To assess 
the impact of loss of AcrA on the function of the AcrD efflux pump the MICs of various 
aminoglycoside antibiotics to L976 could be determined. The MIC of the aminoglycoside 
antibiotic kanamycin to L976 ( acrA) has already been determined (Table 3.1) and was not 
significantly different from that to wild-type but using a panel of aminoglycoside antibiotics 
may reveal increased susceptibilty. It is necessary to use the acrA mutant from which the 
aph gene (an aminoglycoside phosphotransferase) has been removed as this confers 
resistance to kanamycin and may affect susceptibility to other aminoglycoside antibiotics.  
There are multiple reports in the literature of the role of RND systems in resistance to 
antimicrobial peptides (AMPs) (Shafer et al., 1998; Tzeng et al., 2005; Eswarappa et al., 2008; 
Warner et al., 2008). However there is conflicting evidence about the involvement of AcrAB-
TolC of E. coli in the resistance to AMPs (Rieg et al., 2009; Warner and Levy, 2009). To 
investigate the role of AcrAB-TolC in resistance of S. Typhimurium to AMPs the resistance of 
SL1344 and the efflux mutants to a variety of AMPs could be tested by MIC and by killing 
assays.   
Work has begun to further investigate the lack of AcrA protein detected in the TolC mutant. 
The tolC gene has been inserted into the pBAD vector (Invitrogen) and transformed into 
L109, the tolC mutant. Transcription of the tolC gene is inducible by arabinose and inhibited 
by glucose. This will allow a number of experiments to be performed. Firstly, cells will be 
grown in the presence of arabinose, so that the tolC will be transcribed, and then arabinose 
will be removed by washing and glucose added, to inhibit the transcription of tolC. Samples 
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will be taken from the culture before switching to glucose, and at time points afterwards and 
the proteins isolated. Western blotting can then be performed to confirm the level of TolC 
expression and determine whether AcrA can be detected after expression of tolC/TolC is 
stopped. The experiment will also be performed in reverse; the culture will be grown first in 
the presence of glucose, inhibiting tolC transcription, and then switched to arabinose, 
allowing tolC transcription. Western blotting will again be used to confirm TolC levels and 
determine whether AcrA can be detected. If this technique proves useful, another possibility 
is to perform the experiment in a degP mutant. DegP is a protease which degrades misfolded 
proteins in the periplasm (Strauch and Beckwith, 1988) and therefore this may be 
informative as to whether AcrA is absent because it is degraded if the AcrAB-TolC complex is 
unable to form. 
3.9 Key Findings 
 The acrA gene of S. Typhimurium was inactivated by insertion of the aph gene. The 
mutation was transduced back into SL1344 using P22 phage, the aph gene was 
removed using pCP20 and the mutation was complemented. 
 Reverse-transcriptase PCR confirmed that acrB was still transcribed in the acrA 
mutant. Furthermore, western blotting showed that the AcrB protein was still 
translated in the absence of AcrA.  
 The growth of the strain lacking AcrA was not significantly different from SL1344 in 
aerobic conditions. 
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 Inactivation of acrA led to a two-fold greater accumulation of Hoechst H3342 
indicating a lower level of efflux. 
 Lack of AcrA resulted in hyper-susceptibility to a range of antimicrobials. The acrA 
mutant was more susceptible than the acrB mutant to ciprofloxacin, triclosan, 
acriflavine and fusidic acid. Although the tolC mutant was generally the most 
susceptible, the acrA mutant was more susceptible than the tolC mutant to 
ciprofloxacin and triclosan. 
 There was no difference between the size or appearance of the acrA mutant when 
compared to SL1344 using electron microscopy. 
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Chapter Four 
The Role of AcrAB-TolC in infection 
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4. The Role of AcrAB-TolC in infection 
4.1 Background 
Previous work in this laboratory showed that S. Typhimurium mutants lacking either AcrB or 
TolC were less able to infect tissue culture cells. An AcrB mutant had a reduced ability to 
invade human embryonic intestinal cells (INT-407) and murine macrophages (RAW 264.7) 
while mutants lacking TolC had a reduced capacity to both adhere to and invade INT-407 
cells and additionally were unable to invade murine macrophages (RAW264.7). Electron 
microscopy revealed that the acrB and tolC mutants induced fewer membrane ruffles on the 
surface of infected INT-407 cells. Furthermore, in vivo experiments in the avian host showed 
that colonisation and persistence were significantly reduced in mutants lacking either AcrB 
or TolC (Buckley et al., 2006). Coupled with data from Nishino et al., (2006) showing that 
AcrAB and TolC mutants were attenuated in the mouse model of S. Typhimurium infection 
this suggests that the AcrB and TolC proteins are needed for adhesion and invasion of 
S. Typhimurium and therefore have an important role in virulence.  
4.2 Aims and Hypotheses 
The initial aim of this section of work was to determine the effect of loss of acrA on the 
ability of S. Typhimurium to infect tissue culture cells.  It was shown in chapter 3 using the 
fluorescent dye Hoechst 33342 that loss of any component of this efflux system impaired 
efflux function (Section 3.6.2). It was therefore hypothesised that this defect would translate 
into an impaired ability to adhere to and invade eukaryotic cells in vitro, as seen for mutants 
lacking AcrB or TolC. Subsequent work then used confocal imaging of SL1344 and strains 
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lacking AcrA, AcrB or TolC while infecting INT-407 cells to see if the infection patterns were 
variant between the mutants. A secondary aim in this section was to characterise the effect 
of growth in different media on the ability of Salmonella to infect INT-407 and whether this 
influenced the ability of the efflux mutants to infect tissue culture cells. 
4.3 The effect of inactivation of acrA on the ability of S. Typhimurium to infect tissue 
culture cells 
The abilities of S. Typhimurium SL1344 and the acrA, acrB and tolC efflux mutants (L884, 
L110 and L109) to adhere to and invade human embryonic intestine cells (INT-407) and 
mouse macrophages (RAW 264.7) were determined in the same experiments in parallel. 
The acrA mutant (L884, acrA::aph) had a significantly reduced ability to invade INT-407 cells 
compared to SL1344 (11 % of SL1344 invasion, P = 0.0009). However, adhesion was not 
significantly altered by inactivation of acrA (84.4 % of SL1344 adhesion, P = 0.33) (Figure 4.1 
a and b). The levels of adhesion and invasion in the strain in which acrA had been 
complemented with pWKS30acrA were not significantly different from SL1344 levels 
(119.8% of SL1344 adhesion, P = 0.71 and 81.88% of SL1344 invasion, P = 0.47). As previously 
published (Buckley et al., 2006) the ability of the acrB mutant (L110, acrB::aph) to adhere to 
the INT-407 cells was not significantly changed (76.4% of SL1344 adhesion, P = 0.06). Again, 
as found by Buckley et al., (2006) the acrB mutant had a reduced ability to invade the 
INT-407 cell line; this attenuation was greater than that seen upon inactivation of acrA 
(1.004% of SL1344 invasion, P = 0.0002). As previously shown (Buckley et al., 2006), the tolC 
mutant (L109, tolC::aph) was the most attenuated. The level of adhesion was only 33.4% of  
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Figure 4.1 a. The ability of S. Typhimurium SL1344 and various efflux mutants thereof to 
adhere to and invade human embryonic intestine cells (INT-407).  
 
 
 
Data are displayed as mean of at least three separate experiments performed in triplicate + 
standard deviation. Values returning a p value of ≤0.05 from a Student’s T-test comparing 
mutants to the SL1344 values are denoted by *. 
 
 b. Adhesion and Invasion as a % of SL1344 values 
 
 Adhesion (% of SL1344 
value) 
Invasion (% of SL1344 
value) 
SL1344 
 
100 100 
L884 (acrA::aph) 
 
84.4 +/- 22.8 11.00 +/- 2.8 
L979 (acrA::aph, 
pWKS30acrA) 
119.8 +/- 23.4 81.88 +/- 24.8 
L110 (acrB::aph) 
 
76.4 +/- 18.2 1.004 +/- 0.09 
L109 (tolC::aph) 
 
33.4 +/- 11.3 0.003 +/- 0.012 
  
Data are presented +/- standard deviation. Bold values indicate those that are significantly 
different to those for SL1344 
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the SL1344 level (P = 0.0002) and the level of invasion was only 0.003% of the SL1344 level 
(P = 0.0002). 
In the mouse macrophage cell line RAW 264.7 there was a slightly different pattern of 
attenuation. The acrA mutant had a significantly reduced ability to adhere to and invade the 
macrophages (11.22% of SL1344 adhesion, P = 0.030 and 2.1% of SL1344 invasion, P = 0.01) 
(Figure 4.2). The level of adhesion and invasion in the acrB mutant was not significantly 
different from acrA mutant (17.01% of SL1344 adhesion and 0.81% of SL1344 invasion). L109 
(tolC::aph) had an impaired ability to adhere to RAW264.7 cells and was unable to invade 
(4.08% of SL1344 adhesion, P = 0.002 and 0% SL1344 invasion, P = 0.00001). Data in figure 
4.2 was obtained in year one of the PhD programme before the complemented strain and 
transduced strain had been constructed. The experiments were repeated in year three by an 
undergraduate project student and included the transduced strain (L976) and the 
complemented strain (L979) (Appendix 2). The percentage attenuation of L884 was similar 
between the two data sets (14.8% SL1344 adhesion and 4.9% of SL1344 invasion). The level 
of adhesion and invasion by the acrA mutant from which the aph gene has been removed, 
L976 ( acrA), was not significantly different from the L884 levels (P = 0.8). Complementation 
of the acrA mutation with pWKS30acrA in the strain L979, ablated the mutant phenotype 
giving adhesion and invasion levels that were not significantly different from SL1344 (P = 
0.080 and 0.055, respectively). 
4.4 Confidence Interval for level of SL1344 association 
A large number of data sets (>30) for the association, adhesion and invasion levels for the 
control strain SL1344 with INT-407 cells was available from all replicates of this experiment  
147 
 
Figure 4.2 a. The ability of S. Typhimurium SL1344 and various efflux mutants thereof to 
adhere to and invade mouse macrophage cells (RAW 264.7).  
 
 
 
 
 
Data are displayed as mean of at least three separate experiments performed in triplicate + 
standard deviation. 
Values returning a p value of ≤0.05 from a Student’s T-test comparing mutants to the SL1344 
values are denoted by *. 
 
 
 b. Adhesion and Invasion as a % of SL1344 values 
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and also from all subsequent tissue culture experiments as this infection was used as a 
control throughout. This allowed the range in which the CFU/ml for the association of 
SL1344 to be calculated and determination of whether this strain performed the same in 
each experiment. The interval was only calculated for association for simplicity and also 
because the level of association encompasses both adhesion and invasion values. At the 0.05 
level of significance the confidence interval for association of SL1344 to INT-407 cells was 
calculated to be 1.2 x 106 to 1.1 x 107 CFU/ml. Data from further experiments were only 
considered acceptable if the SL1344 association values fell within this range. 
4.5 The Effect of Triton X-100 on Bacterial Survival 
The non-ionic surfactant Triton X-100 was used in all the tissue culture assays to disrupt the 
eukaryotic cell monolayer allowing subsequent enumeration of the bacteria. As inactivation 
of AcrAB-TolC can confer increased susceptibility to detergents it was important to ensure 
that, under the conditions of the tissue culture experiment, this did not influence bacterial 
enumeration. 
The MIC of an agent is determined after 18-24 hours incubation of bacteria and test agent 
and under these conditions the MIC of Triton X-100 for L884 and L110 was the same as for 
SL1344, >20,000 µg/ml (Table 3.1), which is almost double the concentration used in the 
tissue culture assays (10,700 µg/ml or 1%). However, for L109 the MIC of Triton X-100 was 
1200 µg/ml.  Nonetheless it was shown previously that 1% Triton X-100 (as used in the tissue 
culture assays) had no affect on viability of either the acrB or tolC mutants (L110 and L109, 
respectively) during the time-span of exposure (30 minutes) during the experiment (Buckley 
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et al., 2006). Experiments were carried out to ensure that the acrA mutant (L884) was not 
adversely affected by the detergent. 
The growth of the acrA mutant was compared when grown in LB broth alone, in the 
continuous presence of 1% Triton X-100 and when 1% Triton X-100 was added after two 
hours growth (to replicate the tissue culture experiments). In this final test a visible drop in 
optical density (shown by the arrow in Figure 4.3) can be seen at the two hour mark. This 
was caused by the dilution effect of adding Triton-X-100 and the optical density recovers 
quickly. There was no significant difference between the generation times of SL1344 and 
L884 (acrA::aph) grown in LB broth, whether in the continuous presence of 1% Triton X-100 
or when Triton X-100 was added after two hours growth (Figure 4.3).  
4.6 Confocal microscopy images of INT-407 cells infected with SL1344 or mutants lacking 
AcrA, AcrB or TolC 
Confocal imaging was used to visualise infections of INT-407 cells with SL1344 or strains 
lacking AcrA, AcrB or TolC after growth in LB media to see if the effect of loss of the efflux 
pump genes visibly affected the infection pattern on the monolayer. SL1344 and strains with 
either acrA, acrB or tolC inactivated were transformed with the pUA66pacpP plasmid (Neil 
Burton, University of Birmingham) encoding green fluorescent protein (GFP) to give the 
strains L1019, L1020, L1021 and L1022, respectively. INT-407 monolayers were infected with 
each the GFP expressing strains and after fixing the plates were stained red with the F-actin 
specific molecule phalloidin conjugated to the Rhodamine dye. Scanning confocal 
microscopy images were taken of each infection (Figure 4.5). Bacteria lacking either AcrB or 
TolC appeared clumped on the surface of the eukaryotic cells with large areas under the  
150 
 
0.001
0.01
0.1
1
10
0
3
0
6
0
9
0
1
2
0
1
5
0
1
8
0
2
1
0
2
4
0
2
7
0
3
0
0
3
3
0
3
6
0
3
9
0
4
2
0
4
5
0
4
8
0
5
1
0
5
4
0
5
7
0
6
0
0
6
3
0
6
6
0
6
9
0
7
2
0
Time (minutes)
SL1344 growth in LB media alone
SL1344 growth in LB with continuous 1% Triton X-100
SL1344 growth in LB with 1% Triton X-100 added at 2 hrs
Figure 4.3. Growth of SL1344 and L884 in the presence of Triton X-100 
 
 a. The growth SL1344 in LB broth alone or in the presence of 1% Triton X-100  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
b. The growth L884 (acrA::aph) in LB broth alone or in the presence of 1% Triton X-100 
 
 
In each case the arrow indicates the point of addition of Triton X-100. Data is presented as 
the mean of three independent experiments. 
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Figure 4.4 Confocal microscopy images of INT-407 cells infected with wild-type and efflux 
mutant strains containing the GFP encoding pUA66pacpP plasmid. 
Images taken by Dr. Rob Shaw (University of Birmingham). Eukaryotic cells are stained with 
the F-actin specific molecule phalloidin conjugated to the Rhodamine dye. 
A. L1019 = SL1344 with pUA66pacpP   
B. L1020 = L644 (ΔacrB) with pUA66pacpP   
C. L1021 = L742 (ΔtolC) with pUA66pacpP   
D. L1022 = L976 (ΔacrA) with pUA66pacpP 
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clumps staining bright red, indicating actin rearrangement (Figure 4.5 B and C, respectively). 
However, SL1344 and the strain lacking AcrA were evenly spaced over the surface of the 
monolayer and high actin activity was seen around single, or small numbers, of bacteria 
(Figure 4.5 A and D).  
Experiments were performed to determine whether L110 and L109 aggregated in broth 
culture or whether the aggregation only occurred when the mutants came into contact with 
tissue culture cells. SL1344 and the three efflux mutants were grown overnight in broth 
culture and then left to stand for eight hours. Samples were taken from the surface of the 
culture every hour and the optical density measured. Strains which aggregate settle faster in 
broth, causing the optical density at the surface of the culture to clear more quickly. There 
was no significant difference between the optical density of any of the strains at the 
beginning of the experiment and after 8 hours (Figure 4.5). This suggests that neither SL1344 
nor the efflux mutants aggregate in broth culture. Therefore, the aggregation seen by L110 
and L109 in Figure 4.4 is likely to be a result of interaction between the bacteria and the 
eukaryotic cells.  
4.7 Discussion 
Inactivation of the gene encoding the periplasmic adaptor protein, acrA, significantly 
reduced the ability of Salmonella Typhimurium to invade INT-407 cells and to adhere to and 
invade RAW 264.7 cells compared with the parental strain, SL1344. As previously published, 
inactivation of either acrB or tolC also led to a reduction in the invasive ability of each 
mutant compared with the parental strain and inactivation of tolC also affected adherence 
(Buckley et al., 2006). 
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Figure 4.5 Experiment to determine whether strains aggregate in broth culture. 
 
Strain Mean Final OD as % of starting OD 
+/- SD 
T-test (P) 
SL1344 102.9  +/-  24.3 0.42 
L884 113.47  +/-  13.8 0.083 
L110 93.46  +/-  16.83 0.26 
L109 92.95  +/-  2.07 0.3 
EAEC 35.70 +/-  5.0  0.03 
 
Strains were grown overnight in LB broth and then left stationary for eight hours. The optical 
density at 600nm was measured every hour. Data are presented as a percentage of the 
starting OD value for each strain +/- the standard deviation. Data shown are the mean of 
three independent experiments. 
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This method of measuring adhesion and invasion is based on an established and widely used 
technique (for example Dibb-Fuller et al., 1999) and clearly showed a difference in 
phenotype between SL1344 and the efflux mutants. However, there are a number of caveats 
to interpretation of data obtained with this technique. Firstly, it is not possible to distinguish 
between a defect in invasion versus a defect in intracellular survival as these would both 
present as a decrease in the number of bacteria after lysis of the eukaryotic cells. To more 
accurately distinguish between invasion/internalisation versus intracellular survival a time 
course experiment should be carried out in which the number of internal bacteria is 
enumerated at different time points after infection. In this experiment an invasion defect 
would result in low numbers of internal bacteria throughout the time course while a strain 
with a survival defect would have normal initial invasion levels which decreased significantly 
over the course of the experiment as the bacteria would be unable to survive in the 
intracellular environment.  
The number of adhered bacteria could be complicated by bacterial adherence to the plastic. 
The effect of this could be tested by performing a mock assay in wells which do not contain 
eukaryotic cells. This will confirm whether the washing steps are sufficient and whether 
adhesion of bacteria to the plastic is affecting the measured level of adhesion. Furthermore, 
microscopy techniques could be employed to enumerate the number of bacteria adhered to 
the plastic and to the eukaryotic cells. To further investigate, and more accurately measure, 
the level of adhesion of bacteria to the eukaryotic cell surface internalisation could be 
blocked either by the use of cytochalasin B to block phagocytosis (Finlay et al., 1991) or by 
the use of an invA mutant that is completely defective for invasion of cultured epithelial cells 
(Galan et al., 1992). In this way no bacteria should enter the eukaryotic cells and the only 
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bacteria recovered from the assay will be those which have adhered. This approach will also 
allow confirmation that the gentamicin step kills all external bacteria. 
Lastly, it is possible that as the assay was started with a large initial inoculum and then 
incubated for two hours at 37 °C the bacteria could have been growing in the tissue culture 
medium. However, if the mutants are less able to grow in the tissue culture medium than 
SL1344, this could skew the results, amplifying the apparent adhesion or invasion defect. 
Therefore, the growth kinetics of all strains in the different types of media (MEM and 
DMEM) should be studied.  
 In this study the effect of 1% Triton X-100 on bacterial enumeration was ruled out as a 
factor in the observed attenuation of the efflux mutants over the relevant time period. 
However, the effect of Triton X-100 was tested upon bacterial cells which had been grown 
overnight in LB broth whereas, in the subsequent tissue culture assays, the bacteria had 
been grown overnight in LB broth and then maintained in tissue culture medium for at least 
two hours before exposure to Triton X-100. While this is a notable inconsistency in the 
methodology of this study, it is important to note that in a previous study from this 
laboratory tests were carried out that simulated the association and invasion assays more 
precisely and exposure to 1% Triton X-100 had no significant effect on bacterial enumeration 
of the acrB or tolC mutants (Buckley et al., 2006).  
In chapter three, it was shown that inactivation of acrA affected antimicrobial susceptibility 
and efflux levels, and these data suggest that the PAP is also important for the virulence-
related phenotypes of adhesion and invasion. This fits well with the growing body of 
evidence showing that RND systems of many bacterial species are required for virulence. For 
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example mutants lacking either acrB or tolC were less able to colonise and persist in the 
avian gut (Buckley et al., 2006) and Nishino and colleagues reported that S. Typhimurium 
lacking AcrAB-TolC had attenuated virulence in the mouse model (Nishino et al., 2006). 
Other examples of the involvement of homologues of AcrAB-TolC in virulence include the 
finding that AcrAB-TolC of the plant pathogen Erwinia amylovora is needed for virulence 
(Burse et al., 2004), MtrCDE was required for survival of Neisseria gonorrhoeae in the female 
mouse genital tract model (Jerse et al., 2003), MexAB-OprM mutants of P  aeruginosa had a 
reduced ability to invade Madin-Darby Canine Kidney (MDCK) cells (Hirakata et al., 2002) and 
C. jejuni lacking the CmeABC efflux pump was unable to colonise chickens (Lin et al., 2003). 
Collectively, these data provide compelling evidence that these efflux systems are vital to 
the pathogenicity of a range of Gram-negative bacteria. However, this is the first study in 
which the effect of loss of the PAP alone on virulence-related phenotypes has been studied. 
Data presented herein shows that the PAP has its own role in adhesion and invasion and that 
the mutant phenotype is similar, but distinct, from the mutant phenotypes of strains lacking 
either of the other two pump components. 
In the avian model the contribution of these efflux pump proteins to virulence can be 
partially explained because AcrAB-TolC and it homologues are involved in the transport of 
multiple host derived substrates such as bile and antimicrobial peptides, allowing survival in 
the hostile host environment (Warner and Levy, 2009). However, the transport of these host 
derived substrates cannot explain the attenuation seen in tissue culture experiments. 
Another explanation of the attenuation of mutants lacking components of AcrAB-TolC is the 
numerous changes in expression of genes involved in pathogenicity that have been reported 
previously by this laboratory (Webber et al., 2009). For example, inactivation of acrA was 
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associated with lower expression of genes found in SPI-2 while inactivation of acrB or tolC 
caused reduced expression of genes in SPI-1 and a subsequent decrease in the exported SPI-
1 effector SipA, SipB and SipC. Furthermore, other changes included reduced expression of 
genes involved in chemotaxis and motility after inactivation of acrB or tolC, and in the acrB 
mutant this was associated with diminished motility. Furthermore, after inactivation of acrA 
or acrB repression of the nap and nir operons were seen which adversely affected growth in 
anaerobic conditions compared to the parental strain, SL1344 (Webber et al., 2009). 
 Other explanations for the involvement of AcrAB-TolC in virulence and virulence related 
phenotypes include the possibility that it is directly involved in the efflux of a virulence 
related factor which is exported less efficiently in the mutants incurring an infection defect. 
Alternatively it is possible that AcrAB-TolC exports some toxic molecule, possibly a 
metabolite, produced during infection and the inability to do this prevents the salmonella 
from causing infection. These hypotheses are explored further in chapter 5. 
Visualisation of infections of INT-407 cells by GFP marked SL1344 and acrA, acrB and tolC 
mutants by confocal microscopy showed that the mutants have different infection patterns. 
Inactivation of acrB or tolC led to clumping of the bacteria on the eukaryotic cell surface 
while inactivation of acrA did not, giving an infection which looked much more like that of 
SL1344. It was shown that neither SL1344 nor any of the mutant strains aggregated in broth 
culture showing that this is a phenomena associated with infection only. It is postulated, that 
this could contribute to the loss of invasive ability as individual bacteria may be less able to 
induce their own uptake if they associate in aggregates. This finding is in contrast with work 
in Entero-Aggregative E. coli (EAEC) which showed that TolC promoted aggregation as 
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inactivation of tolC caused less aggregation to occur both in broth culture and in Hep-2 
adherence experiments (Imuta et al., 2008).  
There is evidence that commonly used plasmid vectors and also the presence of GFP, 
particularly when constitutively expressed, can inhibit virulence of Salmonella enterica in 
both tissue culture and in the in vivo mouse model (Knodler et al., 2005; Clark et al., 2009). 
Therefore, the presence of a plasmid encoded, constitutively expressed gfp mut2 gene could 
be a contributing factor to the phenotypes seen. This is unlikely as the wild-type also 
contains the plasmid so could only be a factor if the efflux mutants are less able to cope with 
the added burden of maintaining the plasmid and expressing the fluorescent protein. 
Nonetheless, careful controls would need to be included in future experiments to ensure 
that any alteration in phenotype is not an artefact of the presence of the plasmid or GFP. 
These controls are discussed further in section 4.8.  
4.8 Further work 
As discussed in section 4.7, further experiments are required to validate the tissue culture 
technique and dissect out the effect of the gene inactivations on adhesion, invasion and 
intracellular survival. To differentiate between defects in invasion and intracellular survival 
time course assays will be performed in which the level of internal bacteria are enumerated 
at various time points after infection.  
The infection assay should also be performed on wells that do not contain any eukaryotic 
cells. If no bacteria are recovered from these wells this will confirm that the washing 
technique is effective and that results are not being skewed by the differential ability of 
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different strains to adhere to the plastic. This could be further confirmed by microscopy to 
enumerate the number of bacteria adhered to the plastic and to the eukaryotic cells.  
More accurate assessment of the level of adhesion should include blocking internalisation of 
bacteria into the eukaryotic cells. This could be achieved either by the use of the fungal 
metabolite cytochalasin B to block phagocytosis by inhibition of actin polymerisation or by 
the use of an invA mutant that is completely defective for invasion. Bacteria will then not be 
able to enter the eukaryotic cells and the only bacteria recovered from the assay will be 
those which have adhered. This approach along with MIC susceptibility testing would also 
allow confirmation that the gentamicin step kills all external bacteria. Finally, the growth of 
all strains should be measured in both MEM and DMEM to ensure that the attenuation 
discussed is not an artefact of a growth deficiency in these media.  
 
To further investigate the effect of acrA inactivation on the ability to cause infection, 
experiments in the mouse and chicken models of infection, similar to those previously 
described for the acrB and tolC mutants, could be performed. The tissue culture data 
presented in this study suggests that the acrA mutant will be less attenuated than the acrB 
or tolC mutants. 
 
It was suggested in the further work section of chapter 3 that a strain lacking all three 
components of the AcrAB-TolC efflux system and also strains which over-express the acrA, 
acrB and tolC genes could be constructed. The ability of these strains to adhere to and 
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invade tissue culture cells in vitro and cause infection in in vivo infection models could then 
be determined to learn more about the role of this efflux system in infection. 
The aggregative phenotype of the acrB and tolC mutants should be confirmed by repeating 
the experiments with the inclusion of more stringent controls. Clark and colleagues (2009) 
reported that, while plasmid encoded GFP had an inhibitory effect on invasion of Salmonella, 
a chromosomally encoded version did not. Therefore, a better strategy would be to insert 
the gfp gene onto the chromosome and repeat the experiments. To check that there was no 
attenuation of invasive ability another infection assay should be run in parallel to the one to 
be fixed and visualised. In this assay the number of invaded bacteria should be enumerated 
as described previously and compared to the levels of each strain without the chromosomal 
gfp. 
4.9 Key findings 
 Inactivation of acrA reduced the ability of Salmonella Typhimurium SL1344 to invade 
INT-407 cells. 
 Triton X-100 had no adverse affect on the growth of the acrA mutant therefore data 
from the tissue culture experiments are valid. 
 Inactivation of acrB or tolC led to apparent bacterial clumping on the surface of INT-
407 monolayers while inactivation of acrA seemed to have little effect on the 
distribution of the bacteria on the monolayer. 
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Chapter Five 
Does AcrAB-TolC Export A Molecule 
Required For Virulence? 
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Chapter 5 - Does AcrAB-TolC export a molecule required for virulence? 
5.1 Background  
Although the existence of a link between RND efflux pumps of many bacterial pathogens and 
virulence of the organisms is now well established, the reason behind this relationship is not 
fully understood. One hypothesis is that AcrAB-TolC exports a virulence related factor. This 
hypothesis is partly based on the observation by Hirakata et al., (2002) that the addition of 
culture supernatant from MDCK cells infected with wild-type Pseudomonas aeruginosa K767 
restored the ability of a mexAB-oprM (homologous to AcrAB-TolC) triple mutant (K1119) to 
invade MDCK cells. This suggests that the role of MexAB-OprM in virulence is mediated by 
the efflux of a virulence related factor.  
5.2 Aims and Hypotheses  
The initial aim was to recreate these experiments in S. Typhimurium to see whether a 
putative virulence related factor could be detected in culture supernatant. These 
experiments were performed with L109 (tolC::aph), which had the greatest attenuation of 
the acrA, acrB and tolC mutants to ascertain whether the ability to invade INT-407 cells 
in vitro could be restored by the addition of culture supernatant from SL1344 infected 
INT-407 monolayers.  
In order to further explore the hypothesis that AcrAB-TolC exports a virulence related factor, 
experiments were performed to determine whether the ability of the efflux mutants L884 
(acrA::aph), L110 (acrB::aph) or L109 (tolC::aph) to cause infection in vitro could be restored 
by co-infection with SL1344.  
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A related hypothesis was that AcrAB-TolC exports a eukaryotic cell-derived factor and that 
inactivation of components of the system prevent this transport, impairing the ability to 
cause infection in vitro.  This was tested by addition of media conditioned by uninfected 
INT-407 cells to an infection of INT-407 cells with L109 (tolC::aph) to determine whether this 
could restore the invasive ability of the mutants.  
The final hypothesis tested in this section was that AcrAB-TolC exports a bacterially derived 
factor which is required for invasion and that inactivation of components of the system 
prevent this transport which impairs the ability of the mutants to cause infection in vitro. 
This was tested by addition of media conditioned by growth of SL1344 to infections of INT-
407 cells by the efflux mutants to determine whether this could restore the invasive ability 
of the mutants. 
 
5.3 Can the virulence of the tolC mutant be restored by addition of supernatant from 
SL1344 infected INT-407 monolayers? 
Firstly, the protocol of Hirakata et al., (2002) was repeated, keeping as close to the original 
procedure as possible with alterations to certain parameters to make the protocol more 
suitable for investigation using Salmonella as the model organism (Figure 5.1). Instead of 
MDCK (canine kidney) cells INT-407 cells were chosen as the model as these are a human 
intestinal epithelial cell line and so they are more biologically relevant to salmonella 
infection. As a result of the choice of cell line, the eukaryotic cells were incubated for 48  
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Cell Type
Growth phase of bacteria 
used in infection to 
create supernatant
Duration of incubation of 
eukaryotic cells with 
bacteria
Filter type
Dilution of supernatant
Pre-incubation of 
eukaryotic cells with 
supernatant
Bacterial innoculum
Hirakata method
MDCK monolayers infected with wild-
type P. aeruginosa (K767) and mexAB-
oprM mutant (K1119) 
Growth phase of bacteria  not stated.
Supernant from this infection harvested 
after 3 hours
Supernatant filter sterilised (filter type 
not disclosed)
Supernatant "diluted appropriately"
Supernatant from infected MDCK cells 
added and pre-incubated with  fresh 
MDCK cells for one hour before infection.
Monolayers infected with 3.5 x 106
bacterial cells (K767 or K1119)
Association and invasion assays 
performed as previously described.
Parameters changed or 
explored
INT-407 monolayers infected with wild 
type Salmonella (SL1344)
INT-407 cells infected with either 
stationary phase of log phase SL1344 to 
create supernatant.
Supernatant harvested after 30 minutes, 
two hours or 18 hours (overnight).
Supernatant filter sterilised with a low 
protein binding filter (0.2µm Millex®HV 
Durapore®)
Supernatant diluted 1:2 and 1:20
Supernatant from infected  INT-407cells 
added and pre-incubated for one hour 
before infection or added at time of 
infection with no pre-cubation.
Monolayers infected with 1 x 107
bacterial cells (SL1344 or L109)
Figure 5.1 Parameters tested while investigating restoration of invasion of L109 (tolC::aph) 
by addition of supernatant from an infection of INT-407 cells with SL1344.  The Hirakata 
method below is taken from Hirakata et al., (2002). 
 
 
 
N.B. Only one parameter was changed in each experiment and each was performed in 
triplicate.  
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hours after seeding to achieve confluence rather than the 4 days required for MDCK cells. 
The bacterial inoculum for Salmonella infection was increased to 1 x 107 CFU/ml compared 
to the 3.5 x 106 CFU/ml for P. aeruginosa used by Hirakata (2002). This was so that a similar 
infective dose was used in these experiments as used previously during this study and 
previous studies carried out in this, and other, laboratories (Dibb-Fuller et al., 1999; Buckley 
et al., 2006). The test strain chosen for this investigation was L109 (tolC::aph) as this showed 
the greatest attenuation of associative, adhesive and invasive ability during this study and 
also in published data (Buckley et al., 2006), theoretically making reduction in attenuation 
easier to detect. 
However, no restoration of the invasive ability of the efflux mutant (L109, tolC::aph) was 
seen after addition of supernatant from INT-407 infected with SL1344. To determine 
whether this was a technical artefact alterations to various parameters were investigated 
(Figure 5.1).  
The time that SL1344 was exposed to the tissue culture cells to provide the supernatant for 
testing was altered. Initially, the infection was allowed to proceed for only 30 minutes before 
the supernatant was harvested rather than the 3 hours used by Hirakata et al. This time 
scale was thought to be more biologically relevant as this is the time required for this strain 
of S. Typhimurium (SL1344) to adhere to and invade epithelial cells in vitro (La Ragione et al., 
2003). However, the numbers of SL1344 invading the INT-407 cell line was unchanged and 
L109 (tolC::aph) remained attenuated. Therefore, it was postulated that any exported factor 
may not be reaching a sufficiently high concentration to elicit any effect during this shorter 
incubation period. Therefore, the exposure time was increased to 2 hours and, in a separate 
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experiment, to 18 hours (overnight) thereby allowing higher concentrations of any exported 
factor to accumulate. However, the numbers of SL1344 invading was unchanged and L109 
(tolC::aph) remained attenuated (Figure 5.2). 
A bacterially derived factor may only be produced during a certain growth phase therefore 
supernatant was generated with either stationary phase (overnight) bacterial cultures or 
mid-logarithmic phase bacterial cultures (OD600 of 0.6). The number of SL1344 invading was 
unchanged and L109 (tolC::aph) remained attenuated (Figure 5.3). As no difference was 
observed, stationary phase bacterial cultures were used in the remaining experiments to 
emulate those performed by Hirakata and colleagues (2002), earlier work during this study 
and other published work (Dibb-Fuller et al., 1999; Buckley et al., 2006). 
The filter used in the experiments by Hirakata et al., (2002) was not described in the 
publication and no reply to email correspondence was received. It was hypothesised that the 
filters used in earlier experiments with Salmonella may have bound and retained any 
putative exported virulence determinate. Therefore, low protein binding filters (0.2µm 
Millex®HV, Durapore® PVDF membrane) were used to ensure that any proteinaceous factor 
was not lost during filtration. However, this did not affect the outcome of the experiment as 
the number of SL1344 invading was unchanged and L109 (tolC::aph) remained attenuated 
(Figure 5.4). 
The dilution factor for supernatants used in the study by Hirakata et al., (2002) was also not 
specified in their publication and no reply to correspondence was received. Dilution of 
supernates 1:2 and 1:20 in fresh inoculation media were evaluated. The number of SL1344 
invading was unchanged and L109 (tolC::aph) remained attenuated (Figure 5.5).  
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Figure 5.2 The effect of supernatant from SL1344 infected INT-407 cells on the ability of 
SL1344 and L109 (tolC::aph) to invade INT-407 cells: Supernatant harvested at 30 minutes, 
two hours or 18 hours post-infection. 
 
 
 
To obtain the supernatant used in this experiment INT-407 cells were infected with SL1344 
and the infection allowed to proceed for 30 minutes, two hours or 18 hours (overnight). The 
sterile supernatant from an infection of INT-407 cells with SL1344 was diluted 1:2 in 
inoculation media and used to dilute the bacterial suspension for the infection assay.  
Data are displayed as the mean of three separate experiments performed in triplicate + 
standard deviation. 
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Figure 5.3 The effect of supernatant from SL1344 infected INT-407 cells on the ability of 
SL1344 and L109 (tolC::aph) to invade INT-407 cells: Supernatant taken from INT-407 cells 
infected with either stationary phase or log phase SL1344 
 
 
 
 
Supernatant  was harvested from INT-407 cells which were infected with either stationary 
phase SL1344 (grown overnight) or log phase SL1344 (grown for ~ 2 hrs until OD600 of 0.6). 
During this experiment supernatant was harvested after 2 hours and filter sterilised using a 
low protein binding filter (0.2µm Millex®HV Durapore® PVDF membrane). The sterile 
supernatant was diluted either 1:2 in inoculation media and used to dilute the bacterial 
suspension for the infection assay. Data are displayed as the mean of three separate 
experiments performed in triplicate + standard deviation. 
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Figure 5.4 The effect of supernatant from SL1344 infected INT-407 cells on the ability of 
SL1344 and L109 (tolC::aph) to invade INT-407 cells: Supernatant sterilised with different 
filter 
 
 
 
 
During this experiment supernatant from an infection of INT-407 cells with SL1344was 
harvested after 2 hours and filter sterilised with either a Millex® GP 0.45µm filter unit or a 
low protein binding filter (0.45µm Millex®HV Durapore® PVDF membrane).  The sterile 
supernatant was diluted 1:2 in inoculation media and used to dilute the bacterial suspension 
for the infection assay. Data are displayed as the mean of three separate experiments 
performed in triplicate + standard deviation. 
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Figure 5.5 The effect of supernatant from SL1344 infected INT-407 cells on the ability of 
SL1344 and L109 (tolC::aph) to invade INT-407 cells: Supernatant diluted 1:2 or 1:20. 
 
 
 
 
The sterile supernatant from an infection of INT-407 cells with SL1344 was diluted either 1:2 
or 1:20 in inoculation media and used to dilute the bacterial suspension for the infection 
assay. During this experiment supernatant was harvested after 2 hours and filter sterilised 
using a low protein binding filter (0.2µm Millex®HV Durapore® PVDF membrane).  
Data are displayed as the mean of three separate experiments performed in triplicate + 
standard deviation. 
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Once supernatant had been collected and diluted, Hirakata and colleagues added this to 
their monolayers and pre-incubated this for one hour before infection with their test strains. 
In the experiment with Salmonella, the assay was performed both with and without this pre-
incubation step but the number of SL1344 invading was unchanged and L109 (tolC::aph) 
remained attenuated (Figure 5.6).  
None of the variations of the experiment resulted in restoration of the invasive abilities of 
L109 (tolC::aph) or any change in the invasion of SL1344 (Figure 5.2-5.6). 
5.4 Can the ability of the acrA, acrB and tolC mutants to adhere to and invade INT-407 cells 
be restored by co-infection with SL1344? 
To further investigate the hypothesis that AcrAB-TolC exports a virulence related factor, 
INT-407 cells were infected with SL1344 in combination with each of the efflux mutants. The 
hypothesis was that, if a virulence related factor was exported by AcrAB-TolC, the invasive 
ability of the efflux mutants may be restored by co-infection because the factor would be 
provided by the wild-type. 
In addition, these experiments were informative about the competitive fitness of SL1344 and 
the efflux mutants. Previous work with the acrB and tolC mutants included investigation of 
the ability of the mutants to compete with wild-type Salmonella and other gut flora in the 
poultry model of infection (Buckley et al., 2006). In the one day old chick model the tolC 
mutant was unable to colonise and both the acrB and tolC mutants were unable to persist. In 
the two week old  
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Figure 5.6 The effect of supernatant from SL1344 infected INT-407 cells on the ability of 
SL1344 and L109 (tolC::aph) to invade INT-407 cells: Supernatant added at time of 
infection or pre-incubated with un-infected monolayers for 1 hour before infection with 
test strains. 
 
 
During this experiment supernatant was harvested after 2 hours, filter sterilised using a low 
protein binding filter (0.2µm Millex®HV Durapore® PVDF membrane) and diluted 1:2 in 
inoculation media. This sterile supernatant was either used to dilute the bacterial suspension 
for the infection assay and therefore added at the time of infection or was added to the INT-
407 monolayers, to be used in the infection assay, and incubated for one hour before 
infection with SL1344 and L109.  
Data are displayed as the mean of three separate experiments performed in triplicate + 
standard deviation. 
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chick model, in which a gut flora is present, only the acrB mutant was tested; again this 
could colonise but not persist in the avian gastrointestinal tract (Buckley et al., 2006).  
However, for this project on AcrA, the poultry model was not available so equivalent 
experiments were conducted in the tissue culture model to see how well the mutants could 
infect INT-407 cells when in competition with SL1344.  
To establish the ability of each mutant to adhere to and invade INT-407 cells when in direct 
competition with the parental stain, SL1344, experiments were performed in which equal 
numbers of SL1344 and one of the mutants (L884, L109 or L110) were used to infect INT-407 
cell monolayers. Viable counts were performed on the initial inoculum with replica plating 
used to distinguish the number of SL1344 from the kanamycin resistant mutant. In each 
experiment there was no significant difference between the number of SL1344 and mutant 
in the starting inoculum (Table 5.1). Infections with SL1344, L884, L109 or L110 alone were 
also performed in parallel to ensure that the same pattern was seen as described previously 
and so that the level of adhesion and invasion could be compared between infection alone 
and infection in competition. When infecting monolayers alone, each of the mutants 
produced a similar pattern of attenuation as described in section 4.1 and Figure 4.1. As 
before data giving a P value of less than 0.05 from a Student’s t-test were taken as 
significant. Significant data for single infections are the same as those seen on figure 4.1. To 
avoid over complication on figures 4.3 and 4.4 the significant values are not indicated.  
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Table 5.1 Viable counts of inoculum used in competition assays 
 
 SL1344 CFU/ml Mutant CFU/ml 
SL1344 4.8 x105 - 
L884 - 4.9 x105 
L110 - 5.1 x105 
L109 - 4.7 x105 
SL1344 and L884 2.3 x105 2.6 x105 
SL1344 and L110 2.4 x105 2.6 x105 
SL1344 and L109 2.3 x105 2.2 x105 
   
 
Bacterial counts determined by serial dilution and sub-culture onto LB agar. Mutant and 
wild-type counts distinguished by subsequent replica plating onto LB agar supplemented 
with 50µg/ml kanamycin. 
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5.4.1 SL1344 and L884 (acrA::aph) 
Following inoculation of INT-407 cells with a 50:50 mixture of SL1344 and L884, there was no 
significant difference between the mean number of adherent SL1344 and L884 (acrA::aph) 
(P = 0.27) (Figure 5.7 a). Furthermore, the numbers of L884 (acrA::aph) cells per ml that 
adhered when INT-407 cells were infected with L884 alone were not significantly different 
from those when co-infected with SL1344 (P = 0.10) (Figure 5.7 a).   
After infection with a mixture of SL1344 and L884, significantly more of the wild-type strain, 
SL1344, was able to invade the INT-407 cell line than L884 (P = 0.024) (Figure 5.8 a) with the 
mutant only accounting for 26.3% of the total invaded bacteria (Figure 5.8 b). However, the 
numbers of invaded L884 after mixed infection were not significantly different from the 
invasion level when L884 was inoculated alone, indicating that the difference in invasion 
level of the mutant was unaffected by the presence of SL1344. The numbers of SL1344 
bacteria which adhered to the INT-407 cells were not significantly different to those when 
inoculated alone or with L884 (P = 0.23) (Figure 5.7 a). However, significantly fewer SL1344 
were found to have invaded the INT-407 cells when inoculated in combination with L884 
(P = 0.03) (Figure 5.8 a). 
5.4.2 SL1344 and L110 (acrB::aph) 
Following infection of INT-407 cells with a 50:50 mixture of SL1344 and the acrB mutant 
(L110) there was no significant difference between the mean number of each strain which 
adhered to the eukaryotic cells (P = 0.29) (Figure 5.7 a). There was also no significant  
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Figure 5.7 Adhesion of SL1344 in competition with L109 (tolC::aph), L110 (acrB::aph) or 
L884 (acrA::aph) 
a. Adhesion values in CFU/ml for SL1344, L109 (tolC::aph), L110 (acrB::aph) and 
(acrA::aph) alone and the respective values of each when in competition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b. The percentage of 
the total adhesion for SL1344 and 
the respective mutant in each competitive infection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as mean of three experiments (performed in triplicate) + standard 
deviation. 
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Figure 5.8 Invasion of SL1344 in competition with L109 (tolC::aph), L110 (acrB::aph) or L884 
(acrA::aph) 
a. Invasion values in CFU/ml for SL1344, L109 (tolC::aph), L110 (acrB::aph) and 
(acrA::aph) alone and the respective values of each when in competition.  
 
 
 
 
 
 
 
 
 
b. The percentage of the total invasion for SL1344 and the respective mutant in each 
competitive infection. 
 
 
 
 
 
 
 
 
Values are expressed as mean of three experiments (performed in triplicate) + standard 
deviation. 
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difference between the mean number of L110 cells that adhered when L110 infected alone 
compared with the number which adhered during a mixed infection (P = 0. 30) (Figure 5.7 a).  
When a 50:50 mixture of SL1344 and L110 (acrB::aph) were used to infect INT-407 cells, 
significantly more SL1344 were able to invade (P = 0.063) (Figure 5.8 a) with the acrB mutant 
only accounting for 6.3% of the total invaded bacteria (Figure 5.8 b). However, the number 
of invaded L110 after mixed infection was not significantly different from the invasion level 
when L110 was inoculated alone. These data indicate that the invasion level of the mutant 
was not affected by the presence of the wild-type parental strain, SL1344. The number of 
SL1344 which adhered to or invaded the INT-407 cells was not significantly different when 
inoculated alone or in combination with the acrB mutant (P = 0.23 and P = 0.28, respectively) 
(Figure 5.7 and 5.8). 
 5.4.3 SL1344 and L109 (tolC::aph) 
Following infection of INT-407 cells with a 50:50 mixture of SL1344 and L109 (tolC::aph), 
significantly fewer L109 adhered to the surface of the eukaryotic cells than did SL1344 
(p = 0.04) (Figure 5.7 a). The mutant comprised only 2.2% of the total adherent bacteria 
(Figure 5.7 b). The numbers of adherent L109 (tolC::aph) were significantly less when INT-
407 cells were co-infected with SL1344 than when they were infected with L109 (tolC::aph) 
alone (P = 0.02) (Figure 5.7 a).  
When INT-407 cells were co-infected with SL1344 and L109 (tolC::aph), the tolC mutant was 
unable to invade as 100% of the invaded bacteria from the mixed infection were SL1344 (P = 
0.00003) (Figure 5.8 a and b). These data for L109 are significantly different to those 
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obtained when L109 was inoculated alone (P = 0.009) (Figure 5.8 a). The numbers of SL1344 
which adhered to, or invaded, the INT-407 cells were not significantly different when 
inoculated alone or with the tolC mutant (P = 0.23 and P = 0.36, respectively) (Figure 5.7 and 
5.8). 
5.5 Is AcrAB-TolC involved in efflux of a host derived factor which affects adhesion or 
invasion?  
One hypothesis for the involvement of AcrAB-TolC in virulence and virulence related 
phenotypes is that it is involved in the transport of, or resistance to, a eukaryotic cell product 
and that inactivation or lack of components of AcrAB-TolC prevents this transport explaining 
the impaired virulence of the mutants. Giron and colleagues (2002) reported that lack of 
perA (a transcriptional activator), luxS (a quorum sensing autoinducer), bfpA (a type IV pilin) 
and type III secretion genes (including espA, espB and espD) had reduced production of 
flagella and subsequent reduced motility. The motility and flagella production of these E. coli 
mutants could be restored by growth in tissue culture medium conditioned by growth of 
HeLa cells. Therefore, the authors proposed that a eukaryotic cell signal had induced 
expression of flagellar related genes, which ameliorated the mutant phenotype (Giron et al., 
2002). To test the hypothesis that AcrAB-TolC is involved in the transport of, or resistance to, 
a eukaryotic cell product a similar experiment was performed. Inoculation media (MEM with 
5% glutamine and 5% NEAA) was conditioned by incubation with uninfected INT-407 cell 
monolayers and then this media was used to dilute the bacterial suspensions to be used in 
infection assays. 
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To ensure that any exported factor was able to reach a sufficiently high concentration the 
time that fresh media was incubated with the INT-407 cells was explored. Fresh media was 
incubated with INT-407 cells for 30 minutes, 2 hours or 18 hours (overnight) in separate 
experiments, each performed in triplicate, to ensure sufficient time for any exported factor 
to reach a high concentration. The addition of INT-407 conditioned media harvested after 30 
minutes, two hours or 18 hours incubation time had no significant effect on the ability of 
SL1344 or L109 (tolC::aph) to adhere to, or invade, INT-407 cells compared to the control 
infection in which bacteria were inoculated in basic inoculation media (Figure 5.9).  
5.6 Is AcrAB-TolC involved in the efflux of a bacterially derived product or products which 
affect invasion? (Figure 5.10 - 5.13) 
Another hypothesis for the involvement of AcrAB-TolC in virulence is that it is involved in the 
transport of a virulence related factor of bacterial origin. In this case it is possible that 
SL1344 is able to export this product, while the mutants either cannot export it or export it 
less efficiently, resulting in the invasion defect observed.   
5.6.1 Can the invasiveness of the TolC mutant be restored by addition of media 
conditioned by growth of SL1344?  
To investigate this hypothesis wild-type Salmonella (SL1344) or the tolC mutant were grown 
in LB medium overnight and, after filter sterilisation, this media was mixed 1:2 in inoculation 
media and used to dilute the wild-type or mutant bacterial suspension for standard infection 
assays as described in section 2.10.1. The premise of this experiment was that if SL1344 
produced or exported a virulence related factor which was not produced or exported as  
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Figure 5.9 The effect of tissue culture media conditioned by INT-407 cells on the ability of 
SL1344 and L109 (tolC::aph) to invade INT-407 cells. 
 
 
 
 
 
EMEM inoculation media was incubated with INT-407 cells for 30 minutes, 2 hours or 18 
hours and filter sterilised using a low protein binding filter (0.2µm Millex®HV Durapore® 
PVDF membrane). The INT-407 conditioned media was then diluted 1:2 in inoculation media 
and used to dilute the bacterial suspension for the infection assay. 
Data is displayed as mean of three separate experiments each performed in triplicate + 
standard deviation  
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Figure 5.10 The effect of bacterial culture media conditioned by growth of SL1344 or L109 
(tolC::aph) on the ability of SL1344 to adhere to and invade INT-407 cells. 
a. The effect of bacterially conditioned media on the adhesion of SL1344 to INT-407 cells. 
 
b. The effect of bacterially conditioned media on the invasion of SL1344 into INT-407 cells 
 
 
Data are displayed as mean of at least four separate experiments each performed in 
triplicate +/- standard deviation. CM = conditioned media. 
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Figure 5.11 The effect of bacterial culture media conditioned by growth of SL1344 or L109 
(tolC::aph) on the ability of L884 (acrA::aph) to adhere to and invade INT-407 cells. 
c. The effect of bacterially conditioned media on the adhesion of L884 (acrA::aph) to 
INT-407 cells. 
 
d. The effect of bacterially conditioned media on the adhesion of L884 (acrA::aph) into 
INT-407 cells. 
 
 
Data are displayed as mean of at least four separate experiments each performed in 
triplicate +/- standard deviation. CM = conditioned media. 
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Figure 5.12 The effect of bacterial culture media conditioned by growth of SL1344 or L109 
(tolC::aph) on the ability of L110 (acrB::aph) to adhere to and invade INT-407 cells. 
e. The effect of bacterially conditioned media on the adhesion of L110 (acrB::aph) to 
INT-407 cells. 
 
f. The effect of bacterially conditioned media on the invasion of L110 (acrB::aph) into 
INT-407 cells. 
 
 
Data are displayed as mean of at least four separate experiments each performed in 
triplicate +/- standard deviation. CM = conditioned media. 
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Figure 5.13 The effect of bacterial culture media conditioned by growth of SL1344 or L109 
(tolC::aph) on the ability of L109 (tolC::aph) to adhere to and invade INT-407 cells. 
g. The effect of bacterially conditioned media on the adhesion of L109 (tolC::aph) to 
INT-407 cells. 
 
h. The effect of bacterially conditioned media on the invasion of L109 (tolC::aph) into 
INT-407 cells. 
 
 
Data are displayed as mean of at least four separate experiments each performed in 
triplicate +/- standard deviation. CM = conditioned media. 
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efficiently by the tolC mutant (L109) then addition of LB media conditioned by growth of 
SL1344 may be able to restore the invasion defect by exogenously providing the missing 
factor. Standard adhesion and invasion assays, as described previously (section 2.8.3 and 
2.8.4), with the bacteria diluted only in fresh MEM inoculation media were performed in 
parallel. As a control the bacterial suspension was also diluted in a 1:2 mixture of fresh LB 
media with inoculation media to ensure that addition of LB broth alone did not affect the 
adhesion or invasion levels of SL1344 or the efflux mutants.  
Levels of adhesion and invasion of SL1344, L109 (tolC::aph), L110 (acrB::aph) and L884 
(acrA::aph) were not significantly different from the levels reported in chapter 4 (Figure 4.1). 
The presence of LB in the inoculation media did not significantly alter the adhesion or 
invasion or SL1344 or any of the efflux mutants tested (L109, L110 and L884) (Figures 5.10 – 
5.13).  
The addition of media conditioned by the growth of either SL1344 or L109 (tolC::aph) had no 
significant effect on the levels of adhesion or invasion of SL1344 (Figure 5.10 a and b). The 
level of adhesion of the acrA mutant (L884) was also unaffected by the addition of media 
conditioned by either SL1344 or L109 (tolC::aph) (Figure 5.11 a). However, the mean level of 
invasion by L884 (acrA::aph) was significantly increased by addition of media conditioned by 
the growth of SL1344 by 2.39 fold (P = 0.03) but not by addition of media conditioned by the 
growth of the tolC mutant (L109) (P = 0.17) (Figure 5.11 b). 
The addition of media conditioned by overnight growth of SL1344 was able to significantly 
increase adhesion and invasion of the acrB mutant (L110) to INT-407 cells 2.8 fold and 4.08 
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fold, respectively (P = 0.05 and 0.04, respectively). Media conditioned by overnight growth 
of L109 also increased the level of adhesion of the acrB mutant 3.02 fold (P = 0.01). 
However, it did not affect invasion levels (P = 0.21) (Figure 5.12 a and b). 
The level of adhesion of the tolC mutant (L109) was not significantly affected by the addition 
of media conditioned by either SL1344 or L109 (tolC::aph) (Figure 5.13 a). Addition of media 
conditioned by either SL1344 or L109 (tolC::aph) significantly increased the level of invasion 
by 905.56 fold and 15.11 fold, respectively (P = 0.05 and 0.01, respectively) (Figure 5.13 b). 
However, the SL1344 conditioned media had a greater effect than the L109 conditioned 
media and the difference between the two was significantly different (P = 0.0004) (Figure 
5.13 b). 
5.6.2 Is the restorative effect of SL1344 conditioned media abolished by pre-boiling the 
conditioned media?  
To determine whether the factor/s responsible for restoration of the virulence of the mutant 
strains was heat sensitive, LB media conditioned by growth of SL1344 and L109 was boiled 
for ten minutes and, after cooling, was used to dilute the bacteria for the infection assays in 
the same way as in section 2.10.1 to see if the effect was still evident. Infections in which 
SL1344, L109, L110 and L884 were inoculated in fresh MEM inoculation media and in SL1344 
and L109 conditioned LB media were also performed in parallel.  
Adhesion and invasion of strains inoculated in MEM inoculation media, SL1344 conditioned 
LB media or L109 conditioned LB media were not significantly different from the values 
already obtained. Boiled SL1344 conditioned LB media significantly enhanced the ability of 
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the acrA mutant (L884) to invade INT-407 cells (P = 0.02) (Figure 5.11 b) and there was no 
significant difference between the restorative effect of SL1344 conditioned LB media on the 
invasiveness of L884 before or after boiling (P = 0.85). The L109 conditioned LB media had no 
effect on the ability of the acrA mutant to adhere to or invade INT-407 cells and this was not 
significantly altered by boiling (P = 0.07) (Figure 5.11 a and b). 
Boiling of the SL1344 conditioned LB media abolished its restorative effect on adhesion of 
the acrB mutant (P = 0.94). However, boiled SL1344 conditioned media was still able to 
increase the level of invasion of the acrB mutant (L110) (P = 0.04) and there was no 
significant difference between the restorative effect of SL1344 conditioned LB media on the 
invasiveness of L110 before or after boiling (P = 0.66) (Figure 5.12 a and b). The L109 
conditioned media had no effect on the ability of the acrB mutant to adhere to, or invade, 
INT-407 cells and this was not altered by boiling the media (P = 0.51 and 0.16, respectively) 
(Figure 5.12 a and b). 
While both SL1344 and L109 conditioned LB media were able to, at least partially, restore 
the invasion defect of L109, boiling of either type of conditioned LB media abolished the 
restorative effect and resulted in invasion levels that were not significantly different from 
L109 invasion alone (P = 0.67 and 0.50, respectively) (Figure 5.13 b). 
5.6.3 Is the restorative effect of SL1344 conditioned media abolished by treatment with 
Proteinase K?  
To determine whether the molecule or molecules responsible for restoration of the 
virulence of the mutant strains are proteinaceous, filter sterilised LB media conditioned by 
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growth of SL1344 and L109 were treated with proteinase K, a broad spectrum protease. The 
enzyme was then inactivated with ethylene glycol tetraacetic acid (EGTA) and after dilution 
1:2 with inoculation media the proteinase K treated media was used to dilute the bacteria 
for the infection assays in the same way as in section 2.10.1. It was postulated that if the 
molecule or molecules responsible for the effect are proteinaceous, then the effect would 
be abolished by proteinase-K treatment. Infections in which SL1344, L109, L110 and L884 
were inoculated in fresh tissue culture inoculation media and in SL1344 and L109 
conditioned LB media were also performed in parallel. 
Adhesion and invasion of strains inoculated in MEM inoculation media, SL1344 conditioned 
LB media or L109 conditioned LB media were not significantly different from the values 
already obtained. However, no adhesion or invasion was detected for SL1344 or the mutants 
(L109, L110 or L884) in experiments with addition of SL1344 or L109 conditioned LB media 
which had been treated with proteinase K. Data is not shown for these experiments as 
visible destruction of the monolayer during the experiment made counting of bacterial 
colonies and interpretation of data impossible. 
5.6.4 The effect of the bacterially conditioned media on the number and viability of INT-
407 cells. 
To determine whether the bacterially conditioned media affected the number and viability 
of INT-407 cells in the monolayers, the monolayers were incubated with SL1344 and L109 
conditioned LB media, boiled SL1344 and L109 conditioned LB media or Proteinase K treated 
SL1344 and L109 conditioned LB media for two hours to simulate the conditions during an 
assay. No bacteria were present. The monolayers were all washed three times with HBSS 
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before and after the incubation to simulate the protocol used during the assays. Viability of 
the cells was tested by addition of trypan blue before counting. 
The number of cells at the start of the experiment was within the normal range (4-6 x 105 
cells per well) and as used in previously published experiments (Dibb-Fuller et al., 1999). Two 
hours of incubation with fresh MEM inoculation media (with 5% Glutamine, 5% NEAA) or 
media conditioned by the growth of either SL1344 or L109 had no significant effect on the 
number of INT-407 cells present (P = 0.06, 0.24 and 0.62, respectively) or the number of non-
viable cells present in each well (P = 0.68, 0.39 and 0.39, respectively) (Figure 5.14). 
Incubation for two hours with MEM, SL1344 conditioned media or L109 conditioned media 
that had been boiled for 10 minutes also had no significant effect on the number (P = 0.07, 
0.46 and 0.89, respectively) or viability (p = 0.70, 0.38 and 0.47, respectively) of INT-407 cells 
(Figure 5.14). However, incubation for two hours with MEM, SL1344 conditioned media or 
L109 conditioned media that had been pre-treated with proteinase K which was then been 
inactivated with EGTA, significantly reduced the number of cells per well (P = 0.00004, 
0.00002 and 0.0002, respectively) although cell viability was not significantly affected (P = 
0.17, 0.27 and 0.17, respectively) (Figure 5.14).  
5.7 Discussion 
In addition to an established role in antimicrobial resistance, MDR efflux pumps, including 
AcrAB-TolC, have been shown contribute to the basic biology of various pathogens (Piddock, 
2006). RND systems are required for the virulence of several species including S. enterica 
and P. aeruginosa as mutants lacking functional RND efflux systems are attenuated (Hirakata 
et al., 2002; Buckley et al., 2006; Nishino et al., 2006; This study). 
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Figure 5.14. The effect of bacterially conditioned LB medium, boiled bacterially conditioned LB medium and Proteinase-K treated bacterially 
conditioned LB medium  on the number and viability of INT-407 cells per well. 
 
Viable and non-viable cells were differentiated using trypan blue. Data are displayed as mean of three separate experiments each performed in 
triplicate + standard deviation. PK, Proteinase K treated. CM, conditioned medium 
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A recent study from this laboratory showed that one explanation for the attenuation of RND 
efflux mutants is changes in expression of virulence associated genes and concomitant 
changes in effector protein expression, motility and anaerobic metabolism. For example 
stains lacking AcrB or TolC had reduced expression of genes found on SPI-1 and subsequently 
reduced production of the effector proteins SipA, SipB and SipC. The acrA mutant was 
distinct from strains lacking AcrB and TolC in that SPI-1 expression was unchanged but 
repression of genes found in SPI-2 was evident (Webber et al., 2009). Other changes 
included reduced expression of genes involved in chemotaxis and motility after inactivation 
of acrB or tolC, and in the acrB mutant this was associated with diminished motility. 
Furthermore, after inactivation of acrA or acrB repression of the nap and nir operons were 
seen which adversely affected growth in anaerobic conditions compared to the parental 
strain, SL1344 (Webber et al., 2009). 
An alternative explanation for the involvement of RND systems in pathogenicity came from 
work with P. aeruginosa which showed that MexAB-OprM is responsible for export of a 
factor required for bacterial virulence. However, the two hypotheses are not mutually 
exclusive.  
Contrary to the findings of Hirakata and colleagues with P. aeruginosa, the addition of 
supernatant from tissue culture cells infected with SL1344 had no effect on the ability of the 
tolC mutant (L109) to adhere to, or invade, INT-407 cells in vitro (Figure 5.2 - 5.6). This 
suggests that the involvement of AcrAB-TolC in pathogenicity may not be mediated by the 
efflux of an exported virulence related factor, as was suggested of P. aeruginosa. However, 
the possibility remains that either it is not possible to detect rescue of invasive ability in the 
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same way in Salmonella or that some detail of the experiment prevented detection of the 
rescue in the assays performed. For example, Hirakata and colleagues used a triple 
MexAB-OprM mutant while a triple acrAB-tolC SL1344 mutant was not available at this time. 
This may have made detection more difficult. It is also possible that any virulence related 
factor was not able to reach a sufficiently high concentration during this experiment to 
effect virulence. 
The hypothesis that AcrAB-TolC exports a virulence related factor, which is not exported by 
the mutant, was also investigated by infecting INT-407 cells with a 50:50 mixture of SL1344 
and one of the efflux pump mutants. The aim was to determine whether co-infection with 
SL1344 was able to complement the fitness defect of the mutant by supplying an exported 
virulence related factor which the mutant was not able to export. Previously, competitive 
index experiments in poultry showed that when chickens were infected with a 1:1 mixture of 
SL1344 with either an acrB mutant or a tolC mutant that the mutants were out-competed by 
SL1344 (Buckley et al., 2006). Mutants lacking AcrB were able to colonise the avian 
gastrointestinal tract but were unable to persist while lack of TolC rendered the bacteria 
unable to colonise or persist. This is in accordance with the findings of the adhesion and 
invasion tissue culture experiments (Figure 4.1) showing that the acrB mutant (L110) was 
able to adhere but not invade as well as SL1344 and that the tolC mutant (L109) had a 
reduced ability to both adhere to and invade intestinal cells compared to SL1344. These 
experiments were replicated in the in vitro tissue culture model for all three mutants. 
After a mixed infection of SL1344 and the acrA mutant (L884), the mutant accounted for 
significantly less of the total invaded bacteria. The level of invasion by L884 was not 
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significantly different from when L884 alone was used to infect INT-407 cells so the invasion 
defect of L884 had not been complemented by the presence of SL1344. It did not represent 
out competition by SL1344 because the level of L884 invasion reflected the level of 
attenuation seen in a single infection. Similarly, when INT-407 cells were infected with a 
mixture of SL1344 and the acrB mutant (L110), the level of invasion was not significantly 
different from when L110 alone was used to infect INT-407 cells so the invasion defect of the 
acrB mutant had not been complemented by presence of the wild-type. Again, the mutant 
strain was not out-competed by SL1344 as the levels of attenuation seen reflected levels 
when the acrB mutant infected alone. Only the tolC mutant (L109) was truly out-competed 
when inoculated in a mixed infection with SL1344. Not only was there a significantly lower 
mean number of adhered and invaded bacteria, but the levels were significantly lower than 
when L109 was used to inoculate INT-407 cells alone. This is congruent with earlier in vivo 
data where the tolC mutant was shown to be out-competed by SL1344 in the avian 
gastrointestinal tract (Buckley et al., 2006). However, in the tissue culture experiments these 
data cannot be explained by the inability of L109 to withstand bile concentrations. 
The attenuation seen in the efflux mutants could not be complemented by either addition of 
supernatant from SL1344 infected INT-407 cells or co-infection with SL1344. These data 
suggest that there is no virulence related factor exported by wild-type, that is lacking in the 
mutant, which is able to restore the fitness defect of the mutant when supplied 
exogenously. 
In contrast, Hirakata and colleagues concluded from their results that MexAB-OprM (an 
orthologue of AcrAB-TolC) exports “virulence determinants that contribute to bacterial 
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virulence.” However, there are several plausible alternative interpretations of this data, two 
of which have been investigated during this study. The first is that the factor affecting 
invasion originates from the eukaryotic host cells and that the mutants cannot tolerate or 
respond in the same manner as the wild-type, leading to lower infection levels. This 
hypothesis fits with in vitro evidence showing that the E. coli AcrAB-TolC system is involved 
in transport of, and resistance to, several host derived substrates including bile, fatty acids 
and steroid hormones (Ma et al., 1995; Thanassi et al., 1997; Elkins and Mullis, 2006; Drew 
et al., 2008). A similar phenomenon was reported by Giron and colleagues (Giron et al., 
2002) who found that the reduced motility and flagella production of E. coli mutants lacking 
PerA (a transcriptional activator), LuxS (a quorum sensing autoinducer), BfpA (a type IV pilin) 
and certain T3SS proteins (including EspA, EspB and EspD) was restored after growth in 
tissue culture medium conditioned by growth of HeLa cells. This study proposed that a 
eukaryotic signal had induced gene expression changes have affected mutant phenotypes. 
However, evidence presented herein suggests that an exported host cell signal is not the 
reason that the tolC mutant is attenuated as addition of INT-407 conditioned media did not 
restore the ability of the tolC mutant to invade (Figure 5.3). 
The second alternative interpretation of their findings is that the ‘virulence determinant’ is a 
normal product of the wild-type bacteria, not exclusively produced during infection, but 
which is not produced, or not efficiently exported, by the efflux mutants. In this scenario the 
product could be proteinaceous or possibly a metabolic product which either directly effects 
invasion or build up of which is toxic or inhibitory. The restoration of the attenuated 
phenotype of the efflux mutants by SL1344 conditioned media supports the hypothesis that 
a compound produced by SL1344, but not the tolC mutant, was required for invasion.  
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As addition of LB media conditioned by wild-type bacteria (SL1344) was able to restore the 
invasive defect of the mutants, it is somewhat surprising that the same restoration was not 
seen by addition of the supernatant from INT-407 cells infected with SL1344 or in the 
competition assays in which the INT-407 cells were co-infected with one of the mutants and 
SL1344. It is possible that the effective factor did not reach a sufficiently high concentration 
in these experiments or the competition experiments for the effect to be detected. This may 
simply be because the number of bacterial cells per millilitre present in an overnight culture 
is much higher than in an infection experiment and the bacteria are grown for much longer 
to produce the bacterially conditioned media than the time they are present in the tissue 
culture experiments. Another explanation is that the supernatant from infected INT-407 cells 
contains “cell death” signals from infected eukaryotic cells. These could mask the effect of 
any virulence factor. Conversely, the effect of bacterially conditioned media was not seen by 
Hirakata and colleagues when LB broth was conditioned by the growth of either the 
wild-type or mutant P. aeruginosa. The discrepancy between these two sets of results is 
noteworthy but may be at least partially explained by the biological differences between 
S. enterica and P. aeruginosa. 
The virulence factor or factors may be proteinaceous. However, pre-boiling the SL1344 
conditioned media did not ablate its restorative effect on L884 (acrA::aph) and L110 
(acrB::aph) suggesting that the product is unlikely to be proteinaceous. However, the boiled 
SL1344 conditioned media was unable to complement the invasion defect in L109 
(tolC::aph). Unfortunately, it was not possible to confirm whether the factor was 
proteinaceous due to the failure to successfully treat the conditioned media with proteinase 
K at this time. It is likely that the problem with this digestion lies in the inactivation step. 
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Heat could not be used to used to inactivate the proteinase as earlier results had shown that 
boiling the media altered its ability to complement the invasion defect in L109 (tolC::aph). 
There are three compounds suggested by the manufacturer (Promega) for inactivation of 
Proteinase K; phenylmethylsulfonyl fluoride (PMSF), diisopropyl phosphorofluoridate (DFP) 
or ethylene glycol tetraacetic acid (EGTA). Of which, PMSF was unsuitable as it is highly 
cytotoxic and therefore likely to damage or kill the eukaryotic cells. DFP is a potent 
neurotoxin so, along with PMSF, could not be used for safety reasons as both compounds 
must be used only in the fume cupboard making the incubation steps required in the tissue 
culture experiments impossible. EGTA was deemed safe to use in these assays and thought 
unlikely to affect the eukaryotic cells as it has been used in numerous in vitro studies with 
eukaryotic cells and in vivo animal tests (Wang et al., 2000). Proteinase K is stabilised by 
calcium and is inhibited by EGTA because it chelates calcium. However, the manufacturer’s 
guidelines state that after inhibition by removal of calcium up to 20% of the catalytic activity 
of the proteinase K could remain. This incomplete inactivation probably led to destruction of 
the monolayer. An alternative proteinase, which can be completely inactivated without heat, 
will need to be used to determine whether the factor is proteinaceous. 
While pre-boiling the SL1344 conditioned LB media ablated its restorative effect on L109 
(tolC::aph) invasion, the ability to restore invasion of L884 and L110 was not affected. This 
suggests that it may be a different factor or combination of factors which is restoring the 
invasive ability of L109. It is possible that additional factors are required to restore the 
invasive ability of the tolC mutant as TolC functions with numerous other protein partners, 
and the attenuation of one of these functions may contribute to the loss of invasive ability. 
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In that case an additional factor could be involved in the restoration seen after addition of 
SL1344 conditioned media and this factor could be modified by boiling.  
Previously, media pre-conditioned by bacterial growth has been used to study quorum 
sensing (Sperandio et al., 2001). Quorum sensing signals (QSS) are molecules produced by 
bacteria whose concentration increases with increasing bacterial cell density effectively 
allowing cell-cell communication (Miller and Bassler, 2001). In Gram-negative bacteria QSSs 
are normally acylated homoserine lactones. These molecules act as autoinducers which, 
above a threshold concentration, affect the expression of genes controlling numerous 
bacterial processes including biofilm formation, competence, conjugation and virulence 
(Miller and Bassler, 2001; Waters and Bassler, 2005). In the case of quorum sensing studies, 
media pre-conditioned by the growth of bacteria is used to provide the QSS itself. Yang et 
al., postulated that E. coli AcrAB-TolC effluxes quorum sensing molecules (Yang et al., 2006). 
It was shown that E. coli lacking AcrAB (LZ2184) had a similar growth rate to the wild-type 
strain but grew to a higher final optical density in stationary phase. It was shown that media 
conditioned by growth of the wild-type and to a greater extent by an acrAB over-expressing 
strain was able to inhibit growth of E. coli but that media pre-conditioned by growth of the 
acrAB mutant could not. From this, the authors concluded that QSSs are natural substrates 
of AcrAB-TolC. However, there is no evidence that this is the case for Salmonella as no over-
growth seen in Salmonella Typhimurium strains lacking AcrA, AcrB or TolC (Bailey et al., 
2008, Webber et al., 2009, This study). It was thought this may be explained by differences 
between the quorum sensing systems of E. coli and S. Typhimurium (Ahmer et al., 1998). 
However the experiment was repeated using the E. coli strains W4573 (WT) and LZ2184 
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( acrAB) which were used in the study by Yang et al., (2006). The overgrowth effect could 
not be reproduced in our lab using the strains used in the published work so it was 
concluded that it is unlikely that AcrAB-TolC is involved in the transport of QSS and therefore 
that QSSs do not account for the restoration of L109 (tolC::aph) virulence by SL1344 
conditioned media (Webber et al., 2009, supplementary information). 
It is possible that AcrAB-TolC could export a virulence related factor which is a metabolite or 
other small soluble factor. It has been suggested that TolC of E. coli O42 exports such a 
factor. The O42tolC strain did not aggregate in the same way as the wild-type strain as more 
planktonic cells, and less precipitated cells, were present in a micro-titre plate assay. The 
aggregative phenotype of the wild-type is known to be important for virulence. The 
transwell system consisting of a 0.4 µm-pore-size polyester filter insert for a 24 well tissue 
culture assay plate was used. This filter sits inside the well and allows co-culture of the wild-
type, O42, and the mutant O42tolC, in the same well with secreted proteins and cytokines 
able to pass through the polyester membrane, while bacteria are kept separate. When the 
mutant, O42tolC was co-cultured with the wild-type, more precipitated cells were present 
and less planktonic cells showing that the aggregation defect of the  tolC mutant had been 
complemented by presence of the wild-type (Imuta et al., 2008). The authors concluded that 
TolC must secrete a humoral factor able to complement this mutant phenotype which is 
important for virulence. Rosner and Martin recently hypothesised that in E. coli intracellular 
accumulation of toxic bacterial metabolites during growth led to up-regulation of MarA, SoxS 
and Rob, which stimulates up-regulation of tolC to remove the metabolites (Rosner and 
Martin, 2009). 
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Recently, Huang et al., (2008) showed that a Salmonella strain deficient in two key metabolic 
genes, acetate kinase and phosphotransacetylase (ackA-pta), had reduced SPI-1 expression 
and was less able to invade Hep-2 cells. The invasive phenotype could be restored by 
addition of media conditioned by growth of the wild-type strain (Huang et al., 2008). In this 
case the authors found that the mutant strain excreted 68-fold less formate than the parent 
and it was also possible to restore virulence and SPI-1 expression by addition of exogenous 
sodium formate. Furthermore, the mouse distal ileum, the region of the gastrointestinal 
tract into which Salmonella invades, was found to have the appropriate concentration of 
formate found to induce expression of genes involved in invasion in vitro, while the formate 
was undetectable in the cecum (Huang et al., 2008). This study shows that the factor 
allowing SL1344 conditioned media to restore the ability of L109 to invade could be formate, 
or another small diffusible molecule or metabolite. 
5.8 Further work 
Firstly, to allow investigation of whether the molecule effecting virulence of the mutants is 
proteinaceous alternatives to proteinase K will be investigated. 
The study of bacterially conditioned media will be extended to include the effect of media 
conditioned by the acrA mutant and the acrB mutant on the ability of each of the mutants to 
adhere to and invade INT-407 cells. 
Further investigation of the hypothesis that AcrAB-TolC exports a factor required for 
virulence-related phenotypes has begun. To confirm export of a bacterially derived 
molecule, an S. Typhimurium mutant is being constructed in which the tolC gene is present 
201 
 
but contains two single nucleotide polymorphisms such that the protein produced will be 
locked closed and unable to efflux substrates. This will be based upon a paper by Eswaran 
and colleagues where a locked TolC was created in E. coli and used to investigate the 
mechanism of the efflux pump (Eswaran et al., 2003). Once a locked TolC has been created 
in Salmonella the ability of the strain to adhere to and invade INT-407 cells will be 
determined and conditioned media assays will be performed.  
Recently, Hirakata and colleagues (2009) found that PAβN and a MexB specific inhibitor, 
D13-9001, were able to reduce the invasiveness of P. aeruginosa in vitro (Hirakata et al., 
2009). Previous work in Campylobacter also showed that oral administration of PAβN to 
chickens 2-4 days post inoculation with  C. jejuni  significantly reduced colonisation as did 
inactivation of CmeABC, a homologue of AcrAB-TolC (Lin and Martinez, 2006). Association 
and invasion assays will be performed with SL1344 and the three AcrAB-TolC mutants in the 
presence of various concentrations of PAβN. It is thought that PAβN also inhibits AcrB, so 
these experiments will allow confirmation that the attenuation seen in the efflux mutants is 
due to loss of efflux function and not just as a result of other virulence related gene changes.  
NMR and Mass spectrometry experiments on SL1344, L109 (tolC::aph) and L110 (acrB::aph) 
conditioned media are currently under way to identify any differences between the 
exported metabolites from the wild-type, acrA, acrB and tolC mutants. The aim is to identify 
any differences in the metabolites present and eventually to add these exogenously to the 
infection assays to see whether the virulence defect in the mutants can be restored. This 
study should also allow identification of some natural substrates of AcrB and TolC. 
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5.9 Key findings 
 The levels of adhesion and invasion of a tolC mutant could not be restored by the 
addition of supernatant from an infection of INT-407 cells with SL1344 as has 
previously been shown for a mexAB-oprM mutant in P. aeruginosa. 
 The invasion defect seen in mutants lacking AcrA, AcrB or TolC could not be 
complemented by co-infection with SL1344. 
 When INT-407 cells were co-infected with SL1344 and the tolC mutant, the tolC 
mutant was outcompeted: adhesion levels were reduced compared to infection with 
L109 alone and invasion was abolished. While neither the acrA nor acrB mutant was 
out-competed when INT-407 cells were co-infected with SL1344 and either mutant.  
 The levels of adhesion and invasion of a tolC mutant could not be restored by the 
addition of inoculation media conditioned by incubation with INT-407 cells. 
 LB media conditioned by the growth of SL1344 was able to restore the invasive 
defect of the acrA, acrB and tolC mutant. 
 Boiling the SL1344 conditioned media did not affect its ability to restore the invasive 
ability of the acrA or acrB mutants but abolished its restoration of the ability of the 
tolC mutant to invade INT-407 cells. 
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Chapter 6. Overall Discussion and Conclusions 
In this study the periplasmic adaptor protein AcrA of Salmonella enterica serovar Typhimurium was 
inactivated. The strain lacking this protein accumulated significantly more Hoechst H3342 than the 
wild-type strain SL1344 (Figure 3.10) showing that efflux activity in this strain was impaired. This is 
complementary to recent structural data based on extensive site-directed cross-linking studies 
showing that AcrA has an important structural role in the AcrAB-TolC efflux pump (Symmons et al., 
2009).  The model suggests that the interaction between TolC and AcrA is most energetically 
favourable when the TolC channel is in its open state. Once AcrA is bound to AcrB, TolC is recruited 
to the complex causing TolC to open. The outer membrane channel then remains in a constitutively 
open state which allows the high throughput efflux which is characteristic of this system. In this 
model the closure of TolC is not required as the weak interaction between the AcrB and TolC trimers 
is stabilised by three AcrA molecules meaning that there is no leakage of substrates into the 
periplasm (Symmons et al., 2009). Based on this model, it is postulated that lack of AcrA may prevent 
assembly of the trimer. Alternatively, AcrB and TolC may be able to interact, but this interaction may 
be weak and the open state of TolC may not be properly maintained. This could lead to significantly 
diminished efflux levels or even leakage of the substrates into the periplasm. It remains a possibility 
that lack of any of the components of the pump is partially complemented by homologues of the 
system. For example, it is possible that some transport through AcrB and TolC could be supported by 
the periplasmic adaptor protein AcrE which shares 66% identity and 80% similarity with AcrA. 
The reduction in efflux level partially explains the increased susceptibility of the acrA mutant to a 
range of antimicrobials because if toxic compounds are not efficiently extruded they will accumulate 
inside the cell and are lethal at lower concentrations. However, the effect was substrate specific as 
the acrA mutant was the most susceptible to triclosan while it did not have the most attenuated 
efflux level as measured by accumulation of Hoechst H3342. It has been suggested that the PAP may 
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have a role in facilitating recruitment of hydrophobic substrates to the pump from the periplasm due 
to the proximity of the newly modeled membrane proximal domain to the binding pocket identified 
between the PN2 and PC1 subdomains (Zgurskaya et al., 2008; Symmons et al., 2009). If AcrA has a 
role in facilitating recruitment of hydrophobic substrates into this binding pocket it could then 
impose an element of substrate specificity which may contribute to the different susceptibility 
profiles of the mutants. 
Inactivation of acrA attenuated the ability of Salmonella Typhimurium to invade INT-407 cells and to 
adhere to and invade RAW 264.7 cells in vitro (Figures 4.1 and 4.2). This fits well with other evidence 
for AcrAB-TolC in S. Typhimurium, and for RND systems of other species, showing that lack of pump 
components impairs virulence in in vivo infection models as well as attenuating virulence-related 
phenotypes such as adhesion and invasion to eukaryotic cells in vitro. Particularly relevant to this 
project is that lack of S. Typhimurium AcrB or TolC reduced invasion in the tissue culture model of 
infection and lack of TolC also reduced adhesion (Buckley et al., 2006). Furthermore, acrB and tolC 
mutants were less able to colonise and persist in the avian gut (Buckley et al., 2006) and had 
attenuated virulence in the mouse model causing a delay in mortality (Nishino et al., 2006). However, 
this is the first time that the role of the PAP in this process has been determined. Furthermore, it has 
been shown that the AcrA mutant phenotype is similar, but distinct from the mutants lacking AcrB or 
TolC. This is also illustrated by recently reported transcriptomic data showing broad differences in 
gene expression between mutants lacking different components of AcrAB-TolC (Webber et al., 2009). 
Only four genes were differentially expressed in a similar manner in all three mutants (Figure 6.1).  
The acrA mutant had the lowest number of genes with altered transcription, 115, while 171 genes 
had altered transcription in the tolC mutant. The strain with by far the most genes with altered 
expression was the acrB mutant (L110) with 569 genes differentially expressed. The strains lacking 
AcrB and TolC had the most similar transcriptomes having 133 expression changes in common. In 
contrast, the acrA mutant was the most distinct, with 24 gene expression changes in common with  
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Figure 6.1 Comparison of the transcriptomes of the acrA, acrB and tolC mutants 
 
 
 
 
From Webber et al., 2009 
Venn diagram showing the overlap in genes with significantly altered expression in the mutants 
compared to SL1344. In each category, regulators with altered expression are indicated and those 
shown in red have increased expression while those shown in blue have decreased expression 
compared to SL1344. 
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the acrB mutant and none that were changed only in the acrA mutant and the tolC mutant (Figure 
6.1).  
The direct role of RND pumps in virulence and in virulence-related phenotypes is now well 
established but the reasons for this are not fully understood. Recent work in this laboratory has 
shown that one cause of the attenuation of the mutants is the change in expression of virulence-
related genes (Webber et al., 2009). Strains lacking acrB and tolC had reduced expression of genes 
found in SPI-1 and a consequent reduction in secretion of the SPI-1 effectors SipA, SipB and SipC. In 
contrast, in the acrA mutant, genes found in SPI-2 showed widespread decrease in expression, while 
SPI-1 gene expression was unaffected. Reduced expression of chemotaxis and motility genes were 
detected after inactivation of acrB or tolC, and in the acrB mutant this led to decreased motility. 
Expression of genes known to be involved in anaerobic respiration had decreased expression in the 
acrB mutant but increased expression in the acrA mutant. However, both these mutants had an 
impaired ability to grow anaerobically which could contribute to their reduced virulence in vivo 
(Webber et al., 2009).  
As already discussed, lack of components of AcrAB-TolC impair the level of efflux function in S. 
Typhimurium. Consequently, a logical second hypothesis for the attenuation of mutants lacking 
components of RND systems is that reduced efflux of a factor or factors renders the strains less able 
to cause infection. Initial evidence for this hypothesis was presented by Hirakata and colleagues 
(2002) who showed that the ability of a triple efflux mutant (mexAB-oprM) to invade MDCK cells in 
vitro could be restored by addition of supernatant collected from an infection of MDCK cells with 
wild-type P. aeruginosa. They concluded that a factor required for invasion was exported by MexAB-
OprM in wild-type P. aeruginosa and that addition of the supernatant could restore the invasiveness 
of the mutant by exogenously providing this factor (Hirakata et al., 2002). In contrast, the same 
effect was not seen in Salmonella when these experiments were recreated. Addition of supernatant 
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collected from INT-407 cells infected with SL1344 could not restore the invasiveness of the tolC 
mutant (Figures 5.2-5.6). Furthermore, co-infection of the strains lacking AcrA, AcrB or TolC with 
SL1344 was also unable to restore the attenuation of the mutants (Figures 5.7 and 5.8). This began to 
suggest that the attenuation of the Salmonella efflux mutants was not caused by the lack of an 
exported factor as neither supernatant from wild-type infection, or presence of the wild-type itself 
were able to restore the defect.  
Two alternative interpretations of the Hirakata et al., (2002) data were explored. Firstly, it was shown 
that media conditioned by INT-407 cells alone was unable to restore the invasiveness of the mutant 
so it is unlikely that a response to a eukaryotic factor in the mutant was responsible for the 
restoration of the mutant invasiveness. Secondly, it was postulated that the restoration in 
invasiveness seen in P. aeruginosa after addition of culture supernatant, collected from MDCK 
infected with the wild-type strain, was due to addition of a ‘virulence related factor’ which is a 
normal product of the wild-type bacteria, not exclusively produced during infection, but which is not 
produced, or not efficiently exported by the efflux mutants. Media conditioned by the growth of 
SL1344 was able to at least partially restore the ability of the acrA, acrB and tolC mutants to adhere 
to and invade INT-407 cells leading to the conclusion that a compound, produced or exported by 
SL1344 but not the mutants, is required for invasion and that exogenous addition of this factor/s can 
restore invasion (Figures 5.10 to 5.13). It is postulated that the same effect was not seen after 
addition of supernatant or after co-infection with SL1344 because the ‘virulence related factor’ or 
factors did not reach a sufficiently high concentration.  
It is likely that the restorative ability of the SL1344 conditioned media is the result of multiple factors. 
This is because pre-boiling the SL1344 conditioned media ablated its ability to complement the 
invasion defect in L109 (tolC::aph) but did not affect the restoration of in the acrA and acrB mutants. 
This suggests that multiple factors, some of which are heat sensitive while some are not, are involved 
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in the restorative ability of SL1344 conditioned media. It is possible that additional factors are 
required to restore the ability of the tolC mutant to invade INT-407 cells as TolC functions with 
various other systems which may contribute to its attenuation. Further work is underway to identify 
the components of the SL1344 conditioned media which are able to restore the ability of the 
mutants to invade INT-407 cells.  
One possibility is that the virulence related factor is a metabolic product or other small soluble 
factor. It has been suggested that TolC of E. coli is involved in the export of such metabolic products 
and that these products of normal cellular metabolism accumulate in TolC mutants as they are not 
exported as efficiently (Imuta et al., 2008; Rosner and Martin, 2009). In addition, it has been 
reported that reduced export of the metabolic product formate was linked to reduced expression of 
SPI-1 and attenuated ability of Salmonella  to invade HEp-2 cells in vitro (Huang et al., 2008). These 
data together suggest that the active factor of the SL1344 conditioned media could be a product of 
normal cellular metabolism, required for invasion, which is not exported in the TolC mutant and 
exogenous addition of which is able to restore the ability to invade INT-407 cells. A comparison of the 
secreted metabolites of the TolC mutant and SL1344 could help identify such a molecule and this 
would greatly enhance our understanding of the role of AcrAB-TolC in virulence and virulence-related 
phenotypes. 
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Appendix 1 Figure 1. The acrA gene with primer locations indicated 
 
 
 
 
gccacatccaggatgtgttgtcgtgtctccagcgcttgttgtttggtttttcgtgccata 
tgtcggtgaatttacaggcgttagatttacatacatttatggatgtatgtaccatagcac 
gacgataatataaacgcagcaatgggtttaaggacctttgaccattgaccaatttgaaat 
cggacactcgaggtttacatATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTC 
TGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGACAAACAGGACCAGCAAGGCG 
GCCAGCAGATGCCAGAAGTTGGGGTTGTCACACTAAAAACGGAACCACTGCAAATCACAA 
CTGAACTTCCGGGTCGTACCGTTGCTTACCGTATCGCCGAAGTTCGCCCGCAGGTAAGCG 
GCATTATCCTGAAGCGTAATTTCGTTGAGGGAAGTGATATCGAAGCGGGAGTCTCTCTCT 
ATCAGATTGATCCTGCGACCTACCAGGCGACTTACGACAGCGCTAAGGGCGATCTGGCAA 
AAGCGCAGGCCGCCGCGAATATCGCTGAACTGACGGTGAAGCGTTATCAAAAGCTGCTGG 
GTACGCAGTACATCAGTAAGCAGGAATACGATCAGGCGCTGGCTGACGCACAACAAGCGA 
CTGCCGCTGTTGTCGCAGCAAAAGCCGCCGTTGAAACCGCACGTATCAACCTGGCGTATA 
CCAAAGTCACCTCGCCGATTAGCGGTCGTATTGGTAAGTCATCCGTAACGGAAGGCGCAC 
TGGTACAGAACGGTCAGGCGTCGGCGCTGGCGACAGTGCAGCAGCTGGACCCTATTTATG 
TCGATGTGACCCAGTCCAGCAATGACTTCCTGCGCCTGAAGCAGGAGCTGGCAAATGGTT 
CGCTGAAACAGGAAAACGGCAAAGCGAAGGTCGACCTGGTGACCAGCGACGGTATCAAAT 
TCCCGCAGTCCGGTACGCTTGAGTTCTCCGACGTGACCGTTGACCAAACCACCGGGTCTA 
TTACTTTGCGCGCCATCTTCCCTAACCCGGATCACACCTTATTGCCAGGAATGTTCGTTC 
GCGCACGTCTGCAGGAAGGGACAAAACCGACGGCATTACTGGTTCCACAACAGGGCGTTA 
CCCGTACTCCACGCGGCGATGCCACGGTGCTGGTGGTTGGCGCTGATAACAAAGTGGAAA 
CCCGCCAAATCGTCGCAAGCCAGGCGATCGGCGATAAGTGGCTGGTGACTGACGGATTGA 
AAGCGGGCGACCGCGTAGTCGTCAGCGGGCTGCAAAAAGTACGTCCTGGCGCACAGGTTA 
AAGTACAGGAAATTACCGCGGATAACAAACAGCAAGCCGCAAGCGGTGATCAACCTGCTC 
AGCCCAGGTCTTAActtaaacaggagccgttaagacatgcctaatttctttatcgatcgc 
cctatatttgcgtgggtgatcgccatcatcatcatgttggcaggggggctcgcgatcctc 
aaattgccggtagcgcaatatccgacgattgcgccaccagcagtgacgatctccgcaacc 
taccctggcgctgatgcgaaaacggtacaggata 
 
 
The acrA gene is shown in capital letters while the upstream and downstream flanking 
regions are shown in lower case. Blue highlighted regions indicate primers 568 and 569 
(Table 2.4) which were used to amplify the construct containing the aph gene for 
inactivation of the gene. Red highlighted regions indicate the upstream and downstream 
check primers 570 and 571 (Table 2.4). Yellow highlighting indicates the start codon of 
acrA while light grey highlighting indicates the start codon of acrB. 
 
213 
 
Appendix 1. Figure 2. The predicted sequence acrA region after insertion of the aph gene 
by homologous recombination 
 
gccacatccaggatgtgttgtcgtgtctccagcgcttgttgtttggtttttcgtgccata 
tgtcggtgaatttacaggcgttagatttacatacatttatggatgtatgtaccatagcac 
gacgataatataaacgcagcaatgggtttaaggacctttgaccattgaccaatttgaaat 
cggacactcgaggtttacatATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTC 
TGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGACAAACAGGACCAGCAAGGCG 
TGTAGGCTGGAGCTGCTTCGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAG 
GAACTTCAAGATCCCCTCACGCTGCCGCAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAA 
GCGGAACACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGCTA 
CTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGG 
GCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCC 
AGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTT 
GCCGCCAAGGATCTGATGGCGCAGGGGATCAAGATCTGATCAAGAGACAGGATGAGGATC 
GTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAG 
GCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCG 
GCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAA 
TGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGC 
AGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCC 
GGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGA 
TGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAA 
ACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCT 
GGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCAT 
GCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGT 
GGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTA 
TCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGA 
CCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCG 
CCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACG 
CCCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTC 
GGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAG 
TTCTTCGCCCACCCCAGCTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTAGAGAATAGG 
AACTTCGGAATAGGAACTAAGGAGGATATTCATATGGACCATGGCTAATTCCCGCTGCAA 
AAAGTACGTCCTGGCGCACAGGTTAAAGTACAGGAAATTACCGCGGATAACAAACAGCAA 
GCCGCAAGCGGTGATCAACCTGCTCAGCCCAGGTCTTAActtaaacaggagccgttaaga 
Catgcctaatttctttatcgatcgccctatatttgcgtgggtgatcgccatcatcatcat 
Gttggcaggggggctcgcgatcctcaaattgccggtagcgcaatatccgacgattgcgcc 
accagcagtgacgatctccgcaacctaccctggcgctgatgcgaaaacggtacaggata 
 
 
The acrA gene is shown in capital letters while the upstream and downstream flanking 
regions are shown in lower case. Blue highlighted regions indicate primers 568 and 569 
(Table 2.4) which were used to amplify the construct containing the aph gene for 
inactivation of the gene. Red highlighted regions indicate the upstream and downstream 
check primers 570 and 571 (Table 2.4). Yellow highlighting indicates the start codon of 
acrA while light grey highlighting indicates the start codon of acrB. The underlined region 
indicates the aph gene and the start and stop codons are indicated in dark grey. Pink 
highlighted regions indicate primers 237 and 239 which are internal to the aph gene. 
214 
 
Appendix 1. Figure 3. Alignment of the expected sequence for the disrupted acrA region with the 
upstream sequencing data for L823 (acrA::aph) 
The inactivation primers are indicated in blue. The yellow highlighting indicates the start codon of 
the acrA gene and the dark grey highlighting indicates the start codon of the aph gene. 
 
 
Expected   TGTCGGTGAATTTACAGGCGTTAGATTTACATACATTTATGGATGTATGTACCATAGCAC  
L823       CGTCGGTGAATTTACAGGCGTTAGATTTACATACATTTATGGATGTATGTACCATAGCAC  
 
Expected   GACGATAATATAAACGCAGCAATGGGTTTAAGGACCTTTGACCATTGACCAATTTGAAAT  
L823       GACGATAATATAAACGCAGCAATGGGTTTAAGGACCTTTGACCATTGACCAATTTGAAAT  
 
Expected   CGGACACTCGAGGTTTACATATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTC  
L823       CGGACACTCGAGGTTTACATATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTC  
                 
Expected   TGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGACAAACAGGACCAGCAAGGCG  
L823       TGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGACAAACAGGACCAGCAAGGCG  
 
Expected   TGTAGGCTGGAGCTGCTTCGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAG  
L823       TGTAGGCTGGAGCTGCTTCGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAG  
 
Expected   GAACTTCAAGATCCCCTCACGCTGCCGCAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAA  
L823       GAACTTCAAGATCCCCTCACGCTGCCGCAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAA  
 
Expected   GCGGAACACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGCTA  
L823       GCGGAACACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGCTA 
                
Expected   CTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGG  
L823       CTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGG  
                 
Expected   GCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCC  
L823       GCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCC  
 
Expected   AGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTT  
L823       AGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTT                  
 
Expected   GCCGCCAAGGATCTGATGGCGCAGGGGATCAAGATCTGATCAAGAGACAGGATGAGGATC  
L823       GCCGCCAAGGATCTGATGGCGCAGGGGATCAAGATCTGATCAAGAGACAGGATGAGGATC  
                 
Expected   GTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAG  
L823       GTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAG  
                 
Expected   GCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCG  
L823       GCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCG 
                 
 
Expected   GCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAA 
L823       GCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGANCGACCTGTCCGGTGCCCTGAA  
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Appendix 1. Figure 4. Alignment of the expected sequence for the disrupted acrA region with the 
downstream sequencing data for L823 (acrA::aph) 
The inactivation primers are indicated in blue. The yellow highlighting indicates the stop codon of 
the acrA gene and the dark grey highlighting indicates the stop codon of the aph gene. 
 
 
                 
Expected   GCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAA 
L823       GCAATGCGGCGN-TGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAA  
 
Expected   CATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTG  
L823       CATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTG  
 
Expected   GACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATG  
L823       GACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATG  
 
Expected   CCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTG  
L823       CCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTG  
 
Expected   GAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTAT  
L823       GAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTAT  
                 
Expected   CAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGAC  
L823       CAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGAC  
                 
Expected   CGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGC  
L823       CGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGC  
 
Expected   CTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGC  
L823       CTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGC  
                 
Expected   CCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCG  
L823       CCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCG  
                 
Expected   GAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGT  
L823       GAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGT  
               
Expected   TCTTCGCCCACCCCAGCTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTAGAGAATAGGA  
L823       TCTTCGCCCACCCCAGCTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTAGAGAATAGGA  
 
Expected   ACTTCGGAATAGGAACTAAGGAGGATATTCATATGGACCATGGCTAATTCCCGCTGCAAA 
L823       ACTTCGGAATAGGAACTAAGGAGGATATTCATATGGACCATGGCTAATTCC-GCTGCAAA  
                 
 
Expected   AAGTACGTCCTGGCGCACAGGTTAAAGTACAGGAAATTACCGCGGATAACAAACAGCAAG  
L823       AAGTACGTCCTGGCGCACAGGTTAAAGTACAGGAAATTACCGCGGATAACAAACAGCAAG  
                 
Expected   CCGCAAGCGGTGATCAACCTGCTCAGCCCAGGTCTTAACTTAAACAGGAGCCGTTAAGAC 
L823       CCGCAAGCGGTGATCAACCTGCTCAGCCCAGGTCTTAACTTAAACAGGAGCCGTTAAGAC  
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Appendix 2. The ability of S. Typhimurium SL1344 and various efflux mutants thereof to 
adhere to and invade mouse macrophages (RAW264.7)  
 
 
 
 
Experiments performed by Sarah Coleman, a third year undergraduate project student. 
Data are displayed as mean of at least three separate experiments performed in triplicate 
+ standard deviation. Values returning a p value of ≤0.05 from a Student’s T-test 
comparing mutants to the SL1344 values are denoted by *. 
* 
* 
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